ADVANCES IN
Applied MicrobioIogy VOLUME 21
CONTRIBUTORS TO THIS VOLUME
L. T. Fan D. J. D. Hockenhull Philip H. Howa...
78 downloads
1372 Views
15MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
ADVANCES IN
Applied MicrobioIogy VOLUME 21
CONTRIBUTORS TO THIS VOLUME
L. T. Fan D. J. D. Hockenhull Philip H. Howard I. C. Kao Keido KO Lloyd E. McDaniel Juan F. Martin Hewitt W. Matthews Tomomasa Misato Prasanta K. Ray Jitendra Saxena
R. H. Shipman E . J. Vandamme
Barbara Fritche Wade Isamu Yamaguchi
ADVANCES IN
Applied Microbiology Edited by D. PERLMAN School of Pharmacy The University of Wisconsin Madison, Wisconsin
VOLUME 21
@
1977
ACADEMIC PRESS, New York San Francisco London A Subsidiary of Harcourt Brace Jovanovich, Publishers
COPYRIGHT 0 1977, BY ACADEMIC PRESS,INC. ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM OR BY ANY MEANS, ELECTRONIC OR MECHANICAL, INCLUDING PHOTOCOPY, RECORDING, OR ANY INFORMATION STORAGE AND RETRIEVAL SYSTEM, WITHOUT PERMISSION IN WRITING FROM THE PUBLISHER.
ACADEMIC PRESS, INC.
111 Fifth Avenue, New York. New York 10003
United Kingdom Edition published by ACADEMIC PRESS, INC. (LONDON) LTD. 24/28 Oval Road. London N W l
LIBRARY OF CONGRESS CATALOG CARD NUMBER:59-13823 ISBN 0-12-002621-X PRINTED IN THE UNITED STATES OF AMERICA
CONTENTS LIST OF CONTRIBUTORS ..............................................
ix
Production of Polyene Macrolide Antibiotics JUAN
F . MARTIN AND
LLOYD
E . MCDANIEL
I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11. Factors Affecting Polyene Macrolide Production ....................... I11. Interaction of Polyene Macrolide Antibiotics with the Producer Cells . . . . . IV . Genetics of Polyene-Producing Streptomyces ..........................
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 14 37 43 47
Use of Antibiotics in Agriculture
TOMOMASA MISATO. KEIDO KO. AND ISAMU YAMAGUCHI I . Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I1. Agricultural Antibiotics and the Pollution Problem . . ...... .... 111. Utilization of Medical Antibiotics as Agricultural Chemicals . . . . . . . . . . . . . . . . . IV . Antibiotics Developed as Agricultural Chemicals ........................... V . Future Prospects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References ...........................................................
53 54 55
60 82 83
Enzymes Involved in p-Lactam Antibiotic Biosynthesis
E . J . VANDAMME I. I1. 111. IV . V.
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Structure of B-Lactam Antibiotics ........................................ Biosynthesis Mechanisms of B-Lactam Antibiotics and Their Enzymes . . . . . . . . Terminal-Stage Enzyme Reactions in a-Lactam Antibiotic Biosynthesis . . . . . . . Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
89 89 92 97 117 119
Information Control in Fermentation Development
D . J . D . HOCKENHULL I . Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I1 . Research and Development Budget ...................................... V
125 133
vi
CONTENTS
111. Project Initiation Request (Research or Development Program) . . . . . . . . . . . . . .
.......................... V. Periodical Report ................... VI. Laboratory and Plant Protocols . . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . VII. The Standard Operating Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . VIII. Direct Experimental Records . . . ...................... M. Miscellaneous In ........... X. Minutes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . XI. Collection and Flow of Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . XII. Making the Best ....................... References . . . . .............................. ..... IV. Formal Program
133 135 138 142 143 146 153 153 134 156 159
Single-Cell Protein Production by Photosynthetic Bacteria
R. H. SHIPMAN,L. T. FAN,AND I. C. KAO I. Introduction . ...................................... 11. Process Consi ............... ................... ...................... 111. Conceptual Design . . . . . . . . . . . . . . . . . . _............. IV. Economic Analysis . . . . . , . , . , . . . . . . . . . . . . . . . References ........................................
161 166 172 176 181
Environmental Transformation of Alkylated and Inorganic Forms of Certain Metals JITENDRA
I. Introduction
SAXENAAND PHILIPH. HOWARD ..................................
185
.................................
186 194 198 205 210 212 215 217 219 220 222
Test Methods for Studying Transformation ..................... Analytical Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Factors Affecting Transformation of Metals . . . . . . . . . . . . . . . . . . . . . . . Biochemical Pathways and Mechanisms for Transformation of Metals . . . . . . . . . General Discussion of Various Test Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Correlation between Laboratory and Field Results and M. Restoration of Metal-Contaminated Areas . . . . . . . . . . . ............ X. Categorization of Elements . . . . . . . . . . . XI. Summary and Conclusions,. , . . . . . . . . . . . . . . . . . . . . . . . References .....................................................
111. IV. V. VI. VII. VIII.
Bacterial Neuraminidase and Altered Immunological Behavior of Treated Mammalian Cells
PRASANTA K. RAY I. Introduction . . . . . . . . . . . . . , . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Receptor-Destroying Enzyme . . . . . . . . . . . . . . . . . . . . . . . . 111. Sialic Acid and Its Relationship to the Antigenicity of the Cell Surface . . . . . . . . 11. Neuraminidase-The
227 228 237
CONTENTS
....... Iv. Increased Immunogenicity of Neuraminidase-Treated Cells . . . . . . V. Regression of Established Solid-Tissue Tumor . . . . . . . . . . . . . . . . . . . . . . . . . . . . , VI. How Do Neuraminidase-Treated Tumor Cells React in the Host to Establish Specific Antitumor Immunity? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . VII. A Probable Mechanism by Which Neuraminidase-Treated Tumor Cells Give Rise to Specific Antitumor Immunity ..................... VIII. Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . .
vii 243 246
249 259 260 261
Pharmacologically Active Compounds from Microbial Origin
HEWITTw. MATTHEWSAND BARBARAFRITCHE WADE I. Introduction . . . . . . . . . . . . . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11. Types of Pharmacological Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111. Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . , . . . . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ,
SUBJECTINDEX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CONTENTS OF PREVIOUS VOLUMES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
269 269 286
287
289 293
This Page Intentionally Left Blank
LIST
OF CONTRIBUTORS
Numbers in parentheses indicate the pages on which the authors’ contributions begin.
L. T. FAN, Department of Chemical Engineering, Kansas State University, Manhattan, Kansas (161)
D. J. D. HOCKENHULL, Glaxo Laboratories Ltd., Ulverston, Cumbria, England (125) PHILIPH. HOWARD,Lije Science Division, Syracuse University Research Corporation, Syracuse, New York (185) I . C. KAo, Biochemical Development Division, Eli Lilly and Company, Indianapolis, Indiana (161)
KEIDO KO, The Institute of Physical and Chemical Research, Wako-shi, Saitama, Japan (53) LLOYD E. MCDANIEL,WaksmunInstitute of Microbiology, Rutgers University, New Brunswick, New Jersey (1) MARTIN,*Departmnt of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts (1)
JUAN F.
HEWITTW. MATTHEWS, Southern School of Pharmucy, Mercer University, Atlanta, Georgia (269) TOMOMASAMISATO,The Institute of Physical and Chemical Research, Wako-shi, Saitamu, Japan (53) PRASANTAK. RAY, Chittaranjan National Cancer Research Centre, Calcutta, India (227) JITENDRA SAXENA, Li$e
Science Division, Syracuse University Research Corporation, Syracuse, New Ym-k (185)
R. H. SHIPMAN, Department of Chemical Engineering, Kansas State University, Manhattan, Kunsas (161) *Present address: Departamento de Microbiologia, Facultad de Ciencias, Universidad de Salamanca, Salamanca, Spain.
ix
X
LIST OF CONTRIBUTORS
E. J. VANDAMME,Laboratory of General and Industrial Microbiology, University of Gent, Gent, Belgium (89) BARBARAFRITCHEWADE, Southern School of Pharmacy, Mercer University, Atlanta, Georgia (269) ISAMUYAMAGUCHI, The lnstitute of Physical and Chemical Research, Wakoshi, Saitama, Japan (53)
Production of Polyene Macrolide Antibiotics JUAN
F. MARTIN^
Department of Nutrition and Food Science, Massachusetts lnstitute of Technology, Cambridge, Massachusetts AND
LLOYDE. MCDANIEL Waksman Institute of Microbiology, Rutgers University, New Brunswick, New Jersey I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. History of the Discovery of New Polyene Macrolide Antibiotics .......................... . . . . . . . . . . . . . . . B. Chemical Characteristics of Polyene Macrolide Antibiotics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Microbial Species That Produce Polyene Macrolide
..................... A. B. C.
D. E. F. G. H. I. J.
K.
.......
ene Macrolide Production . . . . . . . . . . . . Nutritional Studies ................................. Carbohydrates as Carbon Sources . . . . . . . ........ Relation to the Utilization of Short-Chain Fatty Acids and Alcohols . . . . . . . . . . . . . . . Role of Oxaloacetate . . . . Role of Citrate . . . . . . . . . ...... Interrelation with Fatty Acid Biosynthesis . . . . . . . . . . . . . Nitrogen Sources ..................... ...... Regulation by Arcmatic Amino Acids . . . . . . . . . . . . . . . . . . Effect of Inorganic Orthophosphate . . . . . . . . . . . . . . . . . . . Regulation of the Biosynthesis of Polyene Macrolide Antibiotics by Adenine Nucleotides and/or the Energy Charge of the Cell .................................. Effect of Metal Ions. . . . . .
M. Effect of Redox Potential . . . . . . . . . . . 111. Interaction of Polyene Macrolide Antibioti Producer Cells . .
2 2 3 12 14 14 15 17 20 21 22 24 25 27
31 33 34 36 37 37
Production ........................... C. Polyene Macrolide Production in Mixed Culture with
......................................... D. Susceptibility of the Producer Strains to Polyene Macrolide Antibiotics ............................... E. Feedback Regulatory Effect of Polyene Macrolide Antibiotics on Their Own Production. . . . ...
39 40 41 42
'Present address: Departamento de Microbiologia, Facultad de Ciencias, Universidad de Salamanca, Salamanca, Spain. 1
2
JUAN F. MARTIN AND LLOYD E . MCDANIEL
IV. Genetics of Polyene-Producing Streptomyces ............... A. Natural Variants of Soil-Isolated Strains and Mutational Strain Improvement ................................ B. Effect of Actinophages on Antibiotic Production-Lysogenic Conversion of Antibiotic-Producing Strains ......................... References ............................................
43 43
45 47
1. Introduction
A. HISTORYOF THE DISCOVERY OF NEW POLYENE MACROLIDEANTIBIOTICS Since the early 195Os, when the first polyene macrolide antibiotics were reported, more than 90 different members of this group have been described, and more are being discovered each year. Sixteen polyene macrolides were known in 1957 (Dutcher, 1957), 41 in 1960 pining, 1960), 57 in 1963(Oroshnik and Mebane, 1963), and 84 in 1973 (Hamilton-Miller, 1973). Several more, which have been reported recently, are included in Table I. However, one must be cautious in considering many of these antibiotics to be new, since the question of the identity of many remains open. Most polyene macrolides have not been obtained in pure form, and the chemical compositions of most of them are unknown. Thus, tennecitin and pimaricin have been found to be the same; also lagosin and fungichromin. Polifungin A is identical with nystatin (Porowskaet al., 1972; Roszkowskiet al., 1972), but polhngin B is different from the latter. The pentaenes mycoticins A and B are identical, respectively, with the minor and major components of flavofungin and flavomycoin (Bognar et al., 1970; Uri and Bekesi, 1958). It appears also that the aromatic heptaene macrolides candicidin, trichomycin, levorin, and hamycin are in fact mixtures in different proportions of the same components rather than separate entities. It has been suggested that hamycin and trichomycin are identical (Divekar et al., 1966)and that candicidin is identical with trichomycin (Khokhlovaet al., 1963). Pyrolysis gas chromatography of these heptaene macrolides suggests that they are mixtures, with a single identical main component and varying proportions of similar minor components (Burrows and Calam, 1970; Calam, 1974). Countercurrent distribution studies indicated that of the four components of the levorin complex (&, Al, A,, A3), A,, the main component of the complex, is not distinguishable from the main component of candicidin (Bosshardt and Bickel, 1968). Khokhlova et al. (1963) indicated that strains of Streptomyces griseecs which produce candicidin, Streptomyces canescus (the producer of ascosin), and Streptomyces levoris (the producer of levorin) are the same species, but
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
3
that Streptomyces hachijoensis (the producer of trichomycin) is different. A new polyene antibiotic isolated from Streptomyces helvoloviolaceous is identical with component A3 of the levorin complex (Konev et al., 1973).
B. CHEMICAL CHARACTERISTICS OF POLYENE MACROLIDEANTIBIOTICS The polyene macrolides form a subdivision of the macrolide antibiotics containing hydroxylated macrocyclic lactone rings and usually one or more sugars. Biogenetically the macrolides are a homogeneous group, being synthesized from acetate and propionate via the polyketide pathway (Bu’Lock, 1967). The macrolide antibiotics are divided into two subgroups: (a) polyene antifingal antibiotics and (b) nonpolyene antibacterial antibiotics. The polyene subgroup has a system of conjugated double bonds, or chromophore, in the macrolactone ring. This results in an amphipathic molecule containing both a rigid planar lipophilic portion and a flexible hydrophilic polyhydroxylated region. The chromophore accounts for some of the characteristicphysical and chemical properties of the polyenes (strong light absorption, photolability, and poor solubility in water) and appears to be responsible for the differences in the biological modes of action of the polyene and the nonpolyene macrolide subgroups. The chromophorc gives a typical multipeak ultraviolet-visible light absorption spectrum which permits a rapid characterization and division of the polyene macrolides into dienes, trienes, tetraenes, pentaenes, hexaenes, and heptaenes according to the number of conjugated double bonds in the chromophore. A classification of the existing polyenes is given in Table I. The polyene macrolides have lactone rings of 26-38 atoms, which are much larger than those of the nonpolyene macrolides (e.g., a 14-membered lactone in erythromycin). The aminosugars and aromatic moieties found in polyene macrolide antibiotics attached to the macrolide rings are shown in Fig. 1. Recently, a new class of nonpolyene antifungal macrolides, the axenomycins, with large 34-member lactone rings has been reported. This group appears to be closely related in structure and biological activity to the polyene macrolides in spite of their nonpolyene character (Bianchi et al., 1974). Although purification of polyene macrolide antibiotics is difficult because of their low solubility and instability to heat and light, considerable progress has been achieved in recent years in the determination of the complex chemical structure of these compounds by utilizing sensitive analytical methods, such as electron impact and field desorption mass spectrometry (Rinehart et al., 1974), proton magnetic resonance, and X-ray structure analysis of single crystals for absolute configuration determination
P
TABLE I POLYENE MACROLIDE ANTIBIOTICS (CODENUMBER 22) Berdy's classification" Code number Name (alternative names) ~~~~~~~~~~~
Amino sugar moiety
Producer strain ~
~
Nitrogen
Ionic character
~~~
221 TFUENES (A maxima 262, 272, 283 nm) 2211 Trienin type Streptomyces sp. Mycotrienin Streptomyces sp. Trienine Antibiotic MM-8 Sheptomyces sp. Triene Chainia minutisclerotina 2212 Other trienes Resistaphyllin S. antibioticus 222 TETRAENES (A maxima 291, 304, 308 f 2 nm) 2221 Pimuricin type S . tumemomucerans var. Aeromycin B (P-42-E) griseoarenicolor S . lucensis Etruscomycin (lucensomycin) (1163 FI) S . natalensis, Pimaricin (tennecetin) S . chattanoogensis, S . gilveosporus S . noursei var. Tetramycin jenensis Streptomyces sp. Tetrin A, B Antibiotic PA-I66 Sheptomyces sp.
-
NDb ND None ND
Yes Yes Yes ND
ND
Yes
-
Mycosaminec
Yes
-
Mycosamine
Yes
Amphoteric
M ycosamine
Yes
Amphoteric
Mycosamine
Yes
-
Mycosamine Mycosamine
Yes Yes
Amphoteric Amphoteric
Neutral
-
Aromatic moiety
2222 Rimocidin type Akitamycin S. akitaensis, (toyamycin) S. toyamaensis S. albus sterilis Albotetraen Rimocidin S. rimosus (PA-86) Antibiotic RP-9971 S. gascariensis 2223 Nystatin type Amphotericin A S. nodosus Nystatin A,, A*, A3 S. noursei, S. albulus (fungicidin) (polifungin) S. plumbeus Phmbomycin A Plumbomycin B S . plumbeus 2224 Other less-known tetraenes Antimycoin A S. aureus Chromin S. chromogenes Endomycin A S. endus (helixin A) Flavoviridomycin S. flavoviridus var. fungicidicus, S. hygroscopicus var. enhygrus Ornamycin (17731) S. erumpens, S. ornatus Protocidin Streptomyces sp. NO. 964-A Sistomycosin s. viridosporus Tetraenin A, B Chainia cinnamonea Tetramedyn S. mediocidicus Tetramycoin A, B Chainia grisea, Chainia grisea var. fusca
ND
Yes
Amphoteric
ND M ycosamine
Yes Yes
Basic
ND
Yes
Amphoteric
Mycosamine Mycosamine
Yes Yes
Amphoteric Amphoteric
ND ND
Yes Yes
ND ND ND
-
Yes Yes
Acid Amphoteric
ND
Yes
ND
Yes
Amphoteric
ND ND ND ND
Yes
-
Yes
-
-
(Continued)
VI
TABLE I (Continued) Berdy's classification" Code number Name (alternative names) Unamycin A Antibiotic A-5283 Antibiotic AC2-435 Antibiotic J4-B
Producer strain
S. fungicidicus Streptomyces sp. A5283 Streptomyces sp. ACz-435 Streptomyces sp. (S.fungicidicus) Streptomyces sp. Streptomyces sp. 0777
Antibiotic RP-7071 Antibiotic LIA 0777 223 PENTAENES 2231 Methylpentaenes (aldopentaenes) (A maxima 327, 340, 357 2 2nm) Aurenin S. aureorectus Cabicidin s. gougeroti Chainin Chainia sp. 3047 S. fdipensis Filipin complex (durhamycin) S . cinnamoneus var. Fungichromin cinnamoneus, (moldcidin B) (pentamycin) S. roseoluteus, (Gkxo-A246) S. cellulosae, (Lagosin) S. pentaticus Fungichromatin S. cellulosae Pentaneicin Streptooerticillium sp. S. sanguineus Pentaene Neopentaene Streptomyces sp. S. rubrochlm'nus Rubrochlorin Xantholicin B S. rantholiticus Antibiotic HA-106 Streptooerticillium cinnamoneum var. sparsum
cn
Amino sugar moiety
Nitrogen
Ionic character
Mycosamine ND ND ND
Yes Yes No No
Acid Amphoteric -
ND Mycosamine
Yes Yes
Basic Amphoteric
None None None None
No No No No
Neutral Neutral Neutrd
None
No
Neutrd
None None None None None None None
No No No No No No No
-
Aromatic moiety
-
Acidic
-
-
-
?
r
s0 P
Antibiotic HA-135
Streptoverticillium sporiferum Antibiotic HA-145 Streptooerticillium cinnamneum var. albospwum Antibiotic HA-176 Streptoverticillium cinnamoneum var. lanosum 2232 “Normal” pentaenes (amphoteric pentuenes with amino sugar)(h maxima 317, 331, 350 ? 2 nm) Aliomycin S. acidomyceticus Distamycin C S . distallicus Eurocidin A S . eurocidicus, S . albireticuli Eurocidin B S. albireticuli Fumanomycin S . laoendobrunneus Moldcidin A S . griseofuscus, Streptomyces sp. S. sp. J-4(S. fungicidicus) Onomycin I Pentafungin S. antimycoticus Pentaene G-8 S . anandensis Quinquamycin S . laoendulae E-20-27 Streptomyces sp. Antibiotic A-228 Antibiotic PA-153 Streptomyces sp. Sh-eptomyces sp. 17-41 Antibiotic 17-41 B Antibiotic 0371 Streptovetticillium jenensis krissii 2233 “Normal” pentaenes. (Capacidin type) Capacidin S. noursei (variant) 2234 Gangtokumycin type Gangtokumycin S . gangtokensis ( S . hygroscopicus)
None
No
None
No
None
No
ND ND M ycosamine
-
-
Yes
Amphoteric
Mycosamine ND Mycosamine
Yes Yes Yes
Amphoteric
ND ND ND ND ND ND ND
Yes Yes
Acidic Amphoteric
-
-
Yes Yes
Neutral Amphoteric
Yes
-
-
Yes
-
Yes
-
Yes
sl
Acidic
-
Basic
(Continued)
4
TABLE I (Continued) 00
Berdy's classification" Code number Name (alternative names)
Producer strain
Genimycin Actinosporangium sp. 2235 Carbonyl pentaenes ( h maxima 364 nm; broad peak) Flavohngin S. ruber, (mycoticin A) S. jlavofungini Flavomycoin S. roseoflavus var. jenensis Mycoticin B S. jlaoofungini Surgomycin S . surgutus 224 HEXAENES (A maxima 340, 358, 380 ? 2 nm) 2241 Probably macrocyclic heraenes S . oiridojlavus var. 18A2 Candihexin A, B S. viridoflavus var. 18A2 Candihexin E, F Cryptocidin Streptomyces sp. 963, S. bulgaricum Hexin Streptomyces sp. S. endus, Endomycin B (helixin B) S. hygroscopicus var. enhygrus Flavacid s. jlavus Mediocidin S . mediocidicus Tetrahexin Streptomyces sp. (tetraesin) ATCC 14972 2242 Fradicin type (unknown structures) Fradicin S . fiadiae Mycelin S . roseojlavus, S . diastatochromogenes, S. fiadiae
Amino sugar moiety
Nitrogen
Ionic character
-
Yes
-
None
No
Neutral
None
No
-
None ND
No
Neutral
Aromatic moiety
* W
Mycosamine None ND
Yes Yes Yes
ND ND
-
None ND ND
Yes Yes Yes
Acid Amphoteric Amphoteric
ND ND
Yes No
Basic
Acid
P
6
B
-
-
Mycelin IMO Antibiotic A-1404
S. diastatochromogenes S. fi-adiae A-1404, S. diastatochromogenes 207
2243 Carbonyl hexaenes (A maxima 385 nm; broad peak) S. uiridogsiseus Dermostatin (viridofulvin) 225 HEF'TAENES 2251 Aromatic heptaenes 22511 Containing p-aminoacetophenone S . paucisporogenes Antifungin 4915 Ascosin S. canescus Ayfactin, S. aureofaciens, S. uiridofaciens (AYF), (AE-56), (Aureofacin) S. cinnamoneus Aureofungin var. terricola Azacolutin S. cinnamoneus (F-17-C) var. azacoluta S. griseus Candicidin (G-252) (PA-150) S. griseus H-5592 Eurotin A S. jujuy ATCC 13670 Gerobriecin Hamycin S. primprina S. longisporolavendulae Heptafungin A S . leuoris Levorin Ao, A,, Az, A,, B (26/1)
ND ND
Yes
None
No
Neutral
ND Mycosamine Mycosamine
Yes Yes Yes
ND Amphoteric Acid
ND p-Aminoacetophenone p-Aminoacetophenone
Mycosamine
Yes
Amphoteric
p-Aminoacetophenone
ND
Yes
Amphoteric
p-Aminoacetophenone
Mycosamine
Yes
Amphoteric
p-Aminoacetophenone
ND ND Mycosamine Mycosamine Mycosamine
Yes Yes Yes Yes Yes
Basic ND Amphoteric Amphoteric Amphoteric
p -Aminoacetophenone ND p-Aminoacetophenone p-Aminoacetophenone p-Aminoacetophenone (Continued)
TABLE I (Continued) Berdy's classification" Code number Name (alternative names) Trichomycin A, B
Producer strain
S. hachijoensis, S . abikoends S . surinam Actinoplanes sp.
DJ-400Bz Sch 16656 22512 Containing N-mthylp-aminoacetop henone Candimycin S . echimensis DJ-400 B, Perim ycin (NC-968) (Fungimycin) (Aminomycin) 2252 Nonaromatic heptaenes Amphotericin B Candidin (Candidoin) (Candidinin) Mycoheptin (2814 H)
Amino sugar moiety
Nitrogen
Ionic character
Aromatic moiety
Mycosamine
Yes
Amphoteric
p- Aminoacetophenone
Mycosamine ND
Yes Yes
Amphoteric
p-Aminoacetophenone p-Aminoacetophenone
ND
.h
5 IJ
e %CI
ND
Yes
ND
N-Methyl?aminoacetophenone
S surinam
Mycosamine
Yes
Amphoteric
N-Methyl?aminoacetophenone
3
S. coelicolor var. aminophilus
Perosamined
Yes
Basic
N-Methyl?-
r
.
aminoacetophenone
r
ei z
S . nodosus S . oiridofious
Mycosamine Mycosamine
Yes Yes
Amphoteric Amphoteric
None None
Streptoowticillium mycoheptinicum, S . netropsis
Mycosamine
Yes
Amphoteric
None
S. chartreusis var. tbilisus Antibiotic X-63 Streptomyces sp. Antibiotic A-3 Streptomyces sp. 2253 Noncharacterized heptaenes Grubilin Streptomyces sp. BA-27 Heptamycin Streptomyces sp. Hepcin Actinosporangium griseoroseum Heptaene 757 Streptomyces sp. 757 Monicamycin Streptoverticillum annamoneum var. monicae Neoheptaene Streptomyces sp. S . noursei Nursimycin Takamycin S . takaensis, S . reticuli C-11 Antibiotic 26/1 S. globisporus Antibiotic 2814-H Streptomyces sp. IA-2814 Antibiotic 1645-P, Streptomyces sp. 1645-IAUR LIA 0331 S. chromogenes LIA 0179 Streptomyces sp. Tbilimycin
Mycosamine
Yes
ND
None
ND ND
Yes Yes
ND ND
None None
ND ND ND
ND ND ND
ND Acid ND
ND ND ND
ND ND
ND ND
Acid Acid
ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND Yes Yes
Amphoteric Amphoteric ND
ND ND ND
ND ND
ND ND
ND ND
ND ND
“Berdy (1972). bNo data available. c3-Amino-3, 6-dideoxy-~-mannose. d4-Amino-4,6dideoxy-~-mannose. c c
12
JUAN F. MARTIN A N D LLOYD E . MCDANIEL
MOST POLYENES
OH
PERlMYClN (FUNGIMYCIN)
,N
CH, - H
o c 0 - c H 3
~
a
c
0
-
c
.
P-AMINOACETOPHENONE
ASCOSIN AUREOFUNGIN
AYFACTIN AZACOLUTIN CANDlCl DI N DJ -400.82 HAMYCIN HEPTAMYCIN LEVORIN TRICHOMYCIN SCH 16656 . P-1-METHYLACETOWNONE PERlMYClN CANDIMKIN
DJ- 40081
FIG. 1. Aminosugars and aromatic moieties existing in polyene macrolide antibiotics.
(Mechlinski et al., 1970). For detailed information on the chemistry of polyene macrolides, the reader is referred to the reviews by Oroshnik and Mebane (1963), Dutcher (1968), Hamilton-Miller (1973), and Mechlinski (1973).Only afew polyene macrolides have been fully characterized (Fig. 2). C. MICROBIAL SPECIESTHATPRODUCE POLYENE MACROLIDEANTIBIOTICS The biosynthesis of polyene macrolide antibiotics is a widespread property among the actinomycetes. From 34 to 88% of the Streptomyces species isolated from soil were found to produce polyene macrolides (Ball et al., 1957; Pledger and Lechevalier, 1956). Polyene macrolides are produced mainly by members of the genera Streptomyces, Streptoverticillium, Actinospwangium, and Chainia. In the Russian literature, species belonging to the genus Streptomyces are usually referred to as Actinomyces (e.g., Actinomyces levoris). In order to have a homogeneous description of the producing species, the name Streptomyces has been adopted here.
13
PRODUCTION OF WLYENE MACROLIDE ANTIBIOTICS
PENTAENES
TETRAENES OH
FILIPIN( (R=H)
R
no
no OH
FUNGICHROMIN (LAGOSIN. PENTAMVCIN HOLOClOlN El (R=OHI
MI OH on on OH OH
PlHARlClN(TENNECETIN)(R=CH3) ETRUSCONVCINiLUCENKlN. A R E N M N (R.Cl+i-CH$4rCk$)
MVCOTICIN A (R-H) (FLAVOFUNGIN) HVCOTlClN B (R=CH3)
no
EUROClDlN A (R=CHj) EUROClDlN E ( R = H )
RlHOClMN
TURIN A TETRIN E
(RA)
CHAININ
(R=OHI
HEPTAENES
HEX AENES
-a* AMPHOTERlClN
B
C A NDlOlN HVCOHEPTIN (FHVDRO, 5-DEHVDROCANMMN
FIG. 2. Polyene macrolides of known structure.
14
JUAN F. MARTIN AND LLOYD E . MCDANIEL
Recently a new polyene macrolide (Sch 16656)has been described from a species of the aquatic genus Actinoplanes (Wagman et al., 1975). Proticin, a phosphorus-containing triene antibiotic produced by Bacillus lichenijbrmis var. mesentericus (Vertesy, 1972), does not seem to be a typical polyene macrolide since it has gram-negative activity and no antifungal activity. By contrast, rhizopchin, a polyene antibiotic produced by Rhizopus chinensis, has antifungal activity (Arima and Odahara, 1971). A method of screening for new producers of polyene macrolide antibiotics based on the inactivation of these products by sterols was described recently (Bibikova et al., 1975). By testing for the inhibition of yeasts by Streptomyces isolates, in unsupplemented media and in media supplemented with sterols, it is possible to select those that produce polyene macrolides (active against yeast only in the absence of sterol) and those that produce nonpolyene antifungal agents (active both in the presence and in the absence of sterol).
II. Factors Affecting Polyene Macrolide Production The information available on the production of polyene macrolide antibiotics prior to 1967 was reviewed by Perlman (1967). The objective of this review is to summarize the significant new developments in this field. It is a well-established fact that in most species control mechanisms have evolved that allow only necessary enzymes to be made in the correct amounts. Thus, a normal cell is strictly regulated and does not produce waste metabolites in any environment. Recently, evidence has been found that microorganisms that overproduce metabolites of industrial importance are in fact subnormally regulated (Demain, 1972). In the last few years, considerable understanding of the microbial biosynthesis of secondary metabolites (idiolites) belonging to the macrolide class has been achieved. We are now in a better position than before to understand how nutritional and environmental factors affect the biosynthesis of polyene macrolide antibiotics.
A. NUTRITIONAL STUDIES Most nutritional studies of polyene-producing Streptomyces have been done with batch cultures, usually in shake flasks, but with occasional scaling up to pilot-plant or large-scale fermentors of those polyenes that are produced industrially (see Table 11). In most studies several nutritional factors or physical parameters are studied, singly or in combination, and the combinations giving the highest yields are selected for further use. McDaniel et al. (1976) used factorial and central composite experimental designs with analysis and response surface plotting by computer for optimizing nutrient combinations for polyene macrolide production.
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
15
TABLE I1 POLYENEMACROLIDE ANTIBIOTICS THAT ARE PRODUCED COMMERCIALLY Name
Type
Amphotericin B Candicidin Hamycin Levorin M ycoheptin Nystatin Pimaricin Trichomycin
Heptaene Aromatic heptaene Aromatic heptaene Aromatic heptaene Heptaene Tetraene Tetraene Aromatic heptaene
Empirical medium development studies have not contributed materially to an understanding of regulation and control of the metabolism of the producing strains. In batch cultures, any factors affecting primary metabolism (growth-related biosynthetic processes) of the producing cell are also likely to affect the biosynthesis of antibiotics. The effects of phosphate and divalent cations, for example, could not be attributed to their action on regulation of polyene macrolide synthesis or to unspecific roles at the transcriptional or translational levels. To avoid such uncertainty, a phosphate-limited washed mycelial system has been introduced (Martin and McDaniel, 1976), which has the advantage that it selectively eliminates the effect of growth. Results obtained by both growing and suspension cell systems will be reviewed. A significant core of evidence suggests that since polyene macrolide antibiotics are synthesized via the polyketide pathway, there is a close connection between antibiotic production, cell carbohydrate metabolism, and fatty acid synthesis. B. CARBOHYDRATES AS CARBON SOURCES Most polyene antibiotic fermentations have been carried out using glucose as carbon source. Studies in our laboratory (Ethiraj, 1969)have established that glucose is the carbon source of choice for the production of candicidin. Concentrations of glucose as high as 7% (Brewer and Frazier, 1962)to 9.5% (Liu et al., 1975)have been routinely used. However, in pilot fermentations of candidin it was observed that high initial concentrations of glucose retarded growth and resulted in abnormal fermentation patterns. Slow-feeding of glucose, initially described in the penicillin fermentation (Soltero and Johnson, 1954; Pirt, 1971) to bypass the negative effect of high glucose concentrations, resulted in increased synthesis of the polyenes candidin and candihexin (Martin and McDaniel, 1974). The same increase was obtained
16
JUAN F. MARTIN A N D LLOYD E. MCDANIEL
when the glucose level was maintained at 5 mg/ml or 15 mg/ml. There was a higher respiration rate during the antibiotic production phase (idiophase) when glucose was slow-fed with a very high proportion of the polyene remaining attached to the producing cell. Maximal growth rates and final cell mass accumulations were lower in slow-fed fermentations, but glucose utilization rates were higher than in control fermentations. These results suggest that there is a channeling of substrate to polyene formation under slowfeeding of glucose (Martin and McDaniel, 1974). A similar approach, namely carbohydrate dosing in relation to the physiological state of the producing organism, was proposed earlier (Hosler and Johnson, 1953). Proper choice of carbohydrate feeding at various ages of the producing organism makes it possible to increase the rate of nystatin production severalfold (Tereshin, 1976). This effect is due to an increase in the specific activity of the mycelium. Intermittent addition of glucose in the amphotericin fermentation results in a slight increase in the titer of amphotericin B (Brewer and Frazier, 1962). The addition of sugar during the fermentation has also been used in the production of the heptaene DJ-400 (Siewert and Kieslich, 1971). The higher antibiotic synthesis under slow-feeding of glucose suggests the regulation of the polyene macrolide synthases by the metabolites of rapid glucose utilization (effectors),which is bypassed when glucose is fed slowly. In this context it is interesting to note that several enzymes involved in the biosynthesis of fatty acids which are biosynthetically analogous to macrolides are subject to catabolite repression in Escherichia coli (Overath and Raufuss, 1967; Weeks et al., 1969). Catabolite regulation as defined by Magasanik (1961) appears to occur in the biosynthesis of the antibiotics penicillin (Johnson, 1952), actinomycin (Gallo and Katz, 1972), streptomycin (Demain and Inamine, 1970; Inamine et al., 1969), siomycin (Kimura, 1967), indolmycin (Hurley and Bialek, 1974), and bacitracin (Haavik, 1974). Both catabolite repression of antibiotic synthase formation and catabolite inhibition of the preformed enzyme occur in the actinomycin and streptomycin fermentations, but only enzyme inhibition appears to be involved in the control of siomycin formation. The inhibitory effect of glucose on bacitracin synthesis does not appear to be related to catabolite regulation, but rather is due to acid production and lowered pH. The effectors involved in catabolite regulation of antibiotic biosynthesis have not been identified. However, there are significant differences between catabolite regulation of the biosynthesis of these antibiotics, and the effect of glucose on polyene macrolide synthesis. Actinomycin formation occurred only after glucose was exhausted from the culture medium, and repeated additions of glucose resulted in a transient inhibition of phenoxazinone synthase and actinomycin production, whereas polyene macrolide synthesis requires glucose in the medium. Candicidin production
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
17
stops after glucose exhaustion. Glucose exhaustion is followed by characteristic autolytic changes: oxygen uptake decreases sharply, candicidin synthesis stops, and the antibiotic is released. The pH of the culture and the dissolved oxygen tension of the broth increase, and both dry weight and DNA experience large decreases (Martin and McDaniel, 1975a) (Fig. 3). Similar marked changes were also observed in the nystatin fermentation upon glucose exhaustion (Lopatnevet al., 1973). The evidence existing on catabolite regulation of polyene macrolide biosynthesis by glucose is, therefore, obscured by the fact that glucose is required for synthesis of the product. Early nutritional studies (Acker and Lechevalier, 1954), confirmed recently by Abou-Zeid (1973) and Tereshin (1976), indicated that glucose and mannose support identical growth and candicidin production in a synthetic medium. Less candicidin was produced when galactose, fiuctose, arabinose, or several polysaccharides were used. The disaccharides maltose, sucrose, and lactose supported small candicidin yields. Martin and McDaniel (1976), using a phosphate-limited resting cell system in a defined medium, obtained similar results. Lactose did not support candicidin synthesis under their conditions, but some antibiotic was produced with sucrose. Similarly, disaccharides were poor carbon sources for growth and mycoheptin production by Streptoverticillium mycoheptinicum (Tereshin, 1976). In the amphotericin fermentation glucose was substituted for by British gum (a dextrin) because it gives large amounts of amphotericin B relative to amphotericin A (Brewer and Frazier, 1962). Starch and glucose proved to be the best carbon sources for mycoheptin production. Specific antibiotic production was lower using starch as a single carbohydrate source, but biomass accumulation was greater with starch than with glucose (Tereshin, 1976).
C. RELATIONTO THE UTILIZATIONOF SHORT-CHAIN FATTYACIDS AND ALCOHOLS Acetate and propionate, although they are the immediate precursors for formation of polyene macrolide antibiotics, do not by themselves support antibiotic synthesis. The same is true of malic, lactic, succinic, and citric acids (Acker and Lechevalier, 1954; Abou-Zeid, 1973; Tereshin, 1976). The inability of acetate, propionate, and malonate to substitute for glucose as exogenous precursors of candicidin has been corroborated using a resting cell system (Martin and McDaniel, 1976). However, supplementation of a glucose basal medium with acetate, propionate, malate, or lactate produces a significant stimulation of candicidin synthesis in batch cultures (Acker and Lechevalier, 1954; Martin and McDaniel, 1976). Addition of acetate also stimulates fungimycin biosynthesis (Mohanet al., 1963). Radioactive acetate and propionate are effectively incorporated into the polyene macrolides nys-
18
JUAN F. MARTIN AND LLOYD E. MCDANIEL
FIG.3. Pattern of fermentation parameters in candicidin batch fermentations: (A) dry weight (A), cell DNA (O), residual glucose (M);(B) total candicidin (A), mycelium-associatedcandicidin (O), extracellular candicidin (0); (C) pH (---), dissolved oxygen tension (---), and oxygen uptake rate (-). From Martin and McDaniel (197.5). Reprinted with permission of John Wiley and Sons, Inc.
PRODUCTION OF FOLYENE MACROLIDE ANTIBIOTICS
19
tatin (Birchet al., l W ) , lucensomycin (Manwaringet al., 1969), amphotericin B (Perlman and Semar, 1965; Linke et al., 1974), candicidin (Liu et al., 1972a), and levorin (Belousova et al., 1971). Malonate and methyl malonate are also effectively incorporated into candicidin 0. F. Martin, unpublished). The inability of acetate, propionate, and malonate to substitute for glucose is explained by the bct that not only does glucose provide acetate and propionate, but through the pentose phosphate cycle it is also involved in the biosynthesis of the aromatic moiety (p-aminoacetophenone) and also provides NADPH for the successive reductive steps of the highly oxidized polyketide chain. Lower alcohols (methanol, ethanol, propanol) have been reported to stimulate the production of polyene macrolide antibiotics (Tereshin, 1976). In the case of candicidin, n-propanol, but not isopropanol, ethanol, or butanol, is effective (Martin and McDaniel, 1976). An interesting approach for the understanding of the intermediary metabolism of the producing strain has been used by Soviet investigators. They compared the formation and utilization of short organic acids in highproducing industrial strains and in low or nonproducers, and they studied the enzymes involved in the condensation of acetate and propionate in both types of strains. Toropova et al. (1972) observed that a strain which produces large amounts of polifungin (nystatin) excreted during the growth phase three to four times larger amounts of volatile organic acid (formic, acetic, and butyric) than did nonproducing strains. The acids were subsequently utilized during the antibiotic production phase. Similarly, accumulation of keto acids (acetoacetic and a-ketoglutaric) followed by their utilization, occurred in high-producing strains. There was no significant increase in the total amounts of keto acids in the culture liquids of the inactive strains. Pyruvic acid followed a similar accumulation and utilization pattern, although the differences between producing and nonproducing strains were smaller. Succinic acid was utilized during polifungin production while citric acid accumulated in the medium. Rafalski and Raczynska-Bojanowska(1972) found that intensive synthesis of polifungin is associated with a rapid decrease in the concentration of %carbon acids (pyruvic and lactic) and an increase of 4-carbon acids (oxaloacetic and malic). It appears that C3 acids must play a role in the biosynthesis of polyene antibiotics. Carboxylation of acetate and propionate has been effectively correlated with polyene macrolide biosynthesis (Roszkowskiet al., 1972). The total pool of acyl-CoA in a highly productive strain of Streptomyces noursei var. polijkngini was 4- to 5-fold greater than in a low-producing strain in cells grown either on carbohydrates or lipids (Raczynska-Bojanowska, 1974). Mutants that produce high yields of polifungin have acetyl-CoA and propionyl-CoA carboxylase activities double those of a nonproducer strain. A
20
JUAN F. MARTIN AND LLOYD E . MCDANIEL
correlation also exists between the carboxylase activity toward both acyl-CoA derivatives and antibiotic production with several low-producing strains. The acetyl-CoA and propionyl-CoA carboxylase activities in the wild-type strain reached a maximum at the onset of antibiotic production and decreased about 3-fold during the idiophase.
D. ROLE OF OXALOACETATE Further insight into the role of the C3 acids in polyene biosynthesis was gained by the work of Rafalski and Raczynska-Bojanowska (1972, 1973). In Streptomyces noursei, in addition to nonspecific ATP and magnesiumdependent acetyl-CoA carboxylase (acetyl-CoA:carbon dioxide ligase, EC 6.4.1.2) utilizing carbon dioxide for carboxylation, there is also a carboxyltransferase (methylmdonyl-CoA:pyruvate carboxyltransferase, EC 2.1.3.l), which uses oxaloacetate as a carboxyl group donor. Carboxylating Systems of S . noursei
+
+
+
+
+
Acetyl-CoA ATP C 0 2 H,O = malonyl-CoA ADP phosphate [acetyl-CoA carboxylase (acetyl-CoA ligase) EC 6.4.1.21
+
(1)
+
Propionyl-CoA oxaloacetate = methylmalonyl-CoA pyruvate (2) [carboxyltransferase (methy1malonybCoA:pyruvatecarboxyltransferase,) E C 2.1.3.1]
+
Phosphoenolpyruvate COz = oxaloacetate (phosphoenolpyruvate carboxylase, EC 4.1.1.31)
(3)
The second system is about 100 times more active than the first. AcetylCoA carboxylase and carboxyltransferase of S. noursei are both nonspecific and catalyze with practically equal efficiency carboxylation of acetyl-CoA and propionyl-CoA. Both the carboxylating and transcarboxylating activities are higher in the high-producing mutants. These high activities are associated in high-producing mutants with an equally high activity of the anaplerotic enzyme phosphoenolpyruvate carboxylase, which supplies oxaloacetate. The oxaloacetate pool is thus replenished by carboxylation of phosphoenolpyruvate, which in turn is synthesized from pyruvate and ATP (Fig. 4). These authors propose an active role of oxaloacetate in the biosynthesis of polyene antibiotics, the level of oxaloacetate being the limiting factor. In a series of UV mutants, the oxaloacetate pools were larger in high-producing strains in parallel with higher activities of phosphoenolpyruvate carboxylase and lower activities of malate dehydrogenase and thioesterase as compared to lowproducing strains. In summary, there is a positive correlation between formation of polyene macrolide antibiotics and the activities of the three carboxylating systems, while malate dehydrogenase (which decreases the pool of oxaloacetate) and
PRODUCTION OF FQLYENE MACROLIDE ANTIBIOTICS
21
Glucose
I
Glucosesphosphate Fructose
Erphosphate r.
Fructose I,6diphosphate o i ~ r o x y a c e t m i i 3phos~hafe ~ ~ e
/
1,3-Diphosphoolycemte
1
3Phosphoglycemte
t
2-Phosphoglycerate
i
cx q::;:;i Phosphoenoipyuvate
Oxaloacetate
Ppuvate
ACETYL-CoA U A L o N Y L - c o A ( 2, METHYLMALONYL-CoA PROPIONYL -Co A
w f
cot
FIG.4. Oxaloacetate cycle in polyene macrolide biosynthesis. (1) Acetyl-CoA and propionyl-CoA carboxylases; (2) transcarboxykse;(3) phosphoenolpyruvate carboxylase.
thioesterase (which deactivates acyl-CoA) are negatively correlated (Raczynska-Bojanowska, 1974).
E. ROLE OF CITRATE The effect of citrate on polyene antibiotic biosynthesis deserves special consideration because of the well established regulatory role of citrate on the acetyl-CoA carboxylase of different organisms (Volpe and Vagelos, 1973). Acetyl-CoA carboxylase is considered to be the rate-limiting enzyme in fatty acid synthesis (Ganguly, 1960; Vagelos et al., 1963). Citrate activation of acetyl-CoA carboxylase in mammals is accompanied by polymerization of inactive protomers to active polymeric filaments and is clearly associated with a conformational change of the enzyme. The biotinyl prosthetic group of the carboxylase has been considered to be the locus of the citrate-induced conformational changes. In contrast, there are conflicting reports about activation by citrate of microbial acetyl-CoA carboxylases. Activation occurs in cell-free extracts of Saccharornyces cerevisiae (Rasmussen and Klein, 1968) but not with purified acetyl-CoA carboxylase ofE. coli or S. cerevisiue (Matsuhashi et al., 1964; Alberts and Vagelos, 1968). In the biosynthesis of erythromycin, a nonpolyene macrolide produced by S. erythreus, the activity of propionyl-CoA carboxylase was increased in vivo
22
JUAN F. MARTIN AND LLOYD E . MCDANIEL
by citrate when the effectorwas added to the mycelium, but not when added to sonicates of S. erythreus. The increase in enzymic activity by citrate was abolished by actinomycin added simultaneously. It was concluded that citrate affects directly or indirectly the biosynthesis of propionyl-CoA carboxylase rather than its activity (Raczynska-Bojanowskaet d.,1970). The possible stimulation of biosynthesis of polyene antibiotics by citrate has not been studied in detail. Attempts to stimulate candicidin production by resting cells of S. griseus by the addition of citrate were unsuccessful (J. F. Martin and L. E. McDaniel, unpublished). Similarly, citric acid proved to be a very poor substrate for levorin production. However, when citrate was added at 24 or 48 hours after inoculation (at 5-9 mg/ml) to soybean or cornmeal cultures, there resulted a 30-40% increase in levorin production. Addition at the time of inoculation did not increase antibiotic production. Because of the possible industrial utility of this regulator phenomenon, the “citrate effect” deserves further study.
F. INTERRELATION WITH FATTY ACID BIOSYNTHESIS It had been speculated that biosynthesis of large lactone macrolides (up to
38 carbon atoms in the ring) takes place by condensation of two long-chain acyl-CoA derivatives or by the stepwise addition of malonyl-CoA units to a preformed fatty acyl-CoA starter unit. Evidence summarized below indicates that these hypotheses are incorrect and that macrolide synthases and fatty acid synthases are independent enzyme complexes: (a) Studies on the biosynthesis of the polyketide-derived 6-methylsalicylic acid (Light and Hager, 1968; Dimroth et al., 1970) have demonstrated that the polyketide synthase involved is a multienzyme complex similar to, but different from, the fatty acid synthase. (b) With Streptomyces erythreus which synthesizes the nonpolyene erythromycin by condensation of methylmalonyl-CoA units (Corcoran and Chick, 1966), no long-chain branched fatty acids occurred that could be direct precursors for the biosynthesis of the macrolide (Hofheinz and Grisebach, 1965). Martin and McDaniel (1975~)found that exogenous fatty acids were unable to support candicidin biosynthesis when endogenous condensation of acetyl-CoA units was prevented by cerulenin (a specific inhibitor of the P-ketoacyl-acyl carrier protein synthase, or condensing enzyme). This excludes the hypothesis that polyene macrolides are formed by the condensation of two long-chain fatty acids. Exogenous fatty acids do in fact support growth of E . coli when endogenous fatty acid synthesis is suppressed by cerulenin (Goldberg et al., 1973). Early studies (McCarthy et al., 1955; Brock, 1956) demonstrated that oils and fatty acids stimulate the production of the polyene macrolide antibiotics fungichromin and filipin but not am-
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
23
photericin B (Brewer and Frazier, 1962)and candicidin (Ethiraj, 1969). Several individual fatty acids were able to replace the oils in stimulating filipin synthesis-palmitic acid and its esters, oleic acid, methyl oleate, triolein, etc. (Brock, 1956)-but only oleic acid and the synthetic oleate esters Span 80 (monooleate), Span 85, and Tween 85 (trioleates) replaced oils for fungichromin production. Glycerol was entirely inactive in the stimulation of the production of both antibiotics. It appears, therefore, that it is the aliphatic chains of the natural oils, not glycerol, which stimulate polyene antibiotic biosynthesis. Direct correlation of polyene macrolide biosynthesis and lipogenesis has been found in a number of cases. Belousova et al. (1970a) reported that cultivation of S . levoris in spent broth from a previously grown batch of the same organism stimulated levorin biosynthesis and fatty acid synthesis as well. Cultures grown in spent broth for 1 day incorporated into fatty acids 1.5-3 times more labeled acetate than did a culture of the same age in fresh corn meal medium. It was also noted that different spectra of cellular fatty acids existed in cells grown in the two media. More anteisoacids were synthesized when S . levoris was grown in fresh corn medium, accompanied by lower levorin production. The same stimulatory effect of spent broth from S. noursei fermentations has been observed (Nugamanovet aZ., 1973). Rafalski and Raczynska-Bojanowska (1972) observed that increased activity of the carboxylating enzyme systems involved in polyene macrolide biosynthesis correlated well with increased lipogenesis. Although oils and fatty acids contain more energy per unit weight than glucose, the increased polyene macrolide production with oils cannot be attributed to the added energy available, since the yields are far greater than would be expected from the energy supplied. The stimulation of polyene antibiotic biosynthesis by oils might be a simple precursor effect. Catabolism of fatty acids will result in an increased pool of acetyl-CoA, which is subsequently used for polyene macrolide biosynthesis. However, regulation of the biosynthesis of polyene macrolides by mechanisms other than a direct precursor effect is possible. These include: (1)alterations of the permeability of the cell membrane, (2) feedback regulation of the biosynthetic pathway, and (3)oxygen transfer effects.
1. Alterations of the Permeability of the Cell Membrane In a Streptomyces fradiae mutant that requires oleic acid for neomycin formation, the production of neomycin depends on the cellular fatty acid spectrum, even though neomycin is not a polyketide-derived antibiotic (Arima et al., 1973; Okazaki et al., 1973). Similarly, fatty acid addition is likely to alter the membrane composition and permeability of the polyene macrolide-producing strains, although the
24
JUAN F. MARTIN AND LLOYD E. MCDANIEL
possible influence of these alterations on polyene macrolide antibiotic biosynthesis remains an open question.
2. Feedback Regulation of the Biosynthetic Pathways Fatty acid and polyene macrolide biosynthesis is a typical example of a branched pathway leading to both a primary and a secondary metabolite (Martin, 1976). The regulation of the flow of precursors in branched pathways has been discussed in detail by Demain (1968). Stimulation of the production of the heptaene macrolide levorin by different oils has been shown, but biosynthesis of levorin under the same conditions was inhibited by the component fatty acids (oleic acid, linoleic acid, etc.) (Tereshin, 1976). Martin and McDaniel (1976) also showed that sodium oleate, sodium palmitate, or methyl oleate failed to support the production of candicidin by resting cells of S. griseus in the absence of another carbon source. When added to a glucose-based medium, fatty acids inhibited candicidin biosynthesis. This inhibition seems to involve feedback regulation of the common part of the pathway by high concentrations of long-chain fatty acids. Raczynska-Bojanowska (1974)also described feedback inhibition of the acetyl-CoA carboxylase of the nystatin-producer S. noursei by free fatty acids. It is therefore unclear why oils stimulate the biosynthesis of some polyene macrolides (e.g., fungichromin and filipin) in complex media while fatty acids have an inhibitory effect on the biosynthesis of others by resting cells (e.g., candicidin) or on the activity of biosynthetic enzyme systems (e.g., nystatin). Further studies on the nature of the regulatory mechanisms involved are required. Stimulation of polyene macrolide production may be due to an inhibitory effect of the fatty acids on the independent fatty acid synthase, therefore sparing acetyl-CoA for polyene macrolide biosynthesis. Feedback inhibition of fatty acid synthase by fatty acyl-CoA derivatives is well established (Lust and Lynen, 1968; Birnbaum, 1970; Izui et al., 1970; Satyanarayana and Klein, 1973; Flick and Bloch, 1975). 3. Effect of Antifoam Agents on Oxygen Transfer in the Culture Both oils and fatty acids have detergent properties that affect oxygen uptake and may interact positively or negatively on polyene biosynthesis. G. NITROGEN SOURCES Considerable differences in the ability of different amino acids to support candicidin biosynthesis were described by Acker and Lechevalier (1954). L-Asparagine was the best sole nitrogen source. L-Histidine, glycine,
PRODUCTION OF POLYENE MACROLIDE ANTlBIOTICS
25
L-glutamic acid, and L-aspartic acid were next in effectiveness as nitrogen sources. The D-isomers of the amino acids supported negligible growth and no candicidin production. Similar results were reported recently by AbouZeid (1973) for candicidin and for ayfactin (Abou-Zeid and Abou-el-Atta, 1971). It is interesting to note that p-alanine supported a 10 times higher yield than a-alanine and was the best amino acid source for the production of ayfactin. This result is interesting, as p-alanine is a component of the pantetheinyl moiety of coenzyme A and pantetheinyl-proteins of fatty acid and macrolide synthases. Radioactive p-alanine added to the growth medium of S. erythreus is incorporated into the fatty acid synthases of this organism (Corcoran, 1973). L-Asparagine has been successfully used as nitrogen source in a defined medium for candicidin production by resting cells of S. griseus (Martin and McDaniel, 1976). Inorganic salts are generally poor nitrogen sources for polyene production. However, ammonium salts were found to be acceptable in the case of mycoheptin (Tereshin, 1976). Complex nitrogen sources are the choice for large-scale antibiotic production, and a large variety of plant and animal proteins have been used. These include yeast extract, soya peptone, cottonseed meal, soybean meal, corn meal, casein and its hydrolyzates, corn steep liquor, and distillers’ solubles. Soybean meal is a good nitrogen source for producing many polyene macrolides (Brewer and Frazier, 1962; Mohan et al., 1963; Martin and McDaniel, 1974), probably because of its balance of nutrients (short fatty acid precursors, protein, cations, low phosphate, etc.) and its slow hydrolysis, which create physiological conditions during trophophase favoring antibiotic production in the idiophase (Nefelova and Pozmogova, 1960). Starch-fiee soya peptone supports high yields of candicidin (Liu et al., 1975; Martin and McDaniel, 1975a). In the levorin fermentation, soybean meal hydrolysis by proteases produces an initial increase in soluble nitrogen (Tereshin, 1976).An increase in ammonia that follows is due to deamination of amino acids. H. REGULATIONBY AROMATICAMINO ACIDS As can be seen in Table I, several polyene macrolides (ascosin, aureofungin, ayfactin, azacoultin, candicidin, DJ-400 B2 hamycin, heptamycin, levorin, trichomycin, and Sch 16656)belonging to the heptaene subgroup, have a p-aminoacetophenone moiety. A few others (candimycin, DJ-400 B1, and perimycin) have an aromatic N-methyl-p-aminoacetophenone moiety. The aromatic moiety of candicidin is synthesized from glucose via shikimate and the aromatic amino acid pathway to p-aminobenzoic acid (PABA), which is then incorporated into candicidin (Liu et al., 1972a) (Fig. 5), rather than through the alternative polyketide-derived route (Corcoran and Darby,
26
JUAN F. MARTIN AND LLOYD E . MCDANIEL
ERYMROSE 4- PHOY:
-
+,~OSPHOENOLPYRUVATE c-
1 \
3- DEOXY-D-ARABINO-HEPTULOSONIC ACID-. 7- PHOSPHATE (DHAP)
1
tI I
i
I I
SHlKlMlC ACID
/I\
PREPHENIC ACID
CHORiSMlC ACID
p-AMFIOBENA)H: ACID
I
TYROSINE
I
I
i
PHENYLALANINE CANDlClDlN
FIG.5. Proposed regulatory mechanism of the biosynthesis of aromatic polyene macrolides by aromatic amino acids.
1970). When either (ring UL)-['4C]-p-aminobenzoic acid or 7-[14C]-paminobenzoic acid was added to the candicidin-producingculture, between 33 and 40% of the radioactivity added was incorporated into candicidin. About 98% of the radioactivity in candicidin was recovered from the p aminoacetophenone moiety after hydrolysis. The high incorporation of PABA into candicidin compared with the lower degree of incorporation of glucose or shikimic acid indicates that PABA is a direct precursor of the aromatic moiety. Incorporation of PABA was linear for at least 10 hours and paralleled cellular uptake. The intracellular pool of PABA for antibiotic synthesis appears to be small and strictly regulated, as cellular uptake of PABA stopped soon after candicidin synthesis was blocked by the addition of cerulenin (Martin and McDaniel, 197%). Similar results were obtained in the case of the N-methyl+-aminoacetophenone moiety of perimycin (syn. fungimycin) (Liu et al., 1972b). The N-methyl group of the methyl-p-aminoacetophenone is derived from the methyl group of L-methionine. However, it is unclear whether methylation of PABA takes place prior to the attachment of the aromatic moiety or whether it is an a posteriori modification of the complete amethylfungimycin molecule.
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
27
The biosynthesis of candicidin was 50% inhibited by a mixture of 5 mM L-tryptophan, L-tyrosine, and L-phenylalanine (Liu et al., 1972a). Interestingly, the rate of incorporation of exogenous PABA was stimulated by 50%at inhibitory concentrations of the aromatic amino acids mixture. This was interpreted as indicating that PABA biosynthesis in the cell was retarded by the presence of an excess of aromatic amino acids, presumably by feedback inhibition, causing the exogenous supply of PABA to be more efficiently incorporated. Although no effect of the aromatic amino acids on mycelial growth was observed, an indirect effect could not be excluded with the batch system used. Further studies, using a resting cell system, indicated that the regulation of candicidin biosynthesis by aromatic amino acids is independent of growth and is exclusively produced by L-tryptophan, not by L-phenylalanine or L-tyrosine 0. F. Martin, unpublished). These results suggest that PABA biosynthesis is subject to end-product inhibition exerted by the presence of an excess of aromatic amino acids in the cell. This is a fine example of a regulatory system in which the biosynthesis of a secondary metabolite (candicidin) is regulated by the mechanisms controlling the biosynthesis of primary metabolites such as the aromatic amino acids, as represented in Fig. 5. Similar regulatory examples have been discussed by Demain (1974). A similar branched pathway leading to the biosynthesis of chloramphenicol and aromatip amino acids has been described in Streptomyces sp. 3022 (see review by Malik, 1972). However, the biosynthesis of chloramphenicol does not appear to be regulated by aromatic amino acids (Lowe and Westlake, 1971); i.e., the producing organism has a DHAP synthase insensitive to end-product inhibition or repression. I. EFFECTOF INORGANIC ORTHOPHOSPHATE Negative control of the biosynthesis of secondary metabolites by high inorganic phosphate concentrations has been observed in many Streptomyces fermentations (see reviews by Demain, 1972; Weinberg, 1974). Antibiotics, like most other secondary metabolites, are produced only at inorganic phosphate concentrations that are suboptimal for growth. Inorganic orthophosphate in the range of 0.3 to 300 mM permits excellent cell growth, but 10 mM concentration often suppresses biosynthesis of antibiotics. Several examples of suppression of polyene macrolide antibiotic production along with the range of permissive phosphate concentrations are listed in Table 111. Early reference to the phosphate effect on the biosynthesis of the polyene macrolide antibiotics nystatin and amphotericin B was made by Donovick
TABLE I11 SOME POLYENE MACROLIDEANTIBIOTICS WHOSE PRODUCTION IS CONTROLLED BY INORGANIC PHOSPHATE Range of phosphate permitting antibiotic production
(mM)
Antibiotics
Producer strain
Amphotericin B Ayfactin Candicidin Candidin Levorin Mycoheptin Nystatin
Streptomyces nodosus Streptomyces aureofaciens Streptomyces grkeus Streptomyces viridoflavus Streptomyces levwis Streptoverticillium mycoheptinicum Streptomyces noursei
~
~
~
P Referencesb
~
1.5-2.2 1-17 0.5-5
3, 6 1 4
0.5-5
5 2
0.3-4 3.55 1.62.2"
6
33
=Optimalconcentration of phosphate for antibiotic production. bKey to references: (1) Abou-Zeid and Abou-el-Atta (1971), (2) Belousova et al. (1970a), (3) Donovick and Brown (1965), (4) Liu et al. (1975), (5) J. F. Martin and L. E. McDaniel (unpublished), (6) Tereshin (1976).
t U
r 0 0
P
PRODUCTION OF POLYENE MACROLIDE ANTlBIOTlCS
29
and Brown (1965); however, no detailed study was published. The effect of phosphate on accelerating growth and increasing the rate of carbohydrate utilization by the nystatin producer was described by Popova et al. (1961). Belousova et al. (1970a) found that inorganic phosphate decreased the synthesis of levorin in a corn steep liquor medium. Glycerophosphate also inhibited antibiotic formation, although to a lesser extent. The same authors reported that a decrease in synthesis of levorin was accompanied by an increase of fatty acid formation without changing the percentage ratio of the different fatty acids in the cells (Belousova et al., 1970b). Abou-Zeid and Abou-el-Atta (1971) showed that high concentrations of phosphate inhibited ayfactin formation and increased the utilization of starch. Lopatnev et al. (1973) found that the extracellular phosphate concentration in the nystatin fermentation decreased during growth and remained at a very low level during the production phase. After exhaustion of glucose and cessation of growth, the extracellular phosphate concentration increased again. Liu et al. (1975) found that the addition of 10 mM phosphate to the candicidin producer resulted in a 2-fold increase in mycelial growth. Specific candicidin production was 96% inhibited under these conditions. After phosphate addition, the dissolved oxygen level in the broth decreased sharply, accompanied by increases in mycelial growth rate and sugar utilization. A shift from secondary metabolism to primary metabolism by the action of phosphate could be achieved at any time during idiophase (Fig. 6). Similar results were obtained in the biosynthesis of the nonaromatic heptaene candidin. In batch cultures, phosphate exerted its effect on both primary and secondary metabolism, and it was unclear whether its effect was primarily in stimulating growth or in inhibiting (or repressing) polyene macrolide formation. Further insight was gained during short-term incubation periods by following the incorporation of labeled precursors into candicidin by resting cells of S. griseus. Phosphate at'5 or 10 mM decreased the rate of incorporation of precursors into candicidin without affecting cellular uptake of precursors. Complete inhibition of precursor incorporation was achieved after 120 minutes using 10 mM phosphate. Addition of phosphate did not alter overall protein synthesis in the short-term experiments. The specific regulatory effect of phosphate on the formation or activity of some enzymes involved in candicidin synthesis was studied using chloramphenicol to inhibit protein synthesis. The halting of protein synthesis resulted in partial inhibition of antibiotic formation, suggesting that the formation of candicidin synthases occurs while the system is synthesizing candicidin. The activity remaining in the presence of chloramphenicol was subject to phosphate inhibition, showing that at least a part of the phosphate effect is on the activity of preformed enzymes (A. L. Demain and J. F. Martin, unpublished).
JUAN F. MARTIN AND
0 TIME (hr)
20
40
60 80 TIME (hr)
100
120
FIG. 6. Inhibition of candicidin formation by phosphate. The fermentation was run in a 30-liter fermentor. The medium contained 2.5% soya peptone, 6.5% edible grade glucose, and 5X A4 zinc sulfate. Sixteen hours after incubation the pH of the culture was brought up to 8.0 and maintained at that pH throughout the entire fermentation by adding 20% NaOH solution with an automatic pH control instrument. Two fermentations were run. In one fermentation, K2HP04 was added to the culture at the time indicated; the other fermentation served as control. From Liu et al. (1975). Reprinted with permission of American Society for Microbiology Publication Office.
Several mechanisms have been proposed to explain the effect of phosphate on the production of idiolites. These include the following: 1. Vegetative growth limitation due to a lack of phosphate shifts the metabolism to the production of idiolites. Bu'Lock (1974) suggested that different degrees of nutritional limitation are required to trigger the formation of different idiolites. 2. Herold and Hostdek (1965)attributed the phosphate inhibition of tetracycline biosynthesis to a shift of the carbohydrate catabolic pathways, glycolysis being favored at the expense of the pentose-phosphate cycle; hence NADPH becomes the limiting factor in antibiotic synthesis.
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
31
3. Robbers et al. (1972) observed that phosphate inhibition of the biosynthesis of ergot alkaloids is overcome by tryptophan, an inducer of ergot synthase. Phosphate seems to limit the synthesis of endogenous tryptophan. Tryptophan synthase activity increases 20- to 25-fold in low-phosphate cultures. The synthesis of PABA, a component of the aromatic polyene macrolides, may be the limiting step in polyene macrolide biosynthesis in the presence of excess phosphate. 4. In the biosynthesis of streptomycin (Miller and Walker, 1970),viomycin (Pass and Raczynska-Bojanowska,1968), and vancomycin (Mertz and Doolin, 1973), phosphate acts by preventing the formation of alkaline phosphatases required for antibiotic biosynthesis. Miller and Walker (1970) reported that inactive streptomycin phosphate was formed when inorganic phosphate was added to mycelia synthesizing the antibiotic. Walker (1971)has proposed that the dephosphorylation reaction is the final step in the biosynthesis of streptomycin. Dephosphorylation of streptomycin phosphate to active streptomycin is prevented by excess phosphate. Similar modification by phosphorylation takes place also in the antibiotics lincomycin and neomycin (Majumdar and Majumdar, 1970). Different mechanisms of phosphate effect probably exist in the biosynthesis of different antibiotics. But most likely all of them are different projections of a common parameter, the cellular energy charge, which determines the phosphorylating or energetic capability of the cell. J. REGULATIONOF THE BIOSYNTHESIS OF POLYENE MACROLIDEANTIBIOTICS BY ADENINE NUCLEOTIDES AND/OR
THE
ENERGY CHARGE OF
THE
CELL
The adenine nucleotides adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP) stoichiometrically couple all the metabolic sequences of a living cell. The amount of metabolically available energy that is momentarily stored in the adenylate system is related to the energy charge of the cell, defined by Atkinson and Walton (1967) as follows: Energy charge (EC) = [(ATP)
+ 1/2 (ADP)]/[(ATP)+ (ADP) + (AMP)]
The energy charge is a regulatory parameter coordinating energy-utilizing and energy-regenerating metabolic sequences. Atkinson (1969)has reviewed response curves of activity for several enzymes as a function of the energy charge. Regulatory enzymes from sequences in which ATP is regenerated are highly active at low levels of energy charge and decrease sharply in activity as the energy charge increases above a value of about 0.75. Regulatory enzymes from biosynthetic sequences or others that consume ATP,
32
JUAN F. MARTIN AND LLOYD E. MCDANIEL
exhibit very little activity at low levels of energy charge, and their activities increase sharply at charge values above 0.75. Atkinson and co-workers (Chapman et al., 1971) predicted that the energy-charge values of a cell would be poised between 0.8 and 0.9 in order to maximize the regulatory effect of the energy charge. This is true for E. coli. In light of this theory, the effect of purine and pyrimidine nucleotides on the biosynthesis of candicidin has been studied. It was found that ATP, ADP, AMP, adenosine 3’,5’-cyclicmonophosphate (CAMP),and other purine and pyrimidine nucleotides, but not nucleosides or bases, inhibit candicidin biosynthesis in a resting cell system, similar to the effect of phosphate. It has been suggested that phosphate may be active in regulating polyene antibiotic biosynthesis through mediation of nucleotide levels in the cell. A large increase in the intracellular level of ATP has been found to follow phosphate addition. Steady-state values of energy charge were 0.7-0.8 in resting cells synthesizingcandicidin, and increase to 0.9 following phosphate or nucleotide addition. Since the energy charge acts as a fine control of enzyme reactions, particularly at the branch point, the effect of adenine nucleotides is probably due to a shift of the whole metabolic pattern of the cell. Possible regulatory target enzymes are some amphibolic enzymes of glycolysis, such as phosphofiuctokinase, or enzymes that regulate the entry of acetyl-CoA into the Krebs cycle (citrate synthase) or NAD(P)Hregenerating systems in the Krebs cycle, such as isocitrate dehydrogenase (Atkinson, 1969). Alternatively, phosphate and the adenine nucleotides may act at the transcriptional level by interacting, and therefore changing the substrate specificity of the RNA polymerase. DifEerent parts of the genome will be expressed (read) under low or high energy charge, resulting in growth or production of idiolites. The shift of the carbohydrate catabolic pathways upon phosphate addition proposed by Herold and Hostiilek (1965) is readily understood as an ATP-mediated regulatory effect. Additional evidence supporting the regulatory role of ATP on antibiotic production comes from studies indicating that the level of intracellular ATP drops sharply prior to antibiotic production (J. F. Martin and A. L. Demain, unpublished). The pattern of ATP changes observed during the fermentation might be explained according to Atkinson (1965) and Martin and McDaniel (1974) as follows: when phosphate is exhausted from the medium, the balanced assimilation of nutrients characteristic of trophophase is halted. Biosynthesis of macromolecules, NAD(P)H regeneration, and Krebs cycle reactions slow down since no intermediates are removed. ATP accumulates momentarily during the transition period since the cell is unable to carry out energy-requiring growth processes. This seems to be the case in the fermentation of chlortetracycline (Janglova et al., 1969). Owing to the de-
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
33
cline in growth rate and TCA-cycle activity, glucose catabolites accumulate, as has been found to happen also in the fermentation of nystatin (Toropovaet al., 1972). The entry of acetyl-CoA into the Krebs cycle is further made difEcult by the negative effector action of ATP on citrate synthase and phosphoenolpyruvate carboxylase, the enzymes that catalyze the entry of acetyl-CoA into the Krebs cycle (Hostiileket al., 1969). Acetyl-CoA is in this way shifted toward the production of polyene macrolides or fatty acids. After the transition stage, the intracellular level of ATP drops to very low steady levels probably reflecting utilization for polyene macrolide biosynthesis and turnover metabolism without replenishment of the intracellular pool (Janglova et al., 1969; J. F. Martin and A. L. Demain, unpublished). It appears that the antibiotic-producing cell is essentially unable to regenerate enough ATP because of phosphate limitation. The addition of phosphate or nucleotides reverses this situation, shifting secondary metabolism to that typical of growth.
K. EFFECTOF METAL IONS Early studies indicated that iron and zinc were essential for growth or antibiotic production (Acker and Lechevalier, 1954). Stimulation of the production of the tetraene macrolide, antimycoin, by calcium and magnesium ions was reported by Schaffner et al. (1958). Brewer and Frazier (1962) described stimulatory effects of manganous, nickel, zinc, and cobalt salts on the production of amphotericin B in soybean meal media. Manganous salts, especially in the presence of iron, were the most effective. The stimulatory effect of divalent cations on candicidin production was studied by Liu et al. (1975). Maximum effects were exerted by iron, zinc, and magnesium at 5 x M in a complex medium. However, in a to defined medium metal stimulation of candicidin production occurred only at M level, and higher concentrations were inhibitory. In all cases the 5 x an increase in candicidin yield was accompanied by a reduction of mycelial growth. Addition of zinc at any time during the fermentation resulted in increased candicidin synthesis, reduced dry weight, and an increased rate of glucose utilization. Zinc, iron, and magnesium appear to be common stimulators of polyene macrolide production. Differences among several polyenes may be due to the difFerent nutrients used and the content of metal ions in the complex media. Weinberg (1962, 1970) has reviewed the role of trace metals in secondary metabolism and has concluded that iron and zinc are “key” metals for actinomycetes and fungi. The concentrations of metals required for secondary metabolism are one or more log units higher than the minimum
34
JUAN F. MARTIN AND LLOYD E. MCDANIEL
required for growth (approximately lo-? M).Moreover, primary metabolism tolerates up to M of each metal, about 2 log units higher than the level that is inhibitory for secondary metabolism. Although a large number of examples of metals affecting production of idiolites is known, no unitary role appears to exist; rather, several possibilities in different systems have been suggested. The most likely role of metals is as activator of the synthases of secondary metabolism, although an effect at the transcriptional or translational level has been suggested in some cases. A probable role of metal ions on the biosynthesis of polyene macrolides is either the activation of polyene synthases or the stabilization of the intermediate substrates in polyketide biosynthesis, as suggested by Bu’Lock (1967). P-Polyketide intermediates have a great tendency to form coordination complexes with metal ions. Enzyme-bound growing chains of malonyl units may be maintained in a suitable configuration in this way to allow for the condensation of the malonyl-CoA derivatives and the decarboxylation and transacylation reactions. The stimulatory effect of magnesium ions on polyene macrolide biosynthesis is probably related to the activating effect on acetyl-CoA carboxylase (acetyl-CoA ligase, EC 6.4.1.2), a magnesium-requiring enzyme (Lynen, 1967), as has been found in in uitro studies of this enzyme (Rasmussen and Klein, 1968). Another possible role of metal ions in the production of candicidin, namely the removal of inhibitory concentrations of phosphate, has been suggested by Liu et al. (1975). However, attempts to demonstrate the sequestering effect of metal ions on high concentrations of inorganic phosphate by adding equivalent amounts of zinc and phosphate to soya peptone cultures of S. grlseus were not successful. L. EFFECTOF DISSOLVED OXYGEN
The general role of oxygen in the growth of aerobic microorganisms is well known (see reviews by Harrison, 1972, 1973). The rate of solution of oxygen in a medium has to be at least equal to the requirement of a microorganism for growth and metabolism in order for it not to be limited by oxygen supply. McDaniel and Bailey (1969), studying the effect of oxygen supply rates in shake flasks, found that maximum yields of candidin could not be obtained in conventional unbaffled Erlenmeyer flasks. It was necessary to use baffled flasks in which oxygen transfer rates (sulfite oxidation rates) of 1 mmole per liter per minute or higher could be obtained. The highest yield of fungimycin was obtained at oxygen transfer rates of0.5 mmole per liter per minute or higher (Mohan et al., 1963). In the case of candicidin the limiting rate was reported to be 0.8 mmole per liter per minute (Liu et al., 1975).
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
35
Dissolved oxygen levels are critical for the production of many antibiotics, including cephalosporin and capreomycin (Feren and Squires, 1969), penicillin and bacitracin (Brandl et al., 1966), oleandomycin (Surikova and Zavileiskaya, 1972), and erythromycin (Lobanova and Brinberg, 1971). Ethiraj (1969) studied the effect of dissolved oxygen tension on candicidin production. At 40% of saturation and above, the yields were constant. At 10 and 20% of saturation, candicidin production was reduced. Lopatnev et al. (1973) reported that a mixing speed of 300 rpm was required to supply enough dissolved oxygen to a culture of S. noursei producing nystatin. Lower mixing speeds resulted in depletion of dissolved oxygen and drastic reduction in the formation of nystatin. Under intensive agitation (oxygen transfer coefficient k# >6 min-'), a dependence of the specific productivity of nystatin on the specific rates of growth and carbohydrate utilization was found (Lopatnevet al., 1975);this was not observed with poor agitation (kIp c3.5 min-'). Maximum yields of nystatin were obtained only with the higher oxygen transfer conditions. Agitation speeds of 300 rpm or above were also required to keep the dissolved oxygen levels from falling below 20% of saturation in candidin and candihexin fermentations (Martin and McDaniel, 1974). Saturation levels of 60% or higher were maintained during the production of candicidin using an agitation speed of 420 rpm in a 30-liter fermentor (Martin and McDaniel, 1975a). Under these conditions, maximum oxygen uptake rates were 0.7 mmole per liter per minute in candidin and candihexin fermentations and 0.5 mmole per liter per minute with candicidin. If adequate agitation speeds are not provided, the dissolved oxygen levels will fall below the critical level (the level above which the rate of oxygen uptake by an organism is independent of oxygen concentration). According to Lopatnev et al. (1973), reduction of the dissolved oxygen to a concentration not lower than the critical level does not reduce nystatin synthesis. This is in contrast with the results of Ethiraj (1969), which indicated that the dissolved oxygen tension for maximum candicidin production is well above the critical level (3.5% of saturation). A correlation of the change of oxygen uptake rate with onset of polyene macrolide formation was found in the fermentations of three polyene macrolides, candidin, candihexin, and candicidin. The large increase in oxygen uptake which parallels cellular growth (DNA increase) during trophophase levels off or decreases sharply, coinciding with the onset of antibiotic formation (Martin and McDaniel, 1974, 1975a)(Fig. 3). It is obvious that a change in metabolism occurs at that time owing to exhaustion of some essential nutrient, typically phosphate. Under nutrient limitation, the balanced assimilation of nutrients with associated high oxygen demand is halted, producing a shift to secondary metabolism (Martin and McDaniel, 1974).
36
JUAN F. MARTIN AND LLOYD E . MCDANIEL
A factor directly affecting the interaction of dissolved oxygen in the broth and oxygen uptake by the cell is the addition of antifoam agents. Selection of antifoaming agents is generally done on an empirical basis. Polyether and polyglycol derivatives (e.g., Polyglycol P-2OO0, Dow Chemical Co.) at concentrations of 0.02% are routinely used in fermentations of polyene macrolides. Lvova et al. (1973) studied the comparative effect of natural oils and synthetic antifoam agents on the production of levorin. Most oils could be used only at low concentrations. Sperm oil could be used at a higher level. At 0.5-1% it exerted an antifoam effect and stimulated antibiotic biosynthesis. Polyether synthetic products (e.g., adecanol and propinol B-400) at concentrations of 0.02-0.M% had the significant advantage of suppressing foaming without affecting production, isolation, or purification of levorin.
M. EFFECTOF REDOXPOTENTIAL Another factor that is claimed to affect the production of polyene macrolide antibiotics is the redox potential (Eh)of the culture. The redox potential is easily defined in a simple chemical system by the equation of Nernst, but its exact meaning in complex microbial systems is not clear. In the presence of oxygen all redox systems tend toward the fully oxidized state, and in complex systems redox probes reflect the concentration of dissolved oxygen. In spite of the above, correlations have been made between the redox potential of the culture and different microbial processes (Harrison, 1972). Sukharevich et al. (1970a,b)stated that a change in the redox potential at constant aeration rates leads to substantial changes in the polyene macrolides synthesized by S. leuoris and S. mycoheptinicum, the producers of levorin and mycoheptin. Studies with S. mycoheptinicum revealed that low Eh values during the first 24-26 hours of the fermentation decreased both growth and total antibiotic production. This strain usually produces a heptaene macrolide (mycoheptin) together with a pentaene macrolide component. Specific yields of the pentaene decreased to one-third when low redox potential values were maintained, while that of the heptaene was at the same level as in control fermentations, thus providing a method for specific enrichment of the heptaene macrolide component (Sukharevich et d., 197Oa). In the production of levorin, high-producing strains of S. levoris were grown at reduced redox potentials adjusted with hyposulfite, hydrosulfite, and thioglycolic acid or at increased redox potentials achieved by changing the volume of the medium or by adding potassium ferricyanide. Experiments were done at constant high or low aeration levels and changing redox potentials. The levorin complex is a mixture of several components (Tsyganov and Yakovleva, 1968), the two main ones, levorin A and B, occurring in different proportions in several low- and high-producing strains. Increasing the redox potential of the medium with atmospheric oxygen or an oxidizing agent led
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
37
to a decrease in the fraction of levorin B in the antibiotic complex. When the redox potential was lowered by adding a reducing agent, the fraction of levorin B increased. The changes in the redox potential of the culture did not affect the amount of biomass of S. levoris produced, but at lower redox potentials the total antibiotic yield was only 22% of that of the control. The large amounts of reducing agents (1-2%) required to lower the redox potential from the 450-mV level characteristic of normally aerated fermentations to the 1W150-mV level of “reduced broths may affect antibiotic formation by mechanisms other than the oxidoreduction potential. If the redox potential monitored with a platinum electrode reflects, as assumed, the redox potential of the intracellular components, it is interesting to correlate the NAD(P)/NAD(P)H ratio (the key parameter reflecting the redox potential for driving oxidation-reduction reactions) with changes in the total yield of polyene macrolide and the composition of the polyene macrolide complexes. At artificially low redox potentials, NAD(P)/NAD(P)H should be expected to be low and therefore favor the formation of reduced lipid substances (requiring large amounts of NADPH) at the expense of more oxidized compounds such as macrolides. In effect, Gatenbeck and Hermodsson (1965) have established that the concentration of reduced nucleotides determines the in vitro incorporation of acetate into polyketidederived compounds or fatty acids. Activities of NADP-dependent dehydrogenases responsible for regeneration of NADPH are not limiting for the biosynthesis of the polyene macrolide polifungin, but enzymic activities are nevertheless lower in the nonproducing mutants (Roszkowskiet al., 1971). A large response of intracellular NADH to changes in oxygen supply has been found in Klebsiella aerogenes (Harrison, 1972), but no correlation has been established so far between the redox potential of the culture and the intracellular level of NAD(P)H. The redox potential of the culture may affect the proportion of components in polyene macrolide complexes by favoring the specific reduction of some double bonds or keto groups of the polyketide chain. In addition to the effect on antibiotic production, Sukharevich et al. (1972)reported that decreased redox potentials affect the structure and form of the colonies on a solid medium of 14 species of Streptomyces. Low redox potentials also produce changes in the development of aerial mycelium.
111. Interaction of Polyene Macrolide Antibiotics with the Producer Cells A. MODIFICATION AND DEGRADATION OF POLYENE MACROLIDEANTIBIOTICSBY THE PRODUCER CELLS
In the production of antibiotics, the final amount of extractable product depends on the total amount secreted and the fraction that is degraded
38
JUAN F. MARTIN A N D LLOYD E . MCDANIEL
under the fermentation conditions. Reutilization of exogenous antibiotic by the producing cell does not seem to play a major role in decreasing the yield of antibiotic fermentation. Uptake of antibiotics (e.g., chloramphenicol) by producing cells can occur during the growth phase, but a decreased permeability of the producing cell to the excreted antibiotic develops during idiophase and is one of the mechanisms by which the producer cell avoids suicide (Demain, 1974). Antibiotics may be either modified or degraded under production conditions by mechanisms similar to those evolved by resistant target organisms (Benveniste and Davies, 1973). Phosphorylation of streptomycin by S. griseus (Nimi et al., 1971) and neomycin by S. j-adiae (Majumdar and Majumdar, 1970)or hydrolysis of chloramphenicol by Streptomyces sp. (Malik and Vining, 1971) and penicillin by penicillin acylases of Penicillium chrysogenum (Cole, 1966) are well-known modification mechanisms. There are several reports in the literature indicating that titers of some polyene macrolide antibiotics drop after termination of antibiotic formation (e.g., nystatin, candihexin) whereas those of others remain at the same level for several days (e.g., candidin, candicidin). Spizek et al. (1965b) reported that the addition to the culture medium of fungicidin in concentrations exceeding the amounts that the culture can produce induced enzymic systems that degraded (or transformed) the antibiotic approximately to the same level as that produced in control cultures. However, no proof of the involvement of enzymic activity was provided. In a similar study with candihexin and candidin, it was observed that when candihexin was added at the onset of the idiophase to candihexin-producingcultures there was degradation of the added candihexin (or lack of de n o w candihexin synthesis)and the antibiotic level remained at the same level during the fermentation (J. F. Martin and L. E. McDaniel, unpublished). However, when candidin was added at the same time to candidin-producingcultures there was no effect on the production of candidin as compared to the nonsupplemented control, and the final antibiotic yield was the total accumulation of exogenously added and de nooo synthesized antibiotic. Whether there is an enzymic conversion, a chemical degradation, or a feedback inhibitory effect on antibiotic production is unknown at present. Tereshin (1976) reported that amphotericin B may be used as an endogenous substrate by the producing cell, resulting in the formation of biologically inactive amphotericin B. It is unclear, however, whether formation of inactive components occurs by intracellular modification prior to antibiotic excretion or whether exogenously added amphotericin B is taken up by the cell and modified. The occurrence of nonactive components lacking the aminosugar moiety of polyene macrolides (mycosamine) has been described in the polifungin and candihexin fermentations (Roszkowski et al., 1972; Martin and McDaniel, 1975b), but
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
39
they are believed to be nonglycosylated intermediates rather than transformation products. Determination of the chemical structure of the inactive amphotericin B would help to clarify the inactivation mechanism in polyene macrolide-producerswhich may have some survival significance for the producing strain.
B. STABILIZATIONOF POLYENE MACROLIDE ANTIBIOTICS AFTER PRODUCTION The lability of polyenes to light or heat is well known (Oroshnik and Mebane, 1963; Hamilton-Miller, 1973). Thermal inactivation has been studied with filipin (Tingstad and Garrett, 1960), nystatin (Belenky et al., 1966), amphotericin B (Bonner et al., 1975), and the tetraene fumagillin (Garrett, 1954). Thermal inactivation of nystatin was associated with loss of the polyenic chromophore. In addition to thermal inactivation, two other mechanisms, (1) autoxidation and (2) UV light photolysis, are known to affect the stability of polyene macrolides. Autoxidation of rimocidin and pimaricin in solution has been reported (Dekker and Ark, 1959). It can be prevented by the addition to pimaricin of chlorophyllin or antioxidants, such as ascorbic acid, hydroquinone, or gallic acid. Rickards et al. (1970) studied the autoxidation of solutions of filipin and lagosin and concluded that the reaction products were the corresponding tetraene epoxides. This autoxidation was reduced by the addition of the antioxidant, 2-t-butyl-4-methoxyphenol.Antioxidants have also been reported to protect against the autoxidation of nystatin (Zhdanovich et al., 1967). The photolability of polyene macrolides is well documented. Polyene macrolides show a high specific absorption of long ultraviolet light due to the presence in their molecule of alternating double bond chromophores of different lengths. Dekker and Ark (1959) observed that photolysis of pimaricin can be prevented by chlorophyllin or dyes such as quinoneimine, triphenylmethane, and nitro and azo dyes that act by intercepting UV light. They suggested that UV photolysis brings about a trans to cis isomerization of the chromophore resulting in the loss of activity. Zondag et al. (1960) postulated a similar isomerization mechanism for photolysis of pimaricin. Cis-trans isomerization after UV irradiation has also been described in the heptaene macrolide DJ-400 (Siewert and Kieslich, 1971) and in levorin (Filippova et al., 1972). Thermal inactivation and autoxidation are likely to decrease the yield of polyene macrolides in long-lasting (4-7 days), highly aerated fermentations. Photolysis may also influence the yield of polyene macrolides in shake flasks or glass-jar fermentors although the glass and UV-absorbing substances in
40
JUAN F. MARTIN AND LLOYD E. MCDANIEL
the broth will shield the excreted polyenes against radiations of less than 350 nm. Addition of antioxidants may stabilize the polyene macrolides in the broth but also will interfere with the redox potential of the culture. Complexing of polyene macrolides appears to be a mechanism that stabilizes them in the fermentation. The addition of cholesterol in equimolecular amounts to the candihexin or candidin fermentations increased the production of both products 0. F. Martin, unpublished). Cholesterol forms complexes with polyene macrolides and may act by protecting the extracellular polyene from thermal inactivation or autoxidation. Cholesterol-levorin and cholesterol-amphotericin B have been shown to have a stabilizing effect on polyene antibiotics (Klimov et al., 1971). Other complexing agents of polyene macrolides, such as sodium deoxycholate, which is known to solubilize water dispersions of polyene macrolides, completely inhibit polyene macrolide production. The inhibitory mechanism is unknown. Alternatively, the stimulatory effect of cholesterol on polyene macrolide biosynthesis may be due to the interaction of cholesterol with the polyene macrolides as they are secreted at the membrane level.
c. POLYENE MACROLIDE PRODUCTION IN MIXED CULTURE WITH YEASTS Different types of microbial interaction occurring in mixed cultures of bacteria have been reviewed by Meers (1973). Of these relationships, synergism is that type of interaction in which two species produce more of a given product when growing together than when growing alone. Several examples of this type of interaction have been described (Styczynska et al., 1965; Graveri, 1956). Yakovleva et a2. (1972) and Tsyganov et al. (1973) tested the effect of cocultivation of 56 species of microorganisms with S. levoris on the production of the heptaene macrolide levorin. The species studied included yeastlike fungi, filamentous fungi, and bacteria. Either no effect or an inhibtory effect on antibiotic production was observed when S. levoris was cultivated with bacteria, but considerable stimulation was obtained when it was grown with yeasts. The highest increase in titer (2-fold) was produced by Candida tropicalis. Synergistic stimulation of antibiotic production occurred only when the yeast was grown for 24 hours before inoculation of the Streptomyces, but not when both strains were inoculated simultaneously. The increase in antibiotic titers resulted from an increase in the mycelial dry weight as well as from a higher specific production. After this report an attempt was made to increase candidin and candihexin production by cocultivation of the producing strains of Streptomyces viridoflavus and S . viridoflavus mutant 18A2 with S. cerevisiae. Yeast was added after growth of
PRODUCTION OF FQLYENE MACROLIDE ANTIBIOTICS
41
the Streptomyces had occurred in order to avoid a nonspecific effect on growth. When logarithmically growing yeast cells were added, they overgrew the Streptomyces and no production of antibiotic was observed. However, when the same amount of autoclaved cells was added, there was a stimulation of production of both candidin and candihexin. Two hypotheses are offered to explain the stimulation of antibiotic production: (1)nutrients are excreted by the yeast or are provided by the autoclaved yeasts and utilized by the Streptomyces; (2) polyene macrolides bind to the target sterols of yeast membranes forming complexes that act as stabilizing agents. A reversible complete binding of polyene antibiotics to components of cell-&ee yeast extracts has been described (Klimov and Nikiforova, 1971). An exclusively nutritional role of yeast seems unlikely since yeast extract does not support synthesis of the two polyene macrolides. A polyene macrolide-stabilizing role of the yeast cells is in agreement with the similar role of cholesterol. It is interesting to note that species of Candida that give a high synergistic effect are usually more sensitive to the action of polyenes than filamentous fungi, which proved to have little synergistic action. Mixed cultures with yeasts or the addition of autoclaved yeasts may be important and economical tools for increasing industrial production of polyene macrolide antibiotics. D. SUSCEPTIBILITY OF THE PRODUCER STRAINS TO POLYENE MACROLIDEANTIBIOTICS Several antibiotics have growth-inhibitory effects on their producing strains (see review by Demain, 1974). The producer strains avoid suicide by different mechanisms; these include (1) production of the antibiotic in a phase subsequent to growth, (2) modification of the antibiotic to render it inactive, (3) alteration of the antibiotic target in the cell that becomes antibiotic resistant, and (4) decreased permeability to the excreted antibiotic. No such effect of polyene macrolide antibiotics would be expected a priori since cell membranes of Streptomyces, like other bacterial membranes, are believed to be lacking in sterols. However, there is increasing evidence that at least some polyene macrolides have an inhibitory effect on the growth of their producing strains and on the amount of antibiotic produced by that strain. Dolezilova et al. (1965)reported that a fungicidin-producingstrain of S. noursei was susceptible to the action of fungicidin. There was an inverse correlation between the producing ability and sensitivity to the produced antibiotic. A high-producing strain able to form 15,000 unitdm1 was resistant to concentrations of fungicidin up to 20,000 unitdml. A strain able to produce 6OOO unitdm1 was resistant only to concentrations below 2000 units of hngicididml, and a nonproducing strain of fungicidin was inhibited by 20
42
JUAN F. MARTIN AND LLOYD E . MCDANIEL
unitdml. Similar results were reported with the levorin- and mycoheptinproducing strains (Tereshin, 1976). Levorin and mycoheptin exert a lethal effect on the growth of their producing strains proportional to the antibiotic concentration in the medium. Spores of high- and low-producing strains differ in their susceptibility to levorin. The number of survivor colonies of high levorin-producing strains were lo00 times greater than that of lowproducer strains when both strains were grown on a solid medium containing 4000 units of levorin per milliliter. The inhibitory effect of levorin and mycoheptin on their producing strains resulted in 4-5 days delay of growth. Deep colonies of substrate mycelium were formed in medium supplemented with antibiotic. The colonies returned to their original morphology if transferred to antibiotic-free medium. Preliminary studies on the effect of nystatin on some enzymes of the glycolytic pathway, pentose phosphate pathway, and tricarboxylic acid cycle indicated that glucose-6-phosphate dehydrogenase and transketolase of S t r e p t m y c e s rimosus are sensitive to the effect of nystatin (Egorov and Toropova, 1975). This result, together with the fact that the amount of enzymes of the pentose phosphate cycle in nonproducer mutants is three to four times greater than in the producer strain whereas those of the tricarboxylic acid are 2-4 times less, may indicate a regulatory role of the antibiotic on the intermediary metabolism of the producer stains. It is unclear, however, whether this effect may have an in vivo effect on regulation of the metabolism of the producer strains since the intracellular concentration of nystatin is unknown. E. FEEDBACK REGULATORYEFFECTOF POLYENE MACROLIDEANTIBIOTICS ON THEIROWNPRODUCTION The addition of fungicidin to a culture of S. noursei, which synthesizes cycloheximide and fungicidin, produced an increase in cycloheximide together with an apparent inhibition of synthesis of fungicidin. This was explained on the basis of the competition of the metabolic pathways synthesizing the two antibiotics for malonate, a common precursor in the biosynthesis of cycloheximide and fungicidin. Similarly the addition of candihexin to candihexin-producing cultures stopped further antibiotic production. The addition of candidin to cultures producing candidin did not produce inhibition of antibiotic synthesis. The existing evidence of feedback regulation of polyene macrolide production is only indirect since decreased antibiotic titers following the addition of antibiotic to the producer strain may result from inhibition of antibiotic synthesis or from an increased rate of degradation of the antibiotic. A study of the effect of exogenous antibiotic on the rate of incorporation of labeled precursors into the antibiotic would resolve this question.
PRODUCTION OF FQLYENE MACROLIDE ANTIBIOTICS
43
Levorin seems to have little effect as a selective agent on the range of variability in the production of antibiotic by single colonies of a given population. On the contrary, when the original nonmutated S. mycoheptinicum was grown in agar supplemented with mycoheptin, variants resistant to mycoheptin were isolated which exceeded by 15-40% the production of antibiotic by the parent strain (Tereshin, 1976). Based on the effect of polyene macrolide antibiotics on their producer strains, a procedure for selection of high-producing strains has been proposed by Romankova et al. (1971). It includes repeated passages of the strains in submerged culture, followed by plating of vegetative mycelium on solid medium and selection of highly active variants. It is claimed that strains producing an increased amount of levorin, trichomycin, and amphotericin B were obtained by this procedure. Repeated submerged transfers of S. hachijoensis resulted in a variant whose activity was 90% higher than that of the original strain (Fursenko et al., 1972).
IV. Genetics of Polyene-Producing Streptomyces A. NATURALVARIANTS OF SOIL-ISOLATED STRAINS AND MUTATIONALSTRAINIMPROVEMENT Selection of high-producing mutants after empirical mutagenesis treatment is one of the first steps prior to and during industrial production of an antibiotic. Such work has been carried out with the producers of amphotericin B and nystatin (Thoma, 1971) and most probably with other polyene producers, but only recently have detailed studies on the subject been published. A few recent publications on mutational studies and actinophage conversion of the producing strains are indicative of increasing interest in the genetics of polyene-producing Streptomyces following the pioneering studies on Streptomyces genetics by Hopwood and his co-workers (Hopwood et al., 1973). The original soil isolate of S. levoris was found to consist of as many as nine morphological types of colonies. The isolate produced 6000-8000 units of levorin per milliliter. Several mutagens were used in a strain improvement program. Mutagenesis with ethyleneimine, ultraviolet light, or N-nitrosomethylurea followed by repeated passage in deep culture, resulted in the isolation of a high-producing strain (S. levoris 28) which produced 35,000-40,000 units/ml (Tereshin, 1976). According to Zhukova et al. (1975), S. levoris 28 consists of three morphological colony types; the main one accounts for 99.7% of the total. Different morphological variants ranged from 20 to 180% of the antibiotic production of the original strain. Streptomyces levoris 28 also produces a nonpolyene antifungal antibiotic, levoristatin.
44
JUAN F. MARTIN A N D LLOYD E. MCDANlEL
Population variants differ in the ratio of levorin to levoristatin which they produce. Soil isolates of S. mycoheptinicum also showed a large population variance. In deep culture this species produces a nonaromatic heptaene macrolide, mycoheptin, and a pentaene macrolide antibiotic. The pentaene macrolide content is usually two to three times higher than that of mycoheptin (Tsyganov et al., 1965). Soil isolates always have a ratio of pentaene to heptaene macrolide higher than two. To increase the yield of the desired heptaene, the ratio of components was modified either by lowering the redox potential of the medium (see Section I1,M) or by mutation. Using N-nitrosomethylurea as mutagenic agent, a large degree (17%) of morphological variance was obtained with high variability in antibiotic production. All mutants produced both the pentaene and the heptaene although their ratios varied from 1.9 to 5.0. However, an increased heptaene to pentaene ratio was found to occur always at the expense of high antibiotic titers. High spontaneous variability in the form of spores and sporophores and in antibiotic titers was also found in the amphotericin B-producing organism Streptomyces nodosus. Zhukova et al. (1970) proposed that the high variability is due to the heterogeneous nature of the strain, consisting probably of several genotypes. Mutants with abundant sporulation and sporophores in the form of short tight spirals were highly active in amphotericin B biosynthesis whereas those with poor sporulation and a markedly changed form of sporophore were low or nonproducers. This correlation is frequently observed in Streptomyces which produce antibiotics. It possibly indicates that both phenomena, antibiotic production and sporulation, are regulated by similar metabolic parameters or that antibiotics play a role in the sporogenesis of bacteria (see reviews by Sadoff, 1972; Sarkar and Paulus, 1972). Natural variants of S. hachijoensis, the producer of trichomycin, differ in cultural and physiological properties from the parent strain as well as in the proportion of the components, trichomycins A and B, in the antibiotic complex (Fursenko et al., 1972). The candidin producer, S. viridoflauus, consists of two clearly different morphological types of colonies: yellowish and nonpigmented variants. Nonpigmented variants arise in the normally yellow population with a frequency of 1 3 % (McDaniel, 1976) and are normally nonproducers. Nonpigmented mutants having antifungal activity were found with very low frequency; they excrete a different antibiotic, the hexaene candihexin, instead of the parental heptaene candidin (Martin and McDaniel, 1974). Studies have also been carried out on the development of nystatinproducing strains. Nonproducer strains of S. noursei were selected from
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
45
nystatin-producing strains by mutation with nitrosomethylurea (Toropova et
al., 1971). Producers and nonproducer strains of S. noursei were similar in morphological, cultural, and biochemical properties. The original soil-isolate of S. noursei produced, in addition to the polyene macrolide nystatin, cycloheximide, actinophenol and compounds of the dioxopiperazine type. After mutagenesis with X-rays, UV, or nitrogen mustard, strains were obtained that did not produce either cycloheximide and actinophenol or nystatin (Spizek et al., 1965a). Strains that do not produce any compounds of the cycloheximide series synthesize about double the amount of nystatin (Dolezilova et al., 1965). Another strain, S. noursei var. polifungini, produces in addition to cycloheximide a complex tetraene macrolide named polifungin consisting of polifungins Al, A,, A3, and B (Kotiuszkoet al., 1972), identical with nystatin. Five UV mutants which lost the ability to synthesize cycloheximide still produced the nystatin components, but differences were observed in the ratio of individual components. Two additional mutants were able to produce biologically inactive tetraene macrolides which lack the aminosugar moiety (mycosamine) (Roszkowski et al., 1972), a structureactivity relationship also found in candihexin complex (Martin and McDaniel, 1975b). As indicated before, production by high-producing polifungin mutants was correlated with increased specific activities of the carboxylation systems: acetyl-CoA carboxylase, methylmalonyl-CoA carboxyl transferase, and PEP carboxylase (Walski and Raczynska-Bojanowska, 1972). B. EFFECTOF ACTINOPHAGESON ANTIBIOTIC PRODUCTION-LYSOGENIC CONVERSION OF ANTIBIOTIC-PRODUCING STRAINS The role of phage infections in antibiotic-producing strains is unclear, but they pose a problem for many industrial fermentations. Lysogenicity in Streptomyces species by temperate phages was first reported by Welsch (1956, 1959). Phages and phage mutants of Streptomyces coelicolw (Hopwood et al., 1973) and other streptomycetes have been studied in detail (Welsch, 1969). Early studies showed that many strains of S. leuoris were lysogenic and polylysogenic (Rautenshtein and Muradov, 1965). Streptomyces levoris strain 2638 is reported to contain at least four different temperate phages designated 2638/1, 2638/II, 2638/III, and 2638/IV. Treatment with acridine orange resulted in variants devoid of three prophages. These variants were still able to produce levorin. When the fourth prophage was removed with increased concentrations of acridine orange, the strain was unable to produce the antibiotic (Rautenshtein and Muradov, 1968). Lysogenization of a strain deprived of all the four prophages with phages
46
JUAN F. MARTIN A N D LLOYD E . MCDANIEL
2638/1, 2638/II, and 2638/III, produced strains without the ability to synthesize antibiotic. Lysogenization with phage 2638/IV resulted in variants capable of producing antibiotic. Thus, it appears that prophage 2638/IV is involved in antibiotic production. It must be taken into consideration that acridine orange, which acts primarily by eliminating (curing) plasmids also acts as a mutagenic agent, especially at high concentrations, and therefore the loss of antibioticproducing ability in some of the strains might be due to mutation of chromosomal genes rather than the curing of extrachromosomal DNA. There are a number of recent reports indicating that extrachromosomal DNA elements (plasmids or defective phages) are possibly involved in the biosynthesis of the antibiotics kasugamycin and aureothricin by Streptomyces kasugaensis (Okanishi et al., 1970), oxytetracycline by S . rimosus (Boronin et al., 1975), and turimycin by Streptomyces hygroscopicus (Kahler and Noack, 1974). In S. coelicolor, Kirby et al. (1975)reported that antibiotic synthesis and resistance are plasmid-determined. Structures resembling incomplete phage particles were found in electron micrographs of antibioticproducing strains (Kurylowicz et al., 1974), and covalently linked circular DNA of small size has been found in S. coelicolor (Schrempf et al., 1975). The levorin complex is a mixture of levorin A and levorin B. Levorin A contains four components, A,,, Al, A,, and A3, which differ in antifungal activity as well as in toxicity (Tsyganov and Yakovleva, 1%9a,b). Infection of a high-producing strain of S. levoris with a specific virulent mutant of a temperate phage produced increased variation in cultural characteristics and antibiotic levels. Variants isolated from secondary growth of S. leuoris after phage infection were phage-resistant because of lysogenization. The ability of phage-resistant variants to produce levorin ranged &om 0 to 280% relative to the original strain. However, they lost phage resistance during subsequent subculture as the result of the loss of prophages. Phage-resistant variants and variants that have lost their phage resistance differ from the parent strain in the relative content of the components of the levorin complex (Rautenshtein et al., 1972a). A similar phenomenon has been described in Streptomyces netropsis. Four cultures of S. netropsis that produce a polyene macrolide antibiotic active against Verticillium duhliae, the causative agent of cotton wilt (Askarova et al., 1972), were also found to be lysogenic. These strains gave rise spontaneously to variants that lost their prophage along with the ability to produce the antibiotic that the parent cultures produced. The variants regained the ability to produce the antibiotic by lysogenization with temperate phages isolated &om the original strains (Muradov and Rautenshtein, 1973). The relationship between lysogenic conversion and ability to produce antibiotic is by no means clear. However, it is interesting to speculate on the
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
47
possibility that some of the genes (more likely regulatory genes) coding for antibiotic synthesis are coded by phages or are turned on by phage-coded genes. Expression of genes coding for antibiotic would occur only after lysogenic conversion. Loss of the prophage could possibly be the reason for the well known strain degeneration phenomenon (loss of the ability to produce antibiotic). Lysis of antibiotic-producing strains is a rather common phenomenon. It is generally due to virulent mutants of temperate phages existing in lysogenic cultures (Rautenshtein, 1967). Virulent mutants of the temperate phages of S. netropsis were usually found on the fourth day of growth when high titers of antibiotic were reached. However, if the cultures were treated on the first day with concentrations of antibiotic ranging from 500 to 4000 units/ml, virulent mutants arose during the first 24 hours (Muradov and Rautenshtein, 1972). Similarly, the antibiotic vancomycin produced by Streptomyces orientalis induced the formation of virulent mutants of its phages at concentrations below 1OOO units/ml (Rautenshtein and Deshchits, 1970). Streptomyces rimosus, the producer of oxytetracycline, was also found to be lysogenic under conditions of industrial production. Lysis, however, was caused not by a virulent mutant of the temperate phage, but by a lytic factor that appears to be induced by the temperate phage in the course of transformation of the prophage into mature particles (Rautenshtein et al., 197213). Thus there appears to be a close relationship between actinophage infection and the production of polyene macrolide antibiotics, which deserves further research.
REFERENCES Abou-Zeid, A. A. (1973).Zentralbl. Bakteriol., Parasitenkd., Infectionskr., Hyg. Abt. 2 128,68. Abou-Zeid, A. A,, and Abou-el-Atta, A. Y. (1971). Zentralbl. Bakteriol., Parasitenkd., Znfectionskr. H y g . , Abt. 2 126, 371. Acker, R. F., and Lechevalier, H. (1954). Appl. Microbiol. 2, 152. Alberts, A. W . , and Vagelos, P. R. (1968). Proc. Natl. Acad. Sci. U.S.A. 59, 561. Arima, K., and Odahara, Y. (1971). Japanese Patent 71 30, 703; Chem. Abstr. 75, 150,313 (1971). Arima, K., Okazaki, H . , Ono, H . , Yamada, K., and Beppu, T. (1973). Agric. Biol. Chem.37, 2313. Askarova, S. A,, Khodzhibaeva, S. M., and Khalikov, D. R. (1972). Mikrobiologiya 41, 490. Atkinson, D. E. (1965). Science 150, 851. Atkinson, D. E. (1969). Annu. Reo. Microbiol. 23, 47. Atkinson, D. E., and Walton, G. M. (1967).J. Biol. Chem. 242, 3239. Ball, S . , Bessell, C. J., and Mortimer, A. (1957).J. Gen. Microbiol. 17, 96. Belenky, B. G . , Soloviev, S . N . , Philippova, A. I., Nevinsky, A. A ., Mamtsis, A. M., and Kogan, S. B. (1966). Antibiotiki 11, 112.
48
JUAN F. MARTIN AND LLOYD E. MCDANIEL
Belousova, I. I., Lishnevskaya, E. B., Elgart, R. E., andTereshin, I. M. (1970a).Antibiotiki 15, 224. Belousova, I. I., Lishnevskaya, E. B., Elgart, R. E., and Tereshin, I. M. (1970b). Antibiotiki 15, 916. Belousova, I. I., Lishnevskaya, E. B., and Elgart, R. E. (1971). Anh’biotiki 16, 684. Benveniste, R., and Davies, J. (1973). Proc. Natl. Acad. Sci. U.S.A. 70, 2276. Berdy, J. (1972). In5 Bull., lnt. Cent. In. Antibiot. 10, 1-65. Bianchi, H., Cotta, E., Ferni, G., Grein, A., Julita, P., Mazzoleni, R., and Spdh, C. (1974). Arch. Mikrobiol. 98, 289. Bibikova, M. V., Laiko, A. V., Selezneva, T. I., and Kovsharova, I. N. (1975). Antibiotiki 20, 675. Birch, A. J., Holzapfel, C. W., Rickards, R. W., Djerassi, C., Suzuki, M., Westley, J., Dutcher, J. D., and Thomas, R. (1964). Tetrahedron Lett. p. 1491. Birnbaum, J. (1970).J . Bacteriol. 104, 171. Bognar, R., Brown, B. O., Lockley, W. J. S., Makleit, S., Toube, T. P., Weedon, B. C. L., and Zsupan, K. (1970). Tetrahedron Lett. p. 471. Bonner, D. P., Mechlinski, W., and Schaffner, C. P. (1975).I . Antibiot. 28, 132. Boronin, A. M., Borisoglebskaya, A. N., and Sadovnikova, L. G. (1975). In “Genetics of Industrial Microorganisms” (K. D. MacDonald, ed.). Academic Press, New York. Bosshardt, R., and Bickel, H. (1968).Erperientia 24, 422. Brand], E., Schmid, A., and Steiner, H. (1966).Biotechnol. Bioeng. 8, 297. Brewer, G. A . , and Frazier, W. R. (1962). Antimicrob. Agents Chemother. (1961) p. 212. Brock, T. D. (1956). Appl. Microbiol. 4, 131. Bu’Lock, J. D. (1967). “Essays in Biosynthesis and Microbial Development.” Wiley, New York. Bu’Lock, J. D. (1974). “Industrial Aspects of Biochemistry.” North-Holland Publ., Amsterdam. Burrows, H. J., and Calam, D. H. (1970).J. Chromatogr. 53, 566. Calam, D. H. (1974).J . Chromatogr. Sci. 12, 613. Chapman, A. G., Fall, L., and Atkinson, D. E. (1971).J . Bacteriol. 108, 1072. Cole, M. (1966). Appl. Miwobiol. 14, 98. Corcoran, J. W. (1973). In “Genetics ofhdustrial Microorganisms” (Z. Vanek, 2. Hostilek, and J. Cudlin, eds.), Vol. 2, pp. 339-351. Elsevier, Amsterdam. Corcoran, J. W., and Chick, M. (1966). Biosynth. Antibiot. 1, 159. Corcoran, J. W., and Darby, F. J. (1970). In “Lipid Metabolism” (S. J. Wakil, ed.), pp. 431479. Academic Press, New York. Dekker, J., and Ark, P. A. (1959). Antibiot. Chemother. (Washington, D. C.). 9, 327. Demain, A. L. (1968).Lloydia 31, 395. Demain, A. L. (1972).J. Appl. Chem. 6.Biotechnol. 22, 345. Demain, A. L. (1974). Ann. N. Y. Acad. Sci. 235, 601. Demain, A. L., and Inamine, E. (1970). Bactel-iol. Reo. 34, 1. Dimroth, P., Walter, H., and Lynen, F. (1970). Eur. J . Biochem. 13, 98. Divekar, P. V., Vora, V. C., and Khan, A. W. (1966).J . Antibiot. 19, 63. Dolezilova, L., Spizek, J., Vondracek, M., Paleckova, K., and Vanek, Z. (1965). J. Gen. Mimobiol. 39, 305. Donovick, R.,and Brown, W. E. (1965).In “Biogenesis ofAntibiotic Substances” (Z. Vanek and Z. Hostilek, eds.), pp. 281-286. Academic Press, New York. Dutcher, J. D. (1957). In “Monographs on Therapy,” Vol. 2, pp. 87-98. Squibb Institute of Medical Research, New Brunswick, New Jersey. Dutcher, J. D. (1968). Kirk-Othmer Encycl. Chem. Technol., 2nd Ed. Vol. 16, pp. 13S143. Egorov, N. S . , and Toropova, E . G. (1975). Proc. Symp. Znt. Assoc. Microbiol. Soc., 1974.
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
49
Ethiraj, S. (1969). Ph.D. Thesis, Rutgers University, New Brunswick, New Jersey. Feren, C. J., and Squires, R. W. (1969). Biotechnol. Bioeng. 11, 583. Filippova, A. I . , Soloviev, S. N., Vasilieva, N. G., Dumova, A. M., Egorenkova, A. N., Karnaushkina, A. I., Karpenko, M. P., Fradkova, T. A., and Shenin, Y. D. (1972). Antibiotiki 17, 932. Flick, P. K., and Bloch, K. (1975).J . Biol. Chem. 250, 3348. Fursenko, M. V., Zhukova, R. A., Malyshkina, M. A . , and Motorina, A. G. (1972). Mikrobiologiya 41, 132. Gallo, M., and Katz, E. (1972).J. Bacteriol. 109, 659. Ganguly, J. (1960). Biochim. Biophys. Acta 40, 110. Garrett, E. R. (1954).J. Am. P h a n . Assoc. 43, 539. Gatenbeck, S . , and Hermodsson, S. (1965).Acta Chem. Scund. 19, 65. Goldberg, I . , Walker, J. R., and Bloch, K. (1973).Antimicrob. Agents 6. Chemother. 3, 549. Graven, R. (1956).Rio. Biol. 13, 239. Haavik, H. I. (1974).J. Cen. Microbiol. 84, 321. Hamilton-Miller, J. M. T. (1973). Bacteriol. Reo. 37, 166. Harrison, D. E. F. (1972).J . Appl. Chem. 6. Biotechnol. 22, 417. Harrison, D. E. F. (1973). Crit. Reo. Microbiol. 2, 185. Herold, M., and Hostalek, Z. (1965).Zn “Biogenesis ofAntibiotic Substances” (Z. Vanek and Z. Hostdek, eds.), pp. 93-97. Academic Press, New York. Hofheinz, W., and Grisebach, H. (1965).Z. Naturfursch., Teil B 20, 43. Hopwood, D. A,, Chater, K. F., Dowding, J. E., andVivian, A. (1973).Bacteriol. Reo. 37,371. Hosler, P., and Johnson, M. J. (1953).Znd. Eng. Chem. 45, 871. Hostilek, Z., Rybushko, T. A., Cudlin, J., andvanek, Z. (1969).Foha Microbiol. (Prague) 14, 121. Hurley, L. H., and Bialek, D. (1974).J . Antibiot. 27, 49. Inamine, E., Lago, B. D., and Demain, A. L. (1969).Ferment. Ado., Pup. Znt. Ferment. Symp., 3rd, 1968 pp. 199-221. Izui, K., Yoshinaga, T., Morikawa, M., and Katsuki, H. (1970). Biochem. Biophys. Res. Commun. 40, 949. Janglova, Z., SuchL, J., and Vanek, Z. (1969). Folia Microbiol. (Prague) 14, 208. Johnson, M. J. (1952). Bull. W. H . 0. 6, 99. Kahler, R., and Noack, D. (1974). Z. Allg. Mikrobiol. 14, 529. Khoklova, Y. M., Korenyako, A. I., Nikitina, N. I., and Puchnina, A. V. (1963). 2. Allg. Mikrobiol. 3, 195. Kimura, A. (1967). Agric. Biol. Chem. 31, 837. Kirby, R., Wright, L. F., and Hopwood, D. A. (1975). Nature (London) 254, 265. Klimov, A. N., and Nikiforova, A. A . (1971).Antibiotiki 16, 325. Klimov, A. N . , and Nikiforova, A. A., and Etingov, E. D. (1971).Antibiotiki 16, 243. Konev, Y. E., Tsyganov, V. A,, Etingov, E. D., Zavdnaya, N. M., and Filippova, A. I. (1973). Antibiotiki 18, 354. Kotiuszko, D., Morawska, H., and Porowska, N. (1972).Acta Miwobiol. Pol., S e r . A 4, 201. Kurylowicz, W., Kurzatkowski, W., Woznicka, W., Paskiewicz, and Williams, S. T. (1974). Postepy Hig. Med. Dosw. 28, 419. Light, R. J., and Hager, L. P. (1968). Arch. Biochem. Biophys. 125, 326. Linke, H. A. B., Mechlinski, W., and Schaffner, C. P. (1974).J. Antibiot. 27, 155. Liu, C. M., McDaniel, L. E., and S c h h e r , C. P. (1972a).J. Antibiot. 25, 116. Liu, C. M., McDaniel, L. E., and Schdner, C. P. (1972b).J. Antibiot. 25, 187. Liu, C. M., McDaniel, L. E., and Schdner, C. P. (1975).Antimicrob. Agents 6.Chemother. 7, 196.
50
JUAN F. MARTIN AND LLOYD E . MCDANIEL
Lobanova, V. V., and Brinberg, S. L. (1971).Antibiotiki 16, 697. Lopatnev, S. V., Kleiner, G. I., and Bylinkha, E. S. (1973). Antibiotiki 18, 608. Lopatnev, S. V., Bylinkina, E. S., and Kleiner, G. I. (1975).Antibiotiki 20, 31. Lowe, D. A., and Westlake, D. W. S. (1971). Can. J. Biochem. 49, 448. Lust, G., and Lynen, F. (1968). Eur. J. Biochem. 7, 68. Lvova, L. E., Venkova, I. B., Raigorodskaya, V. Y., Soifer, R. D., andhankova, T. A. (1973). Antibiotiki 18, 439. Lynen, F. (1967). Biochem. J. 102, 381. McCarthy, F. J.. Fisher, W. P., Charney, J., and Tytell, A. (1955). Antibiot. Annu. pp. 71S732. McDaniel, L. E. (1976).J. Antibiot. 29, 195. McDaniel, L. E., and Bailey, E. G. (1969). Appl. Microbiol. 17, 286. McDaniel, L. E., Bailey, E. G., Ethiraj, S., and Andrews, H. P. (1976). Dev. Id.Microbiol. 17, 91. Magasanik, B. (1961). Cold Spring Harbor Symp. Quant. Biol. 26, 249. Majumdar, M. K., and Majumdar, S. K. (1970). Biochem. J. 120, 271. Malik, V. S. (1972).Adv. Appl. Microbiol. 5, 297. Malik, V. S., and Vining, L. C. (1971). Can. J. Microbiol. 17, 1287. Manwaring, D. G., Rickards, R. W., Gaudino, G., and Nicolella, V. (1969).J. Antibiot. 22,545. Martin, J. F. (1976). Dev. Znd. Microbiol. 17, 223. Martin, J. F., and McDaniel, L. E. (1974). Dev. Ind. Mierobiol. 15, 324. Martin, J. F., and McDaniel, L. E. (197%). Biotechnol. Bioeng. 17, 925. Martin, J. F., and McDaniel, L. E. (1975b). Antimicrob. Agents 67 Chemother. 8, 200. Martin, J. F., and McDaniel, L. E. (1975~).Biochim. Biophys. Acta 411, 186. Martin, J. F., and McDaniel, L. E. (1976). Eur. J. Appl. Microbiol. (in press). Matsuhashi, M., Matsuhashi, S., Numa, S., and Lynen, F. (1964). Biochem. Z. 340, 243. Mechlinski, W. (1973). Zn “CRC Handbook of Microbiology” (H. A. Lechevalier and A. Laskin, eds.), Vol. 111, pp. 93-107. CRC Press, Cleveland, Ohio. Mechlinski, W., Schatmer, C. P., Ganis, P., and Avitabile, G. (1970). Tetrahedron Lett. p. 3873. Meers, J. L. (1973). Crit. Rev. Microbiol. 2, 139. Mertz, E. P., and Doolin, L. E. (1973). Can. J. Microbiol. 19, 263. Miller, A. L., and Walker, J. B. (1970).J. Bacteriol. 104, 8. Mohan, R. R., Pianotti, R. S. Martin, J. F., Ringel, S. M., Schwartz, B. S., Bailey, E. G., McDaniel, L. E., and Schaffner, C. P. (1963). Antimicrob. Agents Chemother. p. 462. Muradov, M., and Rautenshtein, Y. I. (1972). Mikrobiologiya 41, 146. Muradov, M., and Rautenshtein, Y. I. (1973). Mikrobiologiya 42, 327. Nefelova, M. W., and Pozmogova, I. N. (1960).Mikrobiologiya 29, 856. Nimi, O., Ito, G., Ohata, Y., Funayama, S., and Nomi, R. (1971).Agric. Biol. Chem. 35, 856. Nugumanov, B. S., Toropova, E. G., and Egorov, N. S. (1973). Antibiotiki 18, 489. Okanishi, M., Ohta, T., and Umezawa, H. (1970).J. Antibiot. 23, 45. Okazaki, M., Ono, H., Yamada, K., Beppu, T., and Arima, K. (1973).Agric. B i d . Chem. 37, 2319. Oroshnik, W., and Mebane, A. D. (1963). Prog. Chem. Org. Nut. Prod. 21, 17. Overath, P., and Raufuss, E. M. (1967). Biochem. Biophys. Res. Cornmun. 29, 28. Pass, L., and Raczynska-Bojanowska, K. (1968). Acta Biochim. Pol. 15, 355. Perlman, D. (1967). Prog. Ind. Microbiol. 6, 1. Perlman, D., and Semar, J. B. (1965).BiotechnoZ. Bioeng. 7, 133. Pirt, S. J. (1971). Biochem. J. 121, 293.
PRODUCTION OF POLYENE MACROLIDE ANTIBIOTICS
51
Pledger, R. A , , and Lechevalier, H. A. (1956).Antibiot. Annu. pp. 24S254. Popova, L. A , , Zavileyskaja, G. F., Dyghem, N. T., and Pestereva, G. D. (1961).Antibiotiki 6, 34. Porowska, N.,Halski, L., Plociennik, D., Kotiusko, H., Morawaska, Z., Kowszyk-Gindifer, Z., and Bojar-Dahlig, H. (1972).Red. Trao. Chim. Pays-Bas 91, 780. Raczynska-Bojanowska, K. (1974). Postepy H i g . Med. Dosw. 28, 499. Raczynska-Bojanowska, K., Rafalski, A , , and Ostrowska-Krysiak, B. (1970).Acta Biochim. Pol. 17, 331. Rafalski, A., and Raczynska-Bojanowska, K. (1972).Acta Biochim. Pol. 19, 71. Rafalski, A , , and Raczynska-Bojanowska, K. (1973).Acta Microbiol. Pol., S e r . B 5, 87. Rasmussen, R. K., and Klein, H. P. (1968).J. Bacteriol. 95, 727. Rautenshtein, Y. I. (1967). Skh. B i d . 4, 499. Rautenshtein, Y. I., and Deshchits, L. A. (1970). Mikrobiologiya 39, 1051. Rautenshtein, Y. I., and Muradov, M. (1965). Mikrobiologiya 34, 1011. Rautenshtein, Y. I., and Muradov, M. (1968).Zzo. Akad. Nauk S S S R , S e r . B i d . 4, 575. Rautenshtein, Y. I . , Zhukova, R. A,, Zhuraleva, N. P., Etingov, E. D., Zurabova, E. R., and Zaval’naya, N. M. (197%). Mikrobiologiya 41, 333. Rautenshtein, Y. I., Borisova, T. G., Gol’dat, S. Y., Zhunaeva, V. V., Vladimorov, A. V., Moskalenko, L. N., Terebkova, L. S., Isaikina, L. S., and Misyureva, N. G. (197213). Mikrobiologiya 41, 1055. Rickards, R. W., Smith, R. M., and Golding, B. T. (1970).J. Antibiot. ‘23, 603. Rinehart, K. L., Cook, J. C., Maurer, K. H., and Rapp, U. (1974).J . Antibiot. 27, 1. Robbers, J. E., Robertson, L. W., Hornemann, K. M., Jindra, A , , and Floss, H. G. (1972).J . Bacteriol. 112, 791. Romankova, A. G., Zurabova, E. R.,Fursenko, M. V., Sukharevich, V. I . , andPronina, M. I. (1971).Antibiotiki 16, 579. Roszkowski, J., Ruczaj, Z., Sawnor-Korszynska, D., Kotiuszko, D., Morawska, H., Siejko, D., and Raczynska-Bojanowska, K. (1971).Acta Microbiol. Pol., S e r . B 3, 97. Roszkowski, J., Kotiuszko, D., Rafalski, A , , Morawska, H., and Raczynska-Bojanowska, K. (1972).Acta Microbiol. Pol., S e r . B 4, 9. Sadoff, H. L. (1972). Spores 5, 157-166. Sarkar, N., and Paulus, H. (1972).Nature (London), New Biol. 239, 228. Satyanarayana, T., and Klein, H. P. (1973).J . Bacteriol. 115, 600. Schafmer, C. P., Steinman, I. D., SaEerman, R. S., and Lechevalier, H. (1958). Antibiot. Annu. p. 869. Schrempf, H., Bujard, H., Hopwood, D. A,, and Goebel, W. (1975).J. Bacteriol. 121, 416. Siewert, G., and Kieslich, K. (1971).Appl. Microbiol. 21, 1007. Soltero, F. V., and Johnson, M. J. (1954). Appl. Microbiol. 2, 41. Spizek, J., Malek, I., Dolezilova, L., Vondracek, M., and Vanek, Z. (1965a).Folia Microbiol. (Prague) 10, 259. Spizek, J., Malek, I., Suchy, J., Vondracek, M., and Vanek, 2. (1965b). Folia Mb-obiol. (Prague) 10, 263. Styczynska, D., Niemczyk, H., and Mazon, M. (1965).Acta Microbiol. Pol. 13, 570. Sukharevich, V. I . , Shvetsova, N. N., and Yakovleva, E. P. (1970a).Antibiotiki 15, 981. Sukharevich, V. I . , Yakovleva, E. P., Tsyganov, V. A , , and Shvetsova, N. N. (1970b). Mikrobiologiya 39, 981. Sukharevich, V. I., Yakovleva, E. P., and Tsyganov, V. A. (1972). Mikrobiologiya 41, 508. Surikova, E. I . , and Zavileiskaya, G . F. (1972). Mikrobiologiya 41, 44. Tereshin, I. M. (1976). “Polyene Antibiotics-Present and Future.” Univ. of Tokyo Press, Tokyo.
52
JUAN F. MARTIN A N D LLOYD E . MCDANIEL
Thoma, R. W. (1971). Folia Microbiol. (Prague) 16, 197. Tingstad, J. E., and Garrett, E. R. (1960).J. Am. Pharm. Assoc. 49, 352. Toropova, E. G., Egorov, N. S., and Nugumanov, B. S. (1971). Antibiotiki 16, 590. Toropova, E. G., Egorov, N. S., Nugumanov, B. S., and Korosteleva, N. L. (1972). Mikrobiologiya 41, 668. Tsyganov, V. A,, and Yakovleva, E. P. (1968).Antibiotiki 13, 723. Tsyganov, V. A., and Yakovleva, E. P. (196%).Antibiotiki 14, 505. Tsyganov, V. A., and Yakovleva, E. P. (1969b). Antibiotiki 14, 635. Tsyganov, V. A , , Konev, Y. E., and Namestnikova, V. P. (1965). Antibiotiki 10, 599. Tsyganov, V. A., Yakovleva, E. P., Morozov, V. M., Sokolova, E. N., Kuznetsova, 0. S., and Ratsun, G. M. (1973). Antibiotiki 18, 358. Uri, J., and Bekesi, I. (1958). Nature (London) 181, 908. Vagelos, P. R., Alberts, A. W., and Martin, D. B. (1963). /. B i d . Chem. 238, 533. Vertesy, L. (1972).J . Antibiot. 25, 4. Vining, L. C. (1960). Hind. Antibiot. Bull. 3, 37. Volpe, J. J., and Vagelos, P. R. (1973). Annu. Rew. Biochem. 43, 21. Wagman, G. H., Testa, R. T., Patel, M., Marquez, J. A., Oden, E. M.,. Waitz, J. A., and Weinstein, M. J. (1975). Antimicrob. Agents 6. Chemother. 7 , 457. Walker, J . B. (1971). Uoydia 34, 363. Weeks, G., Shapiro, M.,Bums, R. O., and Wakil, S. J. (1969).J . Bacteriol. 97, 827. Weinberg, E. D. (1962). Perspect. B i d . Med. 5, 432. Weinberg, E. D. (1970). Adu. Microb. Physiol. 4, 1. Weinberg, E. D. (1974). Dew. Ind. Microbid. 15, 70. Welsch, M. (1956). Virology 3, 703. Welsch, M. (1959). Ann. N . Y. Acad. Sci. 81, 974. Welsch, M. (1969). In “Proceedings of the Symposium on Genetics and Breeding of Streptomyces,” pp. 43-62. Yugoslav Acad. Sci. Arts, Zagreb. Yakovleva, E. P., Solokova, E. N., and Tsyganov, V. A. (1972). Antibiotiki 17, 971. Zhdanovich, Y. V., Lokshin, C. B., and Kuzovkov, A. D. (1967). a i m . Farm. Zh. 1, 42. Zhukova, R. A., Zhuravleva, N. P., and Morozov, V. M. (1970). Antibiotiki 15, 785. Zhukova, R. A., Kuznetsova, I. A., and Bolshakova, L. 0. (1975). Antibiotiki 20, 227. Zondag, E., Posthuma, J., and Berends, W. (1960). Biochim. Biophys. Acta 39, 178.
Use of Antibiotics in Agriculture TOMOMASA MISATO, KEIDO KO,'
AND ISAMU YAMACUCHI
The Znstitute of Physical and Chemical Research, Wako-shi, Saitama, Japan I. Introduction ........ 11. Agricultural Antibiotics an em .......... A. Advantages ........................................ B. Limitations ...................... 111. Utilization of M A. Streptomycin B. Chloramphenicol ................................... C. Cycloheximid D. Griseofulvin E. Novobiocin ......................... . . . . . . . . . . . . . . . IV. Antibiotics Developed as Agricultural Chemicals ............ A. Brief History of Research on Agricultural Antibiotics in Japan ............................................. B. Blasticidin S ....................................... C. Kasugamycin .................... D. Polyoxins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Validamycin ....................................... F. Tetranactin .......................... G . Cellocidin ......................................... H. Ezomycin .............................. I. Other Pro otics .......................... V. Future Prospects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . .
53 54 54 55 55 58 59 59 60
60 60 61 62 66 69 73 76 79 79 80 82 83
1. Introduction
Attempts to control plant diseases by the use of antibiotics have been made by plant pathologists all over the world since the discovery of penicillin. In western countries, however, only a few of these antibiotics have been developed for practical use. These are streptomycin, tetracycline, cycloheximide, and griseofulvin. Streptomycin, the first antibiotic introduced in agriculture, was used in the United States for the control of pear fire blight. This antibiotic and a mixture of streptomycin and tetracycline have been used for the control of bacterial plant diseases, and cycloheximide and griseofulvin have been used for the control of fungal plant diseases. Cycloheximide is a very powerful fungicide, but, unfortunately, highly toxic to plants, which restricts its use against plant diseases. Griseofulvin is a much less phytotoxic systemic fungicide, but its use is also restricted, because the relation of its manufacturing cost to its performance under field conditions is not satisfactory. 'Formerly K. T. Huang. 53
54
TOMOMASA MISATO, K E I W KO, AND ISAMU YAMAGUCHI
In Japan, these four antibiotics had been used only on a very limited scale for practical control of plant diseases until the curative effect of blasticidin S on rice blast was discovered by the author’s research group in 1958. The successful application of blasticidin S against rice blast has stimulated the development of agricultural antibiotics and led to the discovery of several excellent antibiotics, such as kasugamycin, polyoxins, and validamycin. Blasticidin S and kasugamycin are now in practical use for rice blast control instead of mercuric fungicides, and polyoxins and validamycin have been used to control the sheath blight of rice plant instead of arsenic fungicides (Misato, 1969a,b, 1975a,b; Huang and Misato, 1970). The amount of antibiotics used in Japan is shown in Table I. Reviews on many antibiotics tested for agricultural use in western countries have already been published (Dekker, 1963, 1969, 1971, 1975; Thirumalachar, 1968; Woodbine, 1962; Zaumeyer, 1956). It is the purpose of this paper to discuss the present status of antibiotics as plant disease control agents. The discussion will mainly be limited to antibiotics that show promise for practical application or are already so used, especially in Japan. For the older literature, the reader may refer the reviews mentioned above.
II. Agricultural Antibiotics and the Pollution Problem One of the greatest needs in the world is the production of food for billions of people. At present, such production requires the use of pesticides, but, in turn, their use brings the possibility of environmental pollution. Environmental hazards caused by conventional agricultural chemicals are classified into two categories: (1) a nonselective toxicity (parathion); (2) concentration and accumulation of toxic compounds in the environment (DDT and BHC). Pollution-free pesticides, therefore, should have selective toxicity to target organisms and be susceptible to photolysis and degradation by soil microorganisms. In these respects, antibiotics are supposed to be useful biodegradable pesticides. As is true for every scientific technique, the use of agricultural antibiotics too has advantages and limitations. A. ADVANTAGES 1. Since agricultural antibiotics are sprayed at very low concentrations (10-50 ppm), the amount of compounds sprayed in a unit area is fir less (UlO-l/lOO) than of other conventional pesticide chemicals. Also antibiotics should be rapidly degraded by soil microorganisms. Therefore it is expected that the use of agricultural antibiotics will not bring environmental pollution.
USE OF ANTIBIOTICS IN AGRICULTURE
55
2. Antibiotics are produced by utilizing agricultural products obtained from biological photosynthetic conversion of solar energy. The production of antibiotics does not consume much stored energy, such as oil and coal. 3. Novel bioactive compounds with very complex chemical structures that are outside the domain of organic synthesis can be isolated and manufactured on a commercial basis. 4. Various antibiotics can be produced by using a single set of equipment and facilities. This advantage brings a low initial cost of antibiotics. B . LIMITATIONS 1. Antibiotics are generally mixtures of various structurally related components, like polyoxins. This complexity makes difficult the analysis on a microscale and the safety evaluation of compounds. 2. Tolerance or resistance of pathogenic microorganisms to antibiotics has occurred shortly after application of antibiotics for the control of plant diseases. In order to reduce or avoid the emergence of tolerant fungi and bacteria in the field, the alternate or combined application of chemicals with different mechanisms of action is recommended.
111. Utilization of Medical Antibiotics as Agricultural Chemicals The successful use of antibiotics against bacterial diseases of human beings has led to large-scale screening of antibiotics effective for plant disease control in the world. Many antibiotics developed for medical purposes were investigated for activity against plant pathogens. Furthermore, screening of soil organisms for production of antibiotic substances was started with the prime purpose of plant disease control. However, the results obtained with antibiotics and antibiotic-containing culture broth did not fulfill the high expectations. Many were too unstable under field conditions or showed toxic side effects on plants. Most antibiotics were rather expensive, even when used as a crude product. The number of antibiotics that were promising for practical use appeared to be rather restricted (Dekker, 1963). The medical antibiotics streptomycin, oxytetracycline (terramycin), and chloramphenicol are now used in various countries against several bacterial plant diseases. The antibiotics cycloheximide and griseofulvin, developed for agricultural purposes, are also used against several fungal plant diseases. Numerous other antibiotics, among them a number of polyenes, macrolides, polypeptides, purine- and pyrimidine derivatives, have not reached the stage of practical application against plant diseases.
TABLE I AGRICULTURAL ANTIBIOTICSUUSED I N JAPAN
Registration
Antibiotics
Diseases
Amounts used in Japan (1974) Weight cost (ton) (103 yen)
Antifungal antibiotics
1959 1959 1961
1965
1967
Cycloheximide Wettable powder Griseofulvin Paste Blasticidin S Dust Wettable powder Soh tion Kasugamycin Dust Wettable powder Solution Polyoxins Dust Wettable powder Solution
Onion downy mildew, shoot blight of Japanese larch Fusarium wilt of melon
"8 17
35,020
2
4,700
1250 3 152
75,000 2,547 102,426
7930 265 10
507,762 221,805 8,820
387 418 34
32,121 960,982 38,216
Rice blast
Rice blast
Rice sheath blight, fungal diseases of fruits and vegetables
t
z
1970 1972
1957 1964 1964
1968
1974
Ezomycin Wettable powder Validamycin Dust Wettable powder Antibacterial antibiotics Streptomycin Wettable powder Cellocidin Wettable powder Chloramphenicol basic copper Wettable powder Novobiocin Solution
+
Insecticidal antibiotics Tetranactin
Stem rot of kidney bean 0
0
3893 94
513,876 143,256
349
692,086
0
0
10
33,130
0
0
-
-
Rice sheath blight
Bacterial diseases of fruits and vegetables Rice bacterial leaf blight Rice bacterial leaf blight
Bacterial canker of tomatoes
Insects Carmine mite of fruits and tea
58
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
In the following sections, the antibiotics streptomycin, oxytetracycline, chloramphenicol, cycloheximide, griseofulvin, and novobiocin will be discussed. A vast number of antifungal antibiotics developed for medical purposes, which show no promise for practical application against plant diseases, do not fall within the scope of this review.
A. STREPTOMYCIN Streptomycin was the first antibiotic applied against plant diseases. It has been used to control fire blight of apple and pear by foliar application at the concentration of 200 ppm in the United States since 1954. By this work, economic control of plant diseases by the use of antibiotics has been recognized. In Japan it was found that foliar application of 200 ppm of streptomycin was effective to control wild fire of tobacco (Hidaka and Murano, 1955, 1956, 1959), and since then this antibiotic has been in practical use. A mixture of streptomycin and oxytetracycline was also applied against bacterial canker of peach, citrus canker, soft rot of vegetables, and various other bacterial diseases. It is interesting that streptomycin shows an inhibitory effect on plant fungal diseases. Sakurai et aE. (1958) observed its curative effect against downy mildew of rice by dipping rice seedlings infected with Phytophthoru mcrospora in 100-400 pprn of streptomycin solution for 3 hours. In experiments on the translocation of streptomycin in host plants, Mukoo et al. (1954) dipped potato seedlings in 100 ppm of streptomycin solution and found that the absorbed compound reached to the top of the seedlings after 3 hours. Using inhibition zone technique, Hidaka and Murano (1956) noted that streptomycin which was absorbed from tobacco stems translocated to upper leaves and then reached lower leaves. When the antibiotic was absorbed from leaves, it did not translocate. These findings were confirmed by experiments using 35S-labeledstreptomycin sulfate. Streptomycin is effective against bacterial leaf blight of the rice plant at a concentration of 200-500 ppm, but at 500 pprn or more it is toxic to rice leaves not only in expressing chlorotic spots, but also in reducing rice yield, especially when sprayed at near-heading stage. Arada et al. (1961) noted the almost complete losses of assimilated starch near chlorotic spot and its reduced metabolic activity. Kamimura and Takahi (1960)pointed out that mixtures of streptomycin sulfate and iron chloride or citrate were effective to reduce the phytotoxicity of the antibiotic. Tabei and Mukoo (1955) found the occurrence of streptomycin-resistant plant pathogenic bacteria of potato ring rot and soft rot, and they devised a culture medium for the isolation and quantitative estimation of a
USE OF ANTIBIOTICS IN AGRICULTURE
59
streptomycin-resistant strain of rice leaf blight pathogen, Xanthomonas oryzae, from infected plants. Wakimoto and Mukoo (1963) isolated sixteen streptomycin-resistantX . oryzae strains that could grow in medium containing 100 pprn of streptomycin. These streptomycin-resistant strains showed cross-resistance to chloramphenicol and cellocidin. B. CHLORAMPHENICOL By spraying it at 100-200 ppm concentration, chloramphenicol has been used to control bacterial leaf blight of rice in Japan since 1964. The antibiotic is industrially provided by chemical synthesis. The active L base, which is separated from the mixture of L and D forms produced by chemical synthesis, is used for chemotherapy. For purposes of plant protection, the mixture of both forms before separation is used. Recently, the antibiotic was mixed with basic copper chloride and used for controlling some bacterial diseases of fruit plants and vegetables. (ACTIDIONE) C. CYCLOHEXIMIDE
Cycloheximide was found as a by-product of streptomycin in the culture medium of Streptomyces griseus. Naramycin, a stereoisomer of cycloheximide, is produced from Streptomyces naraensis in high amounts without the by-production of streptomycin. Cycloheximide inhibits the growth of various plant pathogenic microorganisms at very low dose levels, but the application is limited because of its high phytotoxicity. Sprays containing 2 ppm of the antibiotic have been used for controlling downy mildew of onions in Japan since 1959, and a 3-ppm solution was found to be effective against shoot blight of Japanese larch (Takaoka, 1961, 1968). This antibiotic is used as a fungicide in forests. When a 500-ppm cycloheximide oil formulation was applied three times to trunks of 4-year-old pines at the height of one-third from the soil level, the antibiotic was absorbed and translocated to the upper part of free branches. By this method, D6ke et al. (1964)succeeded in reducing the damage rate of Japanese larch due to shoot blight by one-third. Akai and co-workers(1962a,b, 1963, 1964) found that cycloheximide-injured leaves contained a reduced amount of chlorophyll and a higher level of RNA. Chromosome aberrations and abnormal cell divisions in root-tip cells of wheat were also observed. Idemizu. (1960) noted that semicarbazone derivatives of cycloheximide showed reduced phytotoxicity while its potential activity against fungi was constant. However, oxime and acetate derivatives showed weak phytotoxicity and antifungal activity.
60
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
D. GRISEOFULVIN Utilization of griseofulvin for plant protection was first introduced by Brian et al. (1951). They succeeded in controlling early blight of tomato and Botrytis disease of lettuce. In Japan, Hoshino and Sawamura (1957) and Terui and Kagawa (1959) observed its inhibitory effect against conidial germination of pathogenic fungus of apple blossom blight. By dusting a mixture of apple pollen grains and lycopodium containing 25% griseofulvin dust at the time of artificial pollination, blossom blight of apple plants could be controlled. By painting a diluted paste of 50%wettable powder of griseofulvin on the diseased parts of melons, fusarium wilt of melons could be controlled. This antibiotic has been used in Japan since 1959, but its cost seems to be too high for agricultural use.
E. NOVOBIOCIN Novobiocin, also called cathomycin, is produced by Streptomyces spheroides and other actinomycetes. Wakimoto et al. (1967) succeeded in reducing the occurrence of bacterial canker of tomato by dipping tomato seedlings in 100 ppm of novobiocin aqueous solution overnight before transplanting. It has been used since 1968.
IV. Antibiotics Developed as Agricultural Chemicals The development of agricultural antibiotics has not been limited to controlling plant diseases, but has extended more widely and more actively over various areas including utilization of insecticides, herbicides, and plant regulators in Japan. As shown in Table 11, many compounds of microbiological TABLE I1 PESTICIDAL COMPOUNDS
OF
MICROBIOLOGICALORIGIN
Fungicides
Antifungal antibiotics" Antibacterial antibiotics" Antiviral antibiotics"
Blasticidin S, etc. Streptomycin, etc. Aabomycin, etc.
Insecticides
Miticidal antibiotics" Bacterial toxins
Tetranactin Bacillus thuringensis
Herbicides
Herbicidal antibiotics
Anisomycin
Growth regulators
Fungal products'
Gibberellins
"In practical use as pesticides.
USE OF ANTIBIOTICS IN AGRICULTURE
61
origin are already used as pesticides or show promise for practical application. Blasticidin S, etc., as antifungal antibiotics, streptomycin, etc., as antibacterial antibiotics, tetranactin as a miticide, and gibberellins as plant growth regulators are used. Aabomycin as an antiviral antibiotic, a product of Bacillus thuringensis as a insecticidal antibiotic, and anisomycin derivatives as herbicides have been tested for practical use in the field. In the following sections, after a brief history of studies on agricultural antibiotics research in Japan, the agricultural antibiotics blasticidin S, kasugamycin, polyoxins, validamycin, cellocidin, tetranactin, and ezomycin will be discussed separately. A few other antibiotics will be mentioned only briefly.
A. BRIEF HISTORYOF RESEARCHON AGRICULTURAL ANTIBIOTICS IN JAPAN Practical plant disease control using antagonistic microorganisms was studied by Nishikado and his co-workers (1950).They discovered some isolates of actinomycetes that were antagonistic to pathogenic microorganisms of bacterial wilt of tomato, black spot of pear, scabs of wheat and barley, southern blight of cowpea, and other diseases. They noted the remarkable antagonistic effect of Trichodemna lignorum against tobacco sclerotium blight pathogen, and devised a mass culture system for this antagonistic organism. Using ' this method, they formulated spore dust of this fungus with over 15 x 1OO spores per gram and showed that sclerotium rots of tobacco and of devil's tongue were practically controlled by using the dust diluted 20-30 times with rice bran or dried soil and sprayed near the roots of these crops. Research on control of rice blast by the use of antibiotics was conducted during World War I1 by Yoshii et al. They found that cephalothecin, an antibiotic produced by Cephalothecium sp., increased the resistance of rice plants to rice blast fungus, Pyricularia w yz ae (Yoshii, 1949, 1950a,b, 1953, 1954). In 1956 Suzuki discovered antiblastin, an effective antibiotic against rice blast under laboratory conditions, and tested its large-scale practical application at agricultural experiment stations in Japan. The experiments failed because of instability of the agent (Suzuki et al., 1956). Nationwide application tests of this antibiotic stimulated interest in the development of new agricultural antibiotics, and extensive research along this line has been started since that time. For example, application tests of many antibiotics, such as antipiriculin (Nakayama et al., 1956), blastmycin (Watanabe et al., 1957), blasticidin A (Fukunaga et al., 1955), trichomycin (Hosoya et al., 1952), hygroscopin (Nakazawa et al., 1954), eurocidin (Nakazawa, 1955), pentamycin (Umezawa et al., 1958), and aureothricin (Umezawa et al., 1949) have been carried out. Although these antibiotics
62
TOMOMASA MISATO, KElDO KO, A N D ISAMU YAMAGUCHI
were effective under laboratory conditions, most were found to be impractical in field tests because of their instability. Misato et al. (1959)found a curative effect of blasticidin S (Takeuchiet aZ., 1958) against rice blast in a foliar spray at concentrations of 10-20 ppm. This antibiotic was found to be effective in wide-scale application tests in 1959and 1960, and it has been in practical use since 1961. After the success of blasticidin S for practical use, research on agricultural antibiotics has become active. Cellmidin against bacterial leaf blight of rice plant (Okimoto and Misato, 1963a), kasugamycin against rice blast (Umezawa et al., 1965), polyoxins against rice-sheath blight (Suzukiet al., 1965), validamycin against rice-sheath blight (Iwasa et al., 1971a), and tetranactin against the adults of carmine mite (Ando et aZ., 1971a), all were registered for practical use.
B. BLASTICIDINS Blasticidin S is the first successful agricultural antibiotic developed in Japan. It was isolated from the culture filtrates of Streptomyces griseoc h r m g e n e s by Takeuchi et al. (1958), and the potent curative effect of blasticidin S on rice blast was found by Misato et al. (1959). Thereafter benzylaminobenzene sulfonate of blasticidin S was reported to be least phytotoxic to the host plant without reduction of antifungal activity against Pyricularia oryzae, the pathogen of rice blast (Asakawa et al., 1963), and this salt has been industrially produced for agricultural use. Three other members of the blasticidin family, blasticidins A, B, and C, have been isolated &om the same strain (Fukunaga et al., 1955; Kono et al., 1968), but these were found to be rather ineffective for practical use. 1 . Chemistry
The chemical structure of blasticidin S has been studied extensively by Yonehara and his co-workers, and the final structure assigned blasticidin S is 1-(1’-cytosinyl)-4-[ ~ - 3-amino-5’ ’ -( 1”-N-methylguanidino)valerylamino] 1,2,3,4-tetradeoxy+3-~-erythro-hex-2-eneuronic acid, as shown in Fig. 1 (Otake et al., 1966;Yonehara and Otake, 1966).The structural interpretation of blasticidin S-hydrobromidehas been provided by X-ray diffraction analysis (Onuma et al., 1966). The molecule of blasticidin S comprises a novel nucleoside designated cytosinine and a new p-amino acid named blastidic acid (E-N-methyl+arginine). The Occurrence of 2,Sunsaturated amino sugar in nature prompted new studies in an attempt to synthesize nucleosides with unsaturated carbohydrates, and Goody et al. (1970) reported the total chemical synthesis of the unsaturated amino sugar of blasticidin S, methyl 4-amino-2,3,4trideoxy~-erythro-hex-2-enopyranosiduronic acid.
USE OF ANTIBIOTICS IN AGRICULTURE
63
FIG. 1. Structure of blasticidin S.
Seto et al. (1966, 1968a) studied the biosynthesis of blasticidin S by the producing organism using 14C-labeled suspected precursors. The results showed that the pyrimidine ring of the antibiotic came from cytosine directly and the sugar moiety from glucose; arginine served as the precursor for blastidic acid, and the N-methyl group of blastidic acid came &om methionine. A metabolic intermediate on the biosynthetic pathway of blasticidin S was found to be leucylblasticidin S, and its biosynthetic role was confirmed by the use of washed cells of S. griseochromogenes (Seto et al.,
1968b). 2. Biological Activity Blasticidin S has a wide range of biological activities. Besides its significant inhibitory effects on the growth of P. oryzae, it also exhibits other antimicrobial (Takeuchiet al., 1961)and antiviral (Hirai and Shimomura, 1965), as well as antitumor (Tanaka et al., 1961) activities although medical application is impeded by its toxic properties. The LDS0by intravenous injection to mice is 2.82 mglkg. Fortunately, it can be used in the paddy field since toxicity to fish is rather low.
3. Mode of Action Misato and his co-workers have studied the biochemical properties of blasticidin S on P. oryzae. They found the curative effect of blasticidin S on rice blast to be due to a strong inhibitory action of mycelial growth of the pathogen, and reported that the antibiotic markedly inhibited the incorporation of 14C-labeledamino acid into protein in the cell-free system ofP. oryzae (Huang et al., 1964a), while metabolic pathways-including glycolysis, the succinic dehydrogenase system, the electron transport system, and the oxidative phospholylation system-or incorporation of 32Pinto the nucleic acid were not inhibited by blasticidin S (Misato et al., 1959, 1961a,b). Yamaguchi and Tanaka (1966) reported that the addition of blasticidin S to the cell-free protein-synthesizing system of extracts &om Escherichia coli and Bacillus megaterium remarkably inhibited the incorporation of leucine and phenylalanine into polypeptide, and that increased concentration of tRNA in this system reversed the inhibition. They suggested that blasticidin
64
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
S acts in the step of peptide transfer from peptidyl-tRNA on the donor site with the incoming amino acyl-tRNA on the acceptor site without effect on the preceding steps in protein biosynthesis. On the other hand, Coutsogeorgopoulos (1967) observed that the inhibition of polypeptide synthesis by blasticidin S could not be reversed with increasing concentration of phenylalanyl-tRNA, and blasticidin S did not act as a competitive inhibitor, with respect to phenylalanyl-tRNA, in polypeptide synthesis. Since blasticidin S markedly interfered with the puromycin reaction (Yamaguchi and Tanaka, 1966), it is also possible that the action of blasticidin S involves the formation of peptidyl-blasticidin S on the 50 S ribosome in a manner similar to the peptidyl-puromycin reaction, though, unlike the case of puromycin reaction, peptidyl-blasticidin S may remain bound to the ribosomes instead of being released. The mode of action of this antibiotic on the molecular level is not known in detail with any certainty, but a process related to peptidyltransferase activity is inhibited by blasticidin S (Coutsogeorgopoulos, 1969; Yukioka et al., 1975). In studying the mechanism of the acquisition of resistance against blasticidin S, Huang et al. (1964b) found protein synthesis in the cell-free system from a resistant strain of P. oryzae or from its susceptible parent strain to be equally inhibited by the antibiotic. From the results obtained, they supposed that the acquisition of resistance of P. uryzae against blasticidin S might be due to the reduction of mycelial permeability of the antibiotic into the cell.
4 . Use against Plant Diseases Rice blast, the most harmful disease of the rice plant in Japan, had been mainly controlled since 1953 by organic mercury compounds sprayed on the plants. Since then, various cases of mercury poisoning in the environment have been reported in the world. Although it was shown that these were not due to the agricultural use of organic mercury compounds, the use of these chemicals for agricultural purposes was forbidden in 1968 in the interests of public health. On the other hand, research for new chemicals for rice blast control to replace organic mercury compounds started by the authors in 1953 under the guidance of Dr. Sumiki, Honorary Professor of Tokyo University, resulted in the discovery of a new antibiotic, blasticidin S, in 1959. Blasticidin S was evaluated in field trials in 1959 and 1960, and since 1961 it has been in practical use for rice blast control instead of organic mercury compounds. For spraying in the field to protect rice blast, the effective concentration of blasticidin S is usually 10-20 ppm (1-3 gm of blasticidin S/lOa), but it occasionally causes chemical injury on rice leaves when sprayed at higher concentrations. Such phytotoxic effects of blasticidin S on rice leaves are also
USE OF ANTIBIOTICS IN AGRICULTURE
65
influenced by frequency of application, application time, rice variety grown, atmospheric conditions such as temperature and moisture, soil type, and fertilizer used. Among crops, the tobacco plant is the most susceptible to blasticidin S, followed by eggplant, tomato, and potato; mulberry plants are rather susceptible; grape, pear, and peach plants are resistant, and water melon, cucumber, and rice plants more resistant to chemical injury by the antibiotic. Hashimoto et al. (1963) found that free amino acids, especially tryptophan, and RNA content increased markedly in injured leaves of rice plant. When blasticidin S is added to sweet potato, phenylalanine ammonialyase activity is severely inhibited, and polyphenol synthesis also stopped (Minamikawa and Uritani, 1965).
5 . Hazard to Mammals Application by dusting occasionally causes conjunctivities if the dust accidentally comes in contact with the eyes, although no accident has been reported as a result of spraying wettable powder or solution. Blasticidin S also induces severe inflammation of mucous membrane or of injured skin exposed to the antibiotic (Ohta, 1963), and this toxic effect on mammals is a most unfavorable characteristic of blasticidin S. Many attempts have been made to remove this defect of blasticidin S. One of these involves chemical modification of the antibiotic; Kawana et al. (1972) synthesized aminoacyl derivatives of cytosinine that contain either alanine or phenylalanine in the amino acid portion instead of blastidic acid. Other replacements of the amino acid portion of blasticidin S were tried, but more favorable results as expected have not yet been obtained (Otake et al., unpublished observations). Biological transformation of blasticidin S was studied by Seto et al. (1966), and they reported that a strain of Aspergillus fumigatus transformed the antibiotic into four substances; the main compound was shown to be deaminohydroxyblasticidin S, which is significantly less toxic to mammals though the antimicrobial activity is also fairly reduced. Recently, Yamaguchi et al. (1975) isolated the enzyme catalyzing the deamination of cytosine nucleus of blasticidin S, from Aspergillus terreus. The enzyme was shown to have properties similar to those of cytidine deaminase in some respects, but was well separated from the coexisting cytidine deaminase by electrophoresis. In addition, they found that the enzyme acts on some derivatives of blasticidin S, but not on cytosine, cytidine, and other well known nucleosides. Yonehara et al. (1968)discovered a new group of compounds designated detoxin; these were produced by Streptomyces caespitosus var. detoxicus and by several strains of Streptomyces mobaraensis. It exhibited unique biological activities as a selective antagonist: it negated the inhibitory action
66
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
of blasticidin S selectively against Baci22us cereus, but did not do so against P. oryzae. Moreover, it has been observed that phytotoxicity to the rice plant was depressed markedly without a decrease in curative effect of the antibiotic, and the combined preparation of detoxin complex and blasticidin S produced less eye irritation. Separation of components of the detoxin complex and their characterization were performed by 6take et al. (1973), and the chemical structures of main components (Detoxin D group) were elucidated (Kakinuma et al., 1972; 6take et al., 1974). While troublesome defects of blasticidin S, such as toxic effects on both plants and mammals, were reduced by the addition of detoxins, some dif€iculties have been remained, so that they are not yet in use. On the other hand, Sugimoto (1972) found a simpler method to alleviate eye irritation caused by blasticidin S; the addition of calcium acetate to blasticidin S dust (5%addition) specifically reduced the eye trouble without influencing the antiblast effect, but other mammalian toxicity or phytotoxicity of the antibiotic is also not affected. This improved dust is now in agricultural use.
6. Environmental Metabolism Takagi et al. (1970) reported the residual amount of blasticidin S in the unpolished rice cropped in the field to be estimated as less 0.05 ppm by biological assay. The behavior and fate of blasticidin S in the environment were investigated using radioactive compounds prepared biosynthetically from [14C]cytosine and [14C]-~-methionine (Yamaguchi et al., 1972). The sprayed antibiotic was located on the surface of the rice plant, and little was diffused or transported into the tissue. From the wound or infected part, however, the compound was incorporated, and it was translocated mainly to upper part. The compound located at the plant surface was decomposed by sunlight and gave rise to cytosine as the main degraded product. A considerable quantity of the blasticidin S sprayed fell to the ground and was tightly adsorbed onto the soil surface. Furthermore, significant generation of [14C]-carbondioxide from the ['4C]-blasticidin S-treated soil was observed, and several microbes usually inhabiting the paddy field were found to lower the biological activity of blasticidin S. From the results obtained, Yamaguchi et al. supposed that, after application to the crop at a very low concentration, the antibiotic might be rapidly broken down in the environment, so that there would be no danger of environmental pollution and food contamination. C. KASUGAMYCIN Kasugamycin is a water-soluble and basic antibiotic produced by Streptomyces kasugaensis (Umezawa et al., 1965). Developed after blasticidin S,
USE OF ANTIBIOTICS IN AGRICULTURE
67
kasugamycin has been used as an agricultural antibiotic for rice blast control in Japan since 1965. This antibiotic controls rice blast disease at a concentration as low as about 20 ppm (Ishiyama et al., 1965). It can be safely used on crops without any toxicity and has very low toxicity to mammals. These advantages are the main reason why blasticidin S is losing ground to kasugamycin. However, the virulence of a kasugamycin-resistant strain in the paddy field recently, has raised a serious problem concerning rice blast control by kasugamycin. 1 . Chemistry
The chemical structure of kasugamycin was studied by Suhara et al. (1966, 1968)using chemical methods and by Ikekawa et al. (1966) with X-ray diffraction analysis. As shown in Fig. 2, the molecule of kasugamycin is constituted by three moieties: D-inositol, kasugamine (2,3,4,6-tetradeoxy-2,4diaminohexopyranose), and an iminoacetic acid side chain. In regard to biosynthesis of kasugamycin, the incorporation of several saccharides and amino acids into the kasugamycin fraction were tried by Fukagawa et al. (1968a). They suggested that the incorporation of ["C]glucose (U) and ['4C]-mannose (U) into kasugamycin was 5-fold that of [14C]-maltose. These saccharides were mainly incorporated into the kasugamine moiety. ['4C]-Myoinositol (U), [14C]-glycine(l), and [14C]-glycine(2) were incorporated into kasugamycin mostly in the part other than kasugamine. From the dilution test of D-inositol, D-inOSitOl was proved by Fukagawa et d . (1968b) not to be incorporated into the D-inositol moiety of kasugamycin. Radio-gas chromatography of [''C]-kasugamycin showed the conversion of ['4C]-myoinositol (U) to the ['4C]-D-inositol moiety of kasugamycin. Furthermore, Fukagawa et al. (1968~) suggested that mass spectroscopic analysis
OH
FIG. 2. Structure of kasugamycin.
68
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
showed that the nitrogen atom of glycine is incorporated into the imino nitrogen of the carboxyformidoyl group. Nakajima and his associates studied the synthesis of kasugamycin and succeeded in synthesizing kasuganobiosamine and related compounds (Nakajimaet al., 1968; Kitahara et al., 1969);this achieves the total synthesis of kasugamycin by the introduction of the oxalimidyl group into kasuganobiosamine.
2. Biological Activity Kasugamycin selectively inhibits the growth of P. oryzae and some bacteria, including Pseudomonas species, and shows little or no activity against other fungi tested. At a concentration of 100 ppm it did not inhibit the growth of species of Fusarium, Glomerella, Gloeosporium, Celletotrichum, Helminthospwium, Ophiobolus, Gibberella, Pelliculuria, Penicillium, and Botrytis. Kasugamycin inhibits the growth of P. wyzae in acidic media (pH 5.0), but hardly inhibits it in neutral media (pH 7.0) (Hamada et al., 1965). On the contrary, kasugamycin showed stronger inhibition against Pseudomonas at pH 7.0 than at pH 5.0 or 6.0. The antibiotic did not show acute or chronic toxicity to mice, rats, rabbits, dogs, monkeys, and human beings. The oral LDS0for mice was 2 gmkg. At a concentration of lo00 ppm there was no toxicity to fish. 3. Mode of Action Kasugamycin enters into the plant tissue and shows both protective and curative action. It does not inhibit spore germination even at a concentration of 120 pglml. Its effect against P. uryzae is expressed in the plant and in uitro only at low pH (Ishiyama et al., 1965). Tanaka et al. (1966)reported that kasugamycin inhibited protein synthesis in a cell-bee system of P . oryzae. Kasugamycin inhibits protein synthesis in Escherichia coli by interfering with the binding of aminoacyl-tRNA to the mRNA-30 S ribosomal subunit complex. The compound does not cause miscoding. 4 . Use against Plant Diseases
Kasugamycin is in large-scale use against rice blast. It controls rice blast when sprayed at about 20 ppm in aqueous solution. For practical disease control, kasugamycin is mainly applied as a dust containing 0.3% of active ingredient. No injury was observed to many other plants. After kasugamycin-resistant strains had been detected in the field, the combined formulations of kasugamycin and chemicals with different action mechanisms came into practical use. Coating the seed with 2% wettable powder protects against rice blast in the field beds for a month; therefore the antibiotic may be used also as a seed disinfectant.
USE OF ANTIBIOTICS IN AGRICULTURE
69
5 . Development of Resistance Ohmori (1967) obtained kasugamycin-resistant strains of P . wyzae from colonies growing on a culture medium containing 100 ppm of kasugamycin. These resistant strains were not different &om parent susceptible strains in sporulation and hyphal elongation ability, but infectivity of the resistant strains was remarkably reduced. Rice blast caused by the resistant strains was not affected by kasugamycin at a concentration of 30 ppm. Uesugi et al. (1971) reported kasugamycin-resistant strains of P . oryzae obtained by selecting from colonies growing on a culture medium containing 500 ppm of the compound. Rice blast infected by the resistant strains was not affected by the antibiotic even at a concentration of 200 ppm. Huang et al. (1969) studied the mechanism of resistance to kasugamycin using resistant strains of P . wyzae obtained by Uesugi et al. and found that ribosomes from resistant cells were not susceptible to kasugamycin. Resistant strains were not detected in the field for several years after kasugamycin came into practical use in 1965. Following the increase of kasugamycin application in the paddy field, the effectiveness of kasugamycin on rice blast gradually decreased. In 1972, problems arising from virulence of kasugamycin-resistant strains occurred at several places in Japan where kasugamycin was mainly used for rice blast control, However, the population of the kasugamycin-resistant strains has gradually decreased since the successive application of kasugamycin was stopped.
D. POLYOXINS The polyoxins, a new group of peptidylpyrimidine nucleoside antibiotics, are producted by Streptomyces cacaoi var. asoensis (Suzuki et al., 1965; Isono et al., 1965). Polyoxins are composed of thirteen components (A-M) of some closely related “peptidic nucleosides,” so designated by Isono and Suzuki (1968b). They can be safely used with no toxicity to man, livestock, fish, and plants. Such excellent characteristics may be due to the fact that polyoxins selectively inhibit the synthesis of cell-wall chitin of sensitive fungi, as was reported by Misato and his co-workers (Sasaki et a l . , 1968a; Endo and Misato, 1969; Ohta et aZ., 1970; Hori et al., 1974a). Polyoxins have been widely used for protection against some pathogenic fungi, such as Alternaria kikuchiana, Pellicularia sasakii, and Cochliobolus miyabeanus in Japan since 1967. 1 . Chemistry
The isolation and chemical elucidation of polyoxins were mainly attributed to the excellent work by Suzuki and Isono et al. (Isono et al., 1965, 1967, 1968, 1970; for review, see Suhadolnik, 1970).
70
TOMOMASA MISATO, K E I W KO, A N D ISAMU YAMAGUCHI
Structure of all polyoxins were given by Isono et al. (1969) as depicted in Fig. 3. Among polyoxins, the C component is the smallest; though it lacks antifungal activity, it was a key compound in elucidating the structure of polyoxins, since hydrolytic degradation of all the polyoxins afforded polyoxin C or its analogs. Isono and Suzuki (1968a) assigned the structure 1-p(5’-amino-5’deoxy-~-allofuranutonosyl)-5-hydroxymeth to polyoxin C on the basis of chemical and physical techniques, and a single-crystal X-ray diffraction analysis of N-brosylpolyoxin C confirmed the structure (Asahi et al., 1968).The identification of nucleoside with 5-aminohexuronic acid as its sugar group is the first rare example in nature. This prompted the elegant work of total synthesis of polyoxin J by Kuzuhara et al. (1973). Prior to total synthesis of polyoxin J, they prepared deoxypolyoxin C (Ohrui
Polyoxin
R,
R3
CH20H
OH
CH20H HO
OH
COOH
HO
OH
COOH
HO
H
COOH
OH
CH20H HO
I
2:
CH,OCONH, H
CH3
J
CH3
K
H
L
H
HO
OH
M
H
HO
H
OH
OH
OH
R HO I
HO
H
OH
FIG.3. Structure of polyoxins.
72
TOMOMASA MISATO, K E I W KO, A N D ISAMU YAMAGUCHI
iting growth; polyoxins caused a marked abnormal bulbous phenomenon on germ tubes of spore and hyphal tips of the pathogen at low concentration, and this abnormally swelled spore became noninfectious. It was also reported that the incorporation of ['4C]-glucosamine into cell wall chitin of Cochliobolus miyabeanus was markedly inhibited by polyoxin D, without inhibitory effect on respiration and synthesis of macromolecules such as protein or nucleic acids (Sasaki et al., 1968a). Endo and Misato (1969) showed in their kinetic studies of the cell-fiee system of Neurospwa crassa that polyoxin D strongly inhibits the incorporation of N-acetylglucosamine (GlcNAc) into chitin in a competitive manner between UDP-GlcNAc and polyoxin D. Ohta et al. (1970)also observed that UDP-GlcNAc was accumulated in the polyoxin D-treated mycelia of C . miyabeanus. More recently Hori et al. (1974a) reported the relation between polyoxin structure and inhibitory activity on chitin synthetase. According to their kinetic analysis, the carbamoylpolyoxamicacid moiety of polyoxins would help to stabilize the polyoxin-enzyme complex, and the pyrimidine nucleoside moiety of the antibiotics would also fit into the binding site of the protein. Therefore, the excellent characteristics of polyoxins may be due to the fact that the antibiotics inhibit the cell wall synthesis of sensitive fungi but have no influence on other organisms, including mammals, since there exist no cell walls in animal cells. 4 . Use against Plant Diseases In order to control rice sheath blight, many organoarsenic chemicals have been used since 1958. However, the trouble with them was their phytotoxic effect; treatments with organoarsenates after the period of young ear initial resulted in delayed blooming, chlorosis of ear, poor extraction of ear, detriment to ripening of grain, etc. Therefore treatment with organoarsenate was accompanied by strict restrictions during application. Meanwhile in pot tests to prevent infestation of sheath blight on rice, polyoxin complex showed better efficacy than organoarsenate, methanearsonic acid-ferric-ammonium salt complex (Sasaki et al., 1968b). Trials to control the sheath blight in the field confirmed the efficacy of polyoxins and their persistence on rice. Application could be made at any stage of plant growth without producing phytotoxicity. Moreover, it was noted that the more the number of applications or the higher the concentration, the greater the tendency to increased yield. Besides sheath-blight control, polyoxins showed high control efficacy against diseases caused by Alternaria spp. of top fruit orchards, such as black spot of pear and Alternaria leaf spot of apple (Eguchi et al., 1968). Polyoxin complex has been used in practice in duplicate forms: a polyoxin D-rich fraction for the sheath-blight control, and a B-rich fraction for diseases caused by Alternaria spp.
USE OF ANTIBIOTICS IN AGRICULTURE
71
et al., 1971)and N-hydroxysuccinimide ester of 3,4-di-0-benzyloxycarbonylamino-5-O-carbamoyl-2-deoxy-~-xylonic acid. The addition of the latter to the triethylammonium salt of deoxypolyoxin C gave a mixture of the coupled product and N-hydroxysuccinimide. After the mixture was hydrogenated, it was subjected to chromatography on Avicel to afford crude polyoxin J, which was then treated with carbon. The purified specimen was identical with the authentic one both in chromatographic behavior and biological activity. In the course of the study on chemical modification of polyoxins, Isono et al. (1972)found a new mechanism of 5-carboxyuracilderivatives to react with aqueous sodium bisulfide under mild conditions, resulting in facile decarboxylation to give corresponding 5-decarboxy-5,6-dihydrouracil-6-sulfonate and uracils in good yield. A mechanistic feature of this reaction implied the initial nucleophilic addition of bisuEte across the 5,6-double bond. The biosynthesis of polyoxins would be very attractive since they contain a unique amino acid and 5-substituted pyrimidine ring in their molecules. Isono and Suhadolnik (1973)reported the biosynthesis of the 5-substituted uracil base of the polyoxins from uracil and C-3of serine by a new enzyme system, which differs from thymidylate synthetase. It was also shown that 5-fluorouracil could replace uracil to form the aberrant 5-fluoropolyoxins (Isono et al., 1973). Furthermore, they found a new metabolic role for L-isoleucine as a precursor for 3-ethylidene-~-azetidine-2-carboxylic acid (polyoximic acid). The distribution of 14Cin this unique cyclic amino acid proved that the intact carbon skeleton of L-isoleucine is utilized directly in its biosynthesis (Isono et al., 1975). 2 . Biological Activity Polyoxins inhibit the growth of some fungi but are inactive against bacteria and yeast. All the polyoxins except C and I showed selective antifungal activity against various plant pathogenic fungi (S. Suzuki et al., 1966). Among polyoxins, polyoxin D was most effective for rice sheath-blight pathogen, Pellicularia sasakii, whereas polyoxins B and L were effective for pear black-spot fungus and apple cork-spot fungus at 50-100 ppm. As for its toxicity, oral administration at 15 gmkg and injection at 800 mgkg to mice did not cause any adverse effect, nor was it toxic to fish during 72 hours of exposure at 10 ppm. Moreover, foliar sprays of 200 ppm of polyoxins have produced no phytotoxicity on most crops, and no injury to the rice plant was observed even at 800 ppm application (Isono et al., 1965,1967; Sasaki et al., 1968b). 3. M o d e of Action In studying the mechanism of fungicidal action of polyoxins, Eguchi et al. (1968)observed a specificphysiological action againstAlternuria spp. in inhib-
USE OF ANTIBIOTICS IN AGRICULTURE
73
5. Development of Resistance Recently, Nishimura et al. (1973) reported the discovery of polyoxinresistant strains of A. kikuchiana in some orchards of Tottori Prefecture, Japan. Hori et al. (197413) suggested that the resistance is caused by a lowered permeability of the antibiotic through the cell membrane into the site of chitin synthesis. Mitani and Inoue (1968) found that inhibition of mycelial growth of P . sasakii by polyoxins was protected by glycyl-L-alanine, glycyl-DL-valine, and DL-danylglycine. Therefore, the peptides may act as antagonists to the incorporation of polyoxins into the cell of the fungus.
E. VALIDAMYCIN Validamycin A (VM-A) is a new antifungal antibiotic recently developed in Japan for the control of rice-sheath blight (Iwasa et al., 1970, 1971a,c). It was isolated from the culture filtrate of Streptomyces hygroscopicus var. limoneus, which also produced five additional components designated validamycins B to F, together with validoxylamine A and B (Iwasa et al., 1971c; Horii et al., 1972). VM-A can be used without injury to plants and with very low toxicity to mammals (Hosokawa et al., 1974). Almost no toxicity was observed for birds, fish, and insects. 1 . Chemistry
The chemical structure of validamycin A was determined by Horii, Kameda, and their co-workers to be N-[(lS)-(1,4,6/5)-3-hydroxymethyl-4,5,6-trihydroxy- 2-cyclohexenyl][0-p-D- glucopyranosy~-( 1+3) -(B)-( 1,2,4/3,5)-2,3,4trihydroxy-5-hydroxymethylcyclohexyl]amine as shown in Fig. 4 (Horiiet al., 1971a,b; Horii and Kameda, 1972; Kamiya et al., 1971). VM-A can be seen to have two kinds of new hydroxymethyl-branched cyclitos in its molecule, Valienamine HOH,C
HO
Validoxylamine
D-Glucose
FIG.4. Structure of validamycins.
74
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
and these cyclitol moieties are quite different from known aminocyclitols, such as streptamine, .%deoxystreptamine,actinamine. VM-A is, therefore, a unique aminoglycosideantibiotic and one of the peculiar examples in the field of pseudosugar chemistry. Validamycins A, C, D, E, and F contain validoxylamine A as a common moiety in their molecules (Horii et al., 1971a, 1972), but they differ from one another at least in one of the following characteristics; the configuration of anomeric center of glucoside, the position of glucosidic linkage, and the number of D-glucose molecules. On the other hand, validamycin B contains validoxylamine B in its molecule, which yielded hydroxyvalidamine instead of validamine derived from VM-A, by hydrogenolysis followed by acid hydrolysis (Horii et al., 1971a). Kameda et al. (1975) studied microbial transformation of validamycins, and they observed that a-or p-glucosidic linkage of validamycin was selectively cleaved by microbial hydrolysis; especially the conversion of validamycin C into VM-A by Endomycosis spp. or Candidu spp. has important significance because validamycin C is about lo00 times less active than VM-A against P . sasakii in the “dendroid-test” established by Iwasa et al. (1971b). Semisynthesis of a new vdidamycin, fl-D-gdactosylvdidoxylamine A, using Rhodotmla glutinis was also reported by Kameda et al., though unfortunately it showed less activity than VM-A.
2. Biological Activity Antimicrobial activity of VM-A against about 3000 species of hngi and bacteria was not detected with ordinary methods (Iwasa et al., 1971a,b),nor was disturbance of microflora on rice plant and crop field observed (Matsuura et al., 1971; Wakae et al., 1974). Wakae and Matsuura (1973)found no phytotoxicity for over 150 species of plants sprayed with VM-A even at a concentration of 10oO ppm. Furthermore, acute and subacute toxicities to mammals were markedly low; in oral administration of validamycin A at a dose of 10 gmkg to mice and rats, or in subcutaneous and intravenous administration at the dose of 2 gmkg to mice, all animals examined survived without change for 7 days (Iwasa et al., 1971a). In addition, Iwasa et al. observed no irritating effects on the skin and the cornea in the rabbit, and the LDS0for killifish was found to be greater than 1000 pg/ml. Oral subacute toxicity of validamycin A for 4 months in beagle dogs was investigated by Hosokawa et al. (1974); they observed no significant abnormalities of the morphological and biochemical parameters accompanyingthe daily administration of 200 mgkg of VM-A. 3. Use against Plant Diseases VM-A is a main component of the validamycin complex and is specifically effective against certain plant diseases caused by Rhizoctonia spp., such as
USE OF ANTIBIOTICS IN AGRICULTURE
75
web blight, bud rot, damping-off, seed decay, root rot, and black scurf of several crops and southern blight of vegetables as well as sheath blight of rice plant (Wakae and Matsuura, 1975). Although the antibiotic showed neither cidal nor static action to Phizoctonia spp., it caused an abnormal branching at the tips of hyphae of the pathogen, followed by cessation of further development (Iwasa et al., 1971a). When it was applied in the early logarithmic phase of lesion expansion on rice plant, sufficient control was achieved by one spraying of 30 ppm of VM-A solution (Wakae and Matsuura, 1973). VM-A has been commercially used upon sheath-blight disease since 1973.
4 . Mode of Action Although validamycin A did not significantly suppress the growth of P . sasaki on a nutritionally rich medium, it caused specifically extensive branching of hyphae and the cessation of colony development on a wateragar, as mentioned above. Therefore, the question arises whether VM-A inhibits the growth of the hngus in quantity or causes morphological changes on the fungus under certain conditions. Nioh and Mizushima (1974) concluded that the antibiotic does not inhibit the fungal growth in mass and no difference in the amount of protein, nucleic acid, and cell wall components occurs, but it alters the morphology of the fungus. Meanwhile, Wakae and Matsuura (1975) observed that VM-A has no need of continual contact with the pathogen in a nutrientless condition for effective control of fungal growth. This point is important in the real state of disease occurrence, since P . sasakii is one of the most typical examples of those that grow rapidly by transporting nutrients from basal part to tip part through long stretches of hyphae; this type of growth provides the tip part rather a condition of poor nutrition. Thus, when VM-A is applied directly to the fungus, there is little concern about residue. As for the mode of action of validamycin A, W a k e and Matsuura (1975) showed that VM-A inhibits the biosynthesis of inositol in P. sasakii, and they supposed that inositol might be indispensable for the normal growth and pathogenic activity of the fungus. Although pathogenicity reduced by VM-A was remarkably recovered by the premixing of inositol in their experiment, further investigation will be required to sort out the specific site and type of action of VM-A.
5. Environmental Metabolism Validamycins have been shown to be susceptible to microbial attack, and their addition to the soil resulted in complete loss of biological activity by soil microbes (Nishi et al., 1973). Their half-life in soil was less than 4 hours. Microbial degradation of VM-A by Pseudomonas denitrijkans gave rise to D-glucose and validoxylamine A, which was further decomposed into valienamine, validamine, and another lower compound (Kameda and Horii,
76
TOMOMASA MISATO, K E l D O K O , AND ISAMU YAMAGUCHI
1972). The metabolic fate of validamycins in the animal has not yet been reported, but orally administered validamycins are expected to be decomposed by enteric bacteria. According to a personal communication by T. Kanai, VM-A was excreted to feces without being adsorbed into the animal body through the intestinal lining, and in the case of intravenous injection it was rapidly excreted intact in the urine. Furthermore, no cross-resistance with medicinal antibiotics, such as streptomycin and kanamycin, was detected in certain human pathogens. Validamycin A has been used to protect sheath blight of the rice plant in formulations of 3%solution or 0.3% dust. Residues in rice grains and straws were less than each detectable limit by gas chromatography (Kameda and Yamamoto, 1970). Thus, validamycin A is considered to be one of the ideal chemicals with respect to safety and to pollution, though additional toxicological studies, including teratologic, carcinogenic, and chronic toxicities, remain to be done.
F. TETRANACTIN Tetranactin, a new miticidal antibiotic, was isolated as crystalline rhombic prisms from the filter cake of fermented broth of Streptomyces aureus strain S-3466 (Ando et al., 1971a). The antibiotic exerted remarkable pesticidal activity specifically against the adults of carmine mite and showed very weak toxicity to warm-blooded animals. Also it showed no phytotoxicity to apple, mandarin orange, and tea when sprayed at high concentration (Hirano et al., 1973). The 'miticidal property of tetranactin in fields of apple and tea have been evaluated in Japan since 1968, and tetranactin has been used as a miticide for plants since 1974. 1 . Chemistry and Mode of Action
Ando et al. (1971a) isolated the active principle in crystalline form by extracting the mycelial cake of S. aureus with acetone followed by silica-gel column chromatography. They also showed that S. aureus produces, along with tetranactin, two other structurally related macrotetrolide antibiotics, i.e., dinactin and trinactin, in minor production (Ando et al., 1971b). From the studies on the chemical characteristics of tetranactin, it was found that the antibiotic also belongs to the class of macroterolide antibiotics and is a cyclic polyester composed of four units of homononactic acid, as shown in Fig. 5 (Ando et al., 1971b). The stereochemical structure was clarified with the use of X-ray crystallography by Iitaka et al. (1972). As depicted in Fig. 5, the molecular shape of free tetranactin is fairly flat, elongated, and twisted, and the outline of the molecule resembles that of a propeller, whereas the molecular conformation
USE OF ANTIBIOTICS IN AGRICULTURE
77
FIG.5. Structure and molecular conformations of tetranactin. Middle left figure is the projection of Rb+-tetranactin complex and upper right one is that of uncomplexed tetranactin. Lower figures are the projections of the corresponding32-membered rings showing the outlines of the molecules. (Reproduced with permission from Iitaka et al.. 1972.)
of the rubidium-complexed one is rather globular and like a ball. The surbce of the ball is covered with lipophilic moieties, such as ethyls, methyls, and methylenes. Therefore, the complex readily dissolves in most organic solvents, such as chloroform, dichloromethane, benzene, and ethyl acetate; this is important because, being enveloped with tetranactin, the cation in the living cells may become lipid soluble, as has been reported in other macrotetrolide antibiotics (Pressman, 1970; Morf and Simon, 1971; Duax et d., 1972). In fact, Ando et al. (1975)observed that tetranactin is an uncoupler in cockroach mitochondria and supposed that the antibiotic caused the leakage of alkali cation, such as K+, through the lipid layer of the biomembrane in mitochondria, followed by uncoupling. Meanwhile, based on this complexforming property, Suzuki et aZ. (1971) presented a method for quantitative determination of tetranactin, which determined the antibiotic with accuracy and simplicity in the assay range of 1 4 0 pgIml.
78
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
2. Biological Properties
Specificity in biological activity is a unique property of tetranactin; it exerted potent pesticidal activity against the adults of a carmine spider mite alone, the LDS0for which is 4.8 pg/ml with the spray method (Sagawaet al., 1972). Azukibean weevil and larva of mosquito were moderately sensitive to the antibiotic, whereas other pests, such as the house fly and cockroach, were insensitive. In addition, it was observed that the ovicidal activity of the antibiotic against sensitive mites is not so significant, this appears to be one of the weak points of tetranactin. The miticidal activity, however, was confirmed in field trials. Tetranactin suspensions were sprayed on apple trees on the leaves of which Kanzawa spider and European red mite were naturally parasitic; proliferation of both mites was completely retarded during 32 days of the experiment. The results obtained indicated the superior activity over a positive control agent, Dicofol. When the powder of tetranactin adheres to the mites, they are never killed because penetration of the antibiotic seems to be negligible in this condition. Therefore, the mites were safe on the dry film of tetranactin on the leaves of a host plant. However, when water was sprayed on the mites on leaves covered with the antibiotic thin film, significant miticidal activity was observed (Hirano et al., 1973). It is suggested that the antibiotic exerts its miticidal action only when an aqueous suspension makes contact with the mites directly; that is, water is an essential factor for the generation of miticidal activity of tetranactin. Tetranactin is not phytotoxic to the young leaves of apples, mandarin orange, and tea when sprayed at lo00 ppm, as mentioned earlier. No systemic miticidal activity was observed in the system in which the mites were transferred on the host plants cultivated in an aqueous medium containing tetranactin. Also it is relatively stable to pH, heat, sunlight, and weathering, since no loss of activity was observed at pH 2-13 for 5 hours at room temperature, at 60°C for 15 days, on exposure to sunlight for several days, and on weathering for 10 days (Hirano et al., 1973). Another characteristic of tetranactin is its safety. Ando et al. (1971a) reported that mice tolerated intraperitoneal administration of 300 mgkg and oral administration of 15 gmkg. They also observed that acute toxicity of the antibiotic is very low; the oral LDms are more than 2 gmkg to rats, guinea pigs, quail, and rabbits (Ando et al., 1975). They suggested that the low toxicity is partly attributable to poor absorption by animals. When [“CItetranactin prepared by biosynthesis was administered orally to mice, it was revealed that the antibiotic was little absorbed, so that the distribution in various organs was negligible and almost all radioactivity was recovered in feces 72 hours after administration (Ando et al., 1975).
USE OF ANTIBIOTICS IN AGRICULTURE
79
Although several miticidal antibiotics have been reported, most of them are highly toxic to warm-blooded animals, so their usefulness is strictly limited. Thus, low toxicity of tetranactin is favorable for agricultural use.
G. CELLOCIDIN Cellocidin is an antibiotic produced by Streptomyces chibaensis (Suzuki et al., 1958; Suzuki and Okuma, 1958). It is an acetylenedicarboxyamide containing only four carbon atoms. As its chemical structure is so simple, it is easy to synthesize chemically. Technical grade cellocidin for commercial formulations is now synthesized from fumaric acid or butynediol. Cellocidin has an excellent preventive effect against rice bacterial leaf blight when sprayed on rice plants at 100-200 ppm (Okimoto and Misato, 1963a). Its toxicity when injected intravenously is high (LD5,, to mice, 11 mgkg), but in oral administration and skin application it is not so highly toxic (LD,, to mice, 89.2-125 mgkg and LD5,, to mice 667 mgkg, respectively). Its toxicity to fish is lower than that of DDT. Cellocidin has been in practical use since 1964. However, its consumption has been remarkably decreased because of its phytotoxicity. The antibacterial action of cellocidin was antagonized by cysteine or glutathione, which indicates interaction with SH-groups. A study of several metabolic systems in Xanthomonas oryzae revealed that cellocidin selectively inhibited NAD-requiring dehydrogenase, especially in the pathway from a-ketoglutaric acid through succinyl-CoA to succinic acid at the minimum growth-inhibitory concentration of 10 ppm (Okimoto and Misato, 1963a,b).
H. EZOMYCIN Ezomycins are antifungal antibiotics produced by a strain of Streptomyces very similar to S . kitazawaensis. Takaoka et al. (1971) isolated a complex of the antibiotics from the culture filtrate of the producing organism and reported that the complex has unique biological activity in suppressing the growth of very limited species of phytopathogenic fungi, such as Sclerotinia and Botrytis spp. Since the complex showed remarkable antimicrobial activity against Sclerotinia scbrotiorum de Bary, which causes stem rot in kidney bean plants (Phaseolus vulgaris L.), isolation and characterization of each component of ezomycins were carried out by Sakata et al. (1974a). According to Sakata et al., ezomycins are new pyrimidine nucleosides, and the presence of L-cystathionine in the ezomycin molecule is responsible for specific antifungal activity. Recently, they elucidated the chemical structure
80
TOMOMASA MISATO, K E I W KO, A N D ISAMU YAMAGOCHI
yz HOOC-C-CHz-S-CHz-CH2I
H
H I C-COOH
0 -C,
I
,NHz
NB
I
HO
FIG. 6. Structure of ezomycin A,
of all the ezomycins (Sakata et al., 1974b, 1975a,b); Fig. 6 shows the chemical structure of ezomycin A. This antibiotic was registrated in 1970 as an agricultural antibiotic for the control of stem rot of kidney bean, but it has scarcely been on the market since then.
I. OTHER PROMISINGANTIBIOTICS
1 . Milbemycins
The milbemycins, a new group of macrolide antibiotics, are metabolites produced by Streptomyces B-41-146 strain and exhibit insecticidal activity (Mishima et al., 1975). Since milbemycins are at the early stage of product evaluation, their full spectra of pesticidal activity, especially in fields, have not been yet available. Mishima et al., however, observed a remarkable pesticidal activity of the antibiotics against mites, such as the two-spotted spider mite and citrus red mite, and insects, such as a rice leaf beetle and a tent caterpillar, in their laboratory tests, without any phytotoxicity toward many varieties of crops at effective dosage. Milbemycins consist of 13 components ( L Y ~ - ~ , pl-& ,, a3and PI components were converted into the urethan derivatives containing a heavy atom, and each structure was determined by X-ray analysis (Mishima et al., 1975). The structures are in common composed of three basic units: a sixteenmembered lactone, a spiroketal ring system consisting of two six-membered rings, and cyclohexenediol or phenol. On the basis of the established structures of ar3 and p1components, Mishima et al. determined the structure of other constituents by chemical correlation andor comparison of spectral data. 2 . NK-049: An Anisomycin Analog Yamada et al. (1972) found a strain of Streptomyces that produced two plant-regulating substances, which were later identified as anisomycin (Nishimura et al., 1956) and toyokamycin (Sobin and Tanner, 1954). They
USE OF ANTIBIOTICS IN AGRICULTURE
81
observed that anisomycin exerted strong growth-inhibitory activity on the roots and shoots of all the plants tested (rice, barnyard grass, crabgrass, lucerne, and tomato) at 12.5 and 50 ppm, respectively. These results led to the investigation of effects of compounds having a p-methoxyphenyl group (p-anisolederivatives) on plant growth-regulating activity, and many anisole derivatives were synthesized and their activities were tested (Yamada et al., 1974a,b). This resulted in the finding of interesting plant growth-regulating activities of p-methoxydiphenylmethanes and p-methoxybenzophenones. Especially, remarkable herbicidal activity was confirmed for 3,3’-dimethyl4-methoxybenzophenone (NK-049) in paddy field tests. NK-049 completely induced chlorosis in barnyard grass and provided a satisfactory herbicidal effect at 4 kg/ha application, although weak chlorosis was occasionally observed in rice stem at 6 kg/ha (Ishida et al. , 1975). According to Ishida et al., NK-049 is quite a stable substance, but it is gradually decomposed by sunlight. In paddy fields, it also seems to be susceptible to microbial attack; the concentration of NK-049 in the soil reached a maximum of 2.16 ppm 7 days after application, but decreased to 0.018 ppm after 30 days and to below 0.004 ppm after 60 days. While the metabolic fate of NK-049 in the environment is presently under investigation, thirteen metabolites have so far been identified; the methoxy group was transformed into the hydroxy group and the benzophenone skeleton was decomposed to m-toluic acid and 4-hydroxy-m-toluic acid. In addition, the acute toxicity of NK-049 to mice and rats was found to be more than 4 gmkg independent of routes of administration (Ishida et al., 1975). Therefore, NK-049 is considered to be a promising herbicide with a high level of safety for use in the environment. 3. Antiviral Antibiotics
One of the most serious problems of plant disease control is the virulence of virus diseases. Trials to develop antiviral antibiotics have been enthusiastically conducted by many workers. Consequently, many antibiotics have been revealed to be effective in inhibiting the multiplication of several plant viruses by in uitro test and pot test. They include blasticidin S, laurusin, bihoromycin, miharamycin, citrinin, and aabomycin A. However, there is no antibiotic in practical use for controlling a plant virus disease. a. Blasticidin S . The antiviral activities of blasticidin S on rice stripe virus and tobacco mosaic virus were reported, respectively, by Kitani and Kiso (1963) and Hirai and Shimomura (1965). By Hirai et al. (1968) it was revealed that blasticidin S inhibited TMV-RNA synthesis without affecting host RNA synthesis. However, blasticidin S was phytotoxic to the tobacco plant when a concentration of more than 2 ppm was sprayed on the plant. Afterward, Yonehara et al. (1968)found that a substance, detoxin, which was isolated from culture broth of Streptomyces spp., was able to suppress the
82
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
phytotoxicity with only slight antiviral activity and made the application range wider. b. Laurusin. Laurusin was found to be an antibacterial substance for controlling bacterial leafblight of rice plant. It was isolated from a culture broth of Streptomyces lavendulae, No. 6600 Gc-1, by Aizawa et al. (1965).Huang et al. (1966) showed that laurusin remarkably inhibits TMV multiplication in tobacco tissue and also inhibits the local lesion formation caused by TMV on pinto bean leaves. However, phytotoxicities were occasionally observed on test plants. c. Bihwomycin. Bihoromycin was isolated from a culture broth of Streptomyces filipinensis var. bihwoensis by Misato et ul. (1967). The biological activity of bihoromycin was observed on inhibiting local-lesion formation of pinto bean caused by TMV, and inhibitory activity on TMV multiplication was rather low. This antibiotic was occasionally phytotoxic on tobacco plant. d . Miharamycin A. Miharamycin A was isolated from a culture broth of Streptomyces miharuensis by Noguchi et al. (1968). They claimed that the antibiotic was effective in controllingTMV, CMV, PVX, and RSV. However, there were phytotoxicities observed on some host plants when miharamycin A was sprayed at a concentration of more than 10 ppm. e. Aabomycin A. Aabomycin A was isolated from culture broth of S hygroscopicus var. aabomyceticus by Aizawa et al. (1969). Yamaguchi et al. (1969), with a leaf disc dipping method, showed aabomycin A to have about 80% inhibition on TMV multiplication in tobacco tissues. Aabomycin A is effective not only in inhibiting disease development of TMV, but is effective also in inhibiting that of CMV and AMV, etc., with pot test. f. Citrinin. Citrinin was isolated from a culture broth of Penicillium citro-viride Biourge, the causal fungus of yellows of rice grains, as a toxin. Yasuda et al. (1969) claimed that the local-lesion formation caused by TMV on Nicotiana glutinosu was remarkably inhibited, while the TMV multiplication in tobacco leaf tissues was not affected. Therefore, citrinin may not be put into the category of antiviral substances, V. Future Prospects The future shape of agriculture in the entire world will depend largely on the availability of the proper kinds of pesticides in adequate quantities. The following considerations might be important for the future development of new agricultural antibiotics. 1. Establishment of screening directions. The development of a new antibiotic is a lengthy and expensive process. Some effective antibiotics, however, were discovered shortly after establishing a new screening project. Examples of these are cellocidin against rice bacterial leaf blight and
USE OF ANTIBIOTICS IN AGRICULTURE
83
polyoxins against rice-sheath blight. It is expected that new antibiotics will be discovered in the search for new applications, for example, as herbicides, insecticides, and antiviral agents. 2. Establishment of novel screening test methods. Introduction of a novel screening test method may carry with it the possibility for development of new effective antibiotics. Kasugamycin was discovered by replacing the assay system using the cup method with direct application of culture broth to young rice plants. 3. The relationship between chemical structure and biological activity. Modifications of existing antibiotics provide new potential chemicals. The best examples of these are synthetic penicillin and modified kanamycin. Structures of more than one thousand antibiotics have been now determined. These compounds should be subjected to more intensive biochemical study as a source of new bioactive compounds, and attention should be focused on finding the relationship between chemical structure and biological activity. 4. Tolerance of pathogens to antibiotics. Kasugamycin, polyoxins, and validamycin show very selective toxicity to pathogenic fungi. They are not toxic to humans, mammals, fish, and plants and are rapidly decomposed by soil microorganisms. In recent years, however, an Occurrence of resistance of plant pathogenic fungi to kasugamycin and polyoxins has been noted in Japan. When pathogenic microorganisms resistant to antibiotics have emerged, the alternate or combined application of chemicals with different action mechanisms should be made. These procedures are effective in controlling the development of resistant pathogents. In this article the present status of agricultural antibiotics has been described. The development of antibiotics in Japan has brought about successful discoveries of blasticidin S, kasugamycin, polyoxins, and validamycin. Recently, studies on agricultural antibiotics have not been limited to controlling plant pathogenic microorganisms, but extended more widely and more actively to various objectives, such as use as antiviral agents, insecticides, herbicides, and plant regulators. It is expected that many potential antibiotics will be developed and applied in agriculture in the near future. REFERENCES
Aizawa, S., Hidaka, T., Otake, N., Yonehara, H . , Isono, K . , Igarashi, N . , and Suzuki, S. (1965). Agric. Biol. Chem. 29, 3 7 5 3 7 6 . Aizawa, S . , Nakamura, Y., Shirato, S . , Taguchi, R . , Yamaguchi, I . , and Misato, T. (1969). J . Antibiot. 22, 457-462. Akai, S., Shishiyama, J . , Watanabe, Y., and Kuwabara, M. (1962a). Ann. Phytopathol. SOC. J p n . 27, 90 (abstr.) (in Japanese).
84
TOMOMASA MISATO, KEIDO KO, A N D ISAMU YAMAGUCHI
Akai, S., Shishiyama, J., Watanabe, Y., and Kuwabara, M. (1962b)Ann. PhytopathoZ. SOC. J p n . 27, 260 (abstr.) (in Japanese). Akai, S., Shishiyama, J., Egawa, H., Watanabe, Y., and Hayakawa, M. (1963). Ann. Phytopathol. SOC. Jpn. 28, 302 (abstr.) (in Japanese). Akai, S., Shishiyama, J., and Watanabe, Y. (1964).Ann. Phytopathol. SOC. Jpn. 29, 98 (abstr.) (in Japanese). Ando, K., Oishi, H., Hirano, S., Okutomi, T., Suzuki, K., Okazaki, H., Sawada, M., and Sagawa, T. (1971a).J. Antibiot. 24, 347-352. Ando, K., Murakami, Y., and Nawata, Y. (1971b).J. Antibiot. 24. 418-422. Ando, K., Sagawa, T., Oishi, H., Suzuki, K., and Nawata, Y. (1975). Proc. Intersect. Congr. ZAMS (Sci. Counc. Jpn.), l s t , 1974 Vol. 3, pp. 630-640. Arada, T., Hori, M., and Inoue, Y. (1961). Ann. Phytopathol. Soc. Jpn. 26, 78 (abstr.) (in Japanese). Asahi, K., Sakurai, T., Isono, K., and Suzuki, S. (1968).Agric. BWZ. Chern. 32, 1046-1047. Asakawa, M., Misato, T., and Fukunaga, K. (1963). Noyaku Seisan Gijutsu 8, 24-30 (in Japanese with English summary). Brian, P. W., Wright, J. M., Stubbs, J., and Way, A. M. (1951).Nature (London) 167,347449. Coutsogeorgopoulos, C. (1967). Biochemistry 6, 1704-1711. Coutsogeorgopoulos, C. (1969). Fed. Proc., Fed. Am. SOC.Erp. BioZ. 28, 844. Dekker, J. (1963).Annu. Rev. Microbiol. 17, 243-262. Dekker, J. (1969).In “Fungicides” (D. C. Torgeson, ed.), Vol. 2, pp. 579-635. Academic Press, New York. Dekker, J. (1971). Wosld Rev. Pest. Control 10, 9-23. Dekker, J. (1975). Proc. Intersect. Congr. IAMS (Sci. Counc. Jpn.), l s t , 1974 Vol. 3, pp. 571-588. D6ke, N., Sato, H., Takiguchi, K., and Kikuchi, I. (1964). Ann. Phytopathol. SOC. Jpn. 29, 68 (abstr.) (in Japanese). Duax, W. L., Hauptman, H., Weeks, C. H., and Norton, D. A. (1972). Science 176,911-914. Eguchi, J., Sasaki, S., Ota, N., Akashiba, T., Tsuchiyama, T., and Suzuki, S. (1968). Ann. Phytopathol. SOC. Jpn. 34, 280-288 (in Japanese with English summary). Endo, A., and Misato, T. (1969). Biochem. Biophys. Res. Commun. 37, 718-722. Fukagawa, Y., Sawa, T., Takeuchi, T., and Umezawa, H. (196Sa).J. Antibiot. 21, 50-54. Fukagawa, Y., Sawa, T., Takeuchi, T., and Umezawa, H. (1968b). J. Antibiot. 21, 185-188. Fukagawa, Y., Sawa, T., Takeuchi, T., and Umezawa, H. (1968~). J. Antibiot. 21, 410-412. Fukunaga, K., Misato, T., Ishii, I., and Asakawa, M. (1955).N i p p o n Nogei Kagoku Kaishi 19, 181-188 (in Japanese). Goody, R. S., Watanabe, K. A., and Fox, J. J. (1970). Tetrahedron Lett. pp. 29S296. Hamada, M., Hashimoto, T., Takahashi, S., Yoneyama, M., Miyake, T., Takeuchi, Y., Okami Y., and Umezawa, H. (1965).J. Antibiot., Ser. A 18, 104-106. Hashimoto, K., Katagiri, M., and Misato, T. (1963).Nippon Nogei Kagaku Kaishi 37,245-250 (in Japanese). Hidaka, J., and Murano, H. (1955). Ann. Phytopathol. SOC. Jpn. 20, 143-147 (in Japanese with English summary). Hidaka, J., and Murano, H. (1956).Ann. Phytopathol. SOC. Jpn. 21, 49-53 (in Japanese with English summary). Hidaka, J., and Murano, H. (1959). Ann. Phytopathol. SOC. Jpn. 24, 161-174 (in Japanese with English summary). Himi, A,, Wildman, S. G., and Hirai, T. (1968). Virology 36, 646-651. Hirai, T., and Shimomura, T. (1965).Phytopathology 55, 291-295.
USE OF ANTIBIOTICS IN AGRICULTURE
85
Hirano, S., Sagawa, T., Takahashi, H., Tanaka, N., Oishi, H., Ando, K., and Togashi, K. (1973).J. Econ. Entomol. 66,34%351. Hori, M., Kakiki, K., and Misato, T. (1974a). Agric. Biol. Chem. 38, 691-698. Hori, M., Eguchi, J., Kakiki, K., and Misato, T. (1974b). J . Antibiot. 27, 260-266. Horii, S., and Kameda, Y. (1972). J . Chem. Soc., Chem. Commun. pp. 747-748. Horii, S . , Iwasa, T., and Kameda, Y. (1971a).J. Antibiot. 24, 57-58. Horii, S., Iwasa, T., Mizuta, E., and Kameda, Y. (1971b). J. Antibiot. 24, 59-63. Horii, S., Kameda, Y., and Kuwahara, K. (1972).J . Antibiot. 25, 48-53. Hoshino, Y., and Sawamura, K. (1957). Ann. Phytopathol. SOC. Jpn. 22, 32 (abstr.). Hosokawa, S., Ogiwara, S., and Murata, Y. (1974). J . Takeda Res. Lab. 33, 119-131. Hosoya, S., Komatsu, N., Soeda, M., Yamaguchi, T., and Sonoda, Y. (1951). J. Antibiot. 5, 564-566 (in Japanese). Huang, K. T., and Misato, T. (1970). Ren. Plant Protect. (Tokyo) 3, 12-23. Huang, K. T., Misato, T., and Asuyama, H. (1964a).J . Antibiot., Ser. A 17, 65-70. Huang, K. T., Misato, T., and Asuyama, H. (1964b). J. Antibiot., Ser. A 17, 71-74. Huang, K. T., Katagiri, M., and Misato, T. (1966).J. Antibiot., Ser. A 19, 75-77. Huang, K. T., Eoshino, Y., and Misato, T. (1969).Ann. Phytopathol. SOC. Jpn. 35,134 (abstr.). Idemizu, T. (1960). Ann. PhytopathoZ. SOC. Jpn. 25, 231 (abstr.). Iitaka, Y., Sakamaki, T., and Nawata, Y. (1972). Chem. Lett. pp. 1225-1230. Ikekawa, T., Umezawa, H., and Iitaka, Y. (1966). J. Antibiot.,Ser. A 19, 49-50. Ishida, S., Yamada, O., Futatsuya, F., Ito, K., Yamamoto, H., and Munakata, K. (1975). Proc. Intersect. Congr. IAMS (Sci. Counc. Jpn.),lst, 1974 Vol. 3, pp. 641-650. Ishiyama, T., Hara, I., Matsuoka, M., Saito, K., Shimada, S . , Izawa, R., Hashimoto, T., Hamada, M., Okami, Y., Takeuchi, T., and Umezawa, H. (1965).J. Antibiot., Ser. A 18, 115-119. Isono, K., and Suhadolnik, R. J. (1973). Fed. Proc., Fed. Am. SOC. E x p . B i d . 32, 1966 (abstr.). Isono, K., and Suzuki, S. (1968a). Tetrahedron Lett. pp. 203-208. Isono, K., and Suzuki, S. (1968b). Tetrahedron Lett. pp. 1133-1137. Isono, K., Nagatsu, J., Kawashima, Y.,and Suzuki, S. (1965).Agric. B i d . Chem. 29, 848-854. Isono, K., Nagatsu, J., Kobinata, K., Sakai, K., and Suzuki, S. (1967).Agric. B i d . Chem. 31, 190-199. Isono, K., Kobinata, K., and Suzuki, S. (1968). Agric. B i d . Chem. 32, 792-793. Isono, K., Asahi, K., and Suzuki, S. (1969).J. Am. Chem. SOC. 91, 74W7505. Isono, K., Suzuki, S., Tanaka, M., Nanbata, T., and Shibuya, K. (1970). Tetrahedron Lett. pp. 425-428. Isono, K., Suzuki, S . , Tanaka, M., Tanabe, T., and Shibuya, K. (1972).Agric. Biol. Chem. 36, 1571-1579. Isono, K., Crain, R. F., Odiorne, T. J., McCloskey, J. A., and Suhadolnik, R. J. (1973).J . Am. Chen. SOC. 95, 5788-5789. Isono, K., Funayama, S., and Suhadolnik, R. J. (1975). Biochemistry 14, 2992-2996. Iwasa, T., Yamamoto, H., and Shibata, M. (1970). J. Antibiot. 23, 595602. Iwasa, T., Higashide, E., Yamamoto, H., and Shibata, M. (1971a).J. Antibiot. 24, 107-113. Iwasa, T., Higashide, E., and Shibata, M. (1971b). J. Antibiot. 24, 114-118. Iwasa, T., Kameda, Y., Asai, M., Horii, S., and Mizuno, K. (1971~). J. Antibiot. 24, 119-123. Kakinuma, K., Otake, N., and Yonehara, H. (1972). Tetrahedron Lett. pp. 2509-2512. Kameda, Y., and Horii, S. (1972).]. Chem. Soc., Chem. Commun. pp. 746-747. Kameda, Y., and Yamamoto, K. (1970). Ann. Phytopathol. SOC. Jpn. 36, 356 (abstr.). Kameda, Y., and Yamamoto, K. (1970). Ann. Phytopathol. SOC. Jpn. 36, 356 (abstr.) (in Japanese).
86
TOMOMASA MISATO, KEIDO KO, AND ISAMU YAMAGUCHI
Kameda, Y., Horii, S., and Yamamoto, T. (1975).J. Antibiot. 28, 298-306. Kamimura, S., and Takahi, Y. (1960).Ann. Phytopathol. SOC. ] p n . 25, 33 (abstr.) (in Japanese). Kamiya, K., Wada, Y., Horii, S. and Nishikawa, M. (1971).J. Antibiot. 24, 317-318. Kawana, M., Streeter, D. G., Rousseau, R. J., and Robins, R. K. (1972).J. Med. Chem. 15, 561564. Kitahara, K., Takahashi, S., Shibata, H., Kurihara, N., and Nakajima, M. (1969).Agric. B i d . Chem. 33, 74S754 Kitani, S., and Kiso, A. (1963). Ann. Phytopathol. SOC. J p n . 28, 293 (abstr.) (in Japanese). Kono, Y., Takeuchi, S., and Yonehara, H. (1968).J . Antibiot. 21, 433438. Kuzuhara, H., Ohrui, H., and Emoto, S. (1973). Tetrahedron Lett. pp. 50555058. Matsuura, H., Oniki, E., and Wakae, 0. (1971). Ann. Phytopathol. SOC. J p n . 37, 39 (abstr.) (in Japanese). Minamikawa, T., and Uritani, I. (1965).Agric. Biol. Chem. 29, 1021-1026. Misato, T. (1!369a).] p n . Pestic. Znf. 1, 15-18. Misato, T. (1969b). Residue Reo. 25, 93-106. Misato, T. (1975a). Proc. Intersect. Congr. ZAMS (Sci. Counc. J p n . ) , l s t , 1974 Vol. 3, pp. 589-597. Misato, T. (1975b).Entiiron. Qual. Saf 5, 4 M 5 . Misato, T., Ishii, I., Asakawa, M., Okimoto, Y., and Fukunaga, K. (1959).Ann. Phytopathol. SOC.Jpn. 24, 302-306 (in Japanese with English summary). Misato, T., Ishii, I., Asakawa, M., Okimoto, Y., and Fukunaga, K. (1961a). Ann. Phytopathol. SOC. Jpn. 26, 19-24 (in Japanese with English summary). Misato, T., Okimoto, Y., Ishii, I., Asakawa, M., and Fukunaga, K. (1961b).Ann. Phytopathol. SOC. Jpn. 26, 25-30 (in Japanese with English summary). Misato, T., Huang, K. T., Katagiri, M., Ueda, M., Fukaku, S., and Niida, T. (1967). J. Antibwt., S e r . A 20, 254-260. Mishima, H . , Kurabayashi, M., Tamura, C., Sato, S., Kuwano, H., and Saito, A. (1975). Tetrahedron Lett. pp. 711-714. Mitani, M., and Inoue, Y. (1968).J. Antibiot. 21, 492-496. Mod, W. E., and Simon, W. (1971). Helti. Chim. Acta 54, 2683-2704. Mukoo, H., Nakagawa, K., and Yoshida, K. (1954). Ann. Phytopathol. SOC. ]pn. 18, 177 (abstr.). Nakajima, M., Shibata, H., Kitahara, K., Takahashi, S., and Hasegawa, A. (1968). Tetrahedron Lett. pp. 2271-2274. Nakayama, K. Okamoto, F., and Harada, Y. (1956).J. Antibiot.. Ser. A 9, 63-66. Nakazawa, K. (1955). Nippon Nogei Kogaku Koishi 29, 650-652 (in Japanese). Nakazawa, K., Oki, K., Tadokoro, I., Honjo, M., Hitomi, H., and Ueyanagi, I. (1954).Nippon Nogei Kagaku Koiahi 28, 296-299 (in Japanese). Nioh, T., and Mizushima, S. (1974).I . Gen. A p p l . Microbiol. 20, 372-383. Nishi, K., Takabatake, A., Hattori, M., Wakae, O., and Makuura, K. (1973). Ann. Phytopathol. SOC. Jpn. 39, 169 (abstr.) (in Japanese). Nishikado, G . , Ohshima, T., and Morita, H. (1950). Nogaku Kenkyu 39, 1 4 , 121-125. Nishimura, H., Katagiri, K., Sato, K., Mayama, M., and Shimaoka, N. (1956).]. Antibiot., Ser. A 9, 60-62. Nishimura, M., Kohmoto, K., and Udagawa, H. (1973). Ann. Phytopathol. SOC. ] p n . 39, 168 (in Japanese). Noguchi, T., Yasuda, Y., Niida, T., and Shomura, T. (1968).Ann. Phytophatol. SOC. J p n . 34, 323-327. Ohmori, K. (1967).I. Antibiot., Ser. A 20, 109-144. Ohrui, H., Kuzuhara, H., and Emoto, S. (1971). Tetrahedron Lett. pp. 4267-4270.
USE OF ANTIBIOTICS IN AGRICULTURE
87
Ohta, N., Kakiki, K., and Misato, T. (1970). Agric. B i d . Chem. 34, 122,4-1234. Ohta, Y. (1963). Ind. Health 1, 47-55. Okimoto, Y., and Misato, T. (1963a). Ann. Phytopathol. SOC. J p n . 28, 209-215 (in Japanese). Okimoto, Y., and Misato, T. (196313). Ann. Phytopathol. Soc. J p n . 28, 250-257 (in Japanese). Onuma, S., Nawata, Y., and Saito, Y. (1966). Bull. Chem. SOC. Jpn. 39, 1091. Otake, N.,Takeuchi, S., End6, T., and Yonehara, H. (1966). Agric. Biol. Chem. 30, 132-141. Otake, N., Kakinuma, K., and Yonehara, H. (1973). Agric. Biol. Chem. 37, 2777-2780. Otake, N., Furihata, K., Kakinuma, K., and Yonehara, H. (1974).]. Antibiot. 27, 484-486. Pressman, B. C. (1970). Antimicrob. Ag. Chemother. pp. 28-34. Sagawa, T., Hirano, S., Takahashi, H., Tanaka, N., Oishi, H., Ando, K., and Togashi, K. (1972). J . Econ. Entomol. 65, 372-375. Sakata, K., Sakurai, A., and Tamura, S. (1974a). Agric. B i d . Chem. 38, 1883-1890. Sakata, K., Sakurai, A,, and Tamura, S. (197413). Tetrahedron Lett. pp. 4327-4330. Sakata, K., Sakurai, A , , and Tamura, S. (1975a). Agric. Biol. Chem. 39, 885-829. Sakata, K., Sakurai, A,, and Tamura, S. (1975b). Tetrahedron Lett. pp. 31913194. Sakurai, Y., Sekizawa, H., and Kono, S. (1958). Annu. Rep. Plant Prot. N o r t h J p n . 9, 191-197 (in Japanese). Sasaki, S., Ohta, N., Yamaguchi, I., Kuroda, S., and Misato, T. (1968a).Nippon Nogei ffigaku ffiishi 42, 63W338 (in Japanese with English summary). Sasaki, S . , Ota, N., Eguchi, J., Furukawa, Y., Akashiba, T., Tsuchiyama, T., and Suzuki, S. (1968h). Ann. Phytopathol. Soc. J p n . 34, 272-279 (in Japanese). Seto, H., Yamaguchi, I., Otake, N., and Yonehara, H. (1966). Tetrahedron Lett. pp. 37933799. Seto, H., Yamagucbi, I., Otake, N., and Yonehara, H. (1968a). Agric. B i d . Chem. 32, 12921298. Seto, H.,Otake, N., and Yonehara, H. (1968b). Agric. Biol. Chem. 32, 129S1305. Sobin, B. A,, and Tanner, F. W., Jr. (1954).1.Am. Chem. SOC. 76, 4053. Sugimoto, T. (1972. Nihon Ndson lgakukui Zasshi 21, 3 1 W 1 7 (in Japanese). Suhadolnik, R. J. (ed.) (1970). In “Nucleoside Antibiotics,” pp. 218-233. Wiley, New York. Suhara, Y., Maeda, K., and Umezawa, H. (1966). Tetrahedron Lett. pp. 1239-1244. Suhara, Y., Sasaki, F., Maeda, K., Umezawa, H., and Ohno, M. (1968).J. Am. Chem. SOC. 90, 6559-6360. Suzuki, H., Takahashi, T., Nakamura, M., Yusa, T., Kimura, T., and Motonaga, K. (1956). Nippon Nogei Kugaku Knishi 30, 11-14 (in Japanese). Suzuki, K., Nawata, Y., and Ando, K. (1971). J. Antibiot. 24, 675479. Suzuki, S., and Okuma, K. (1958). 1.Antibiot., S e r . A 11, 84-86. Suzuki, S., Nakamura, G., Okuma, K., and Tomiyama, Y. (1958).J. Antibiot. 11, 81-83. Suzuki, S., Isono, K., Nagatsu, J., Mizutani, T., Kawashima, Y., and Mizuno, T. (1965). J. Antibiot. S e r . A 18, 131. Tabei, H., and Mukoo, H. (1955). Ann. Phytopathol. SOC. J p n . 20, 42 (abstr.) (in Japanese). Takagi, K., Kojima, T., Shibuya, K., Ebata, E., Koizumi, T., and Kishida, H. (1970). Nippon Nogei Kagaku Kaishi 44, 512-518 (in Japanese with English summary). Takaoka, K., Kuwayama, T., and Aoki, A. (1971). Japanese Patent 615,332. Takaoka, Y. (1961). Ann. Phytopathol. Soc. J p n . 26, 236 (ahstr.) (in Japanese). Takaoka, Y. (1968). Ann. Phytopathol. SOC. J p n . 34, 369 (abstr.) (in Japanese). Takeuchi, S., Hirayama, K., Ueda, K., Sakai, H., and Yonehara, H. (1958).J. Antibiot. Ser. A 11, 1-5. Tanaka, N., Sakagami, Y., Yamaki, H., and Umezawa, H. (1961).1. Antibiot., Ser. A 14, 12s126. Tanaka, N., Yamaguchi, H., and Umezawa, H. (1966).J. Biochem. (Tokyo) 60, 429434.
88
TOMOMASA MISATO, KElDO KO, A N D ISAMU YAMAGUCHI
Terui, M., and Kagawa, H. (1959).Ann. Phytopathol. SOC.Jpn. 22,31-32 (abstr.) (in Japanese). Thirumalachar, M. J. (1968).Ado. Appl. Microbial. 10,313-337. Uesugi, Y., Katagiri, M., and Fukunaga, K. (1971).Bull. Natl. Znst. Agric. Sci., Ser. C 23, 93-112 (in Japanese with English summary). Umezawa, H., Tazaki, T., Maeda, K., Kosaka, H., and Fukuyama, S. (1949).J. Antibiot. 2, 105-111. Umezawa, H., Okami, Y., Hashimoto, T., Suhara, Y., Hamada, M., and Takeuchi, T. (1965).J. Antibiot., Ser. A 18, 101-108. Umezawa, S., Tanaka, Y., Ooka, M., and Shiotsu, S. (19.58).J. Antibiot., Ser. A 11, 26-29. Wakae, O., and Matsuura, K. (1973).Absh. Int. Congr. Plant Pathol., 2nd, 1973 No. 129. Wakae, O., and Matsuura, K. (197.5).Proc. Intersect. Congr. ZAMS (Sci. Counc.Jpn.), lst, 1974 Vol. 3,pp. 620-4527, Wakae, O.,Matsuura, K., Endo, T., Fujimori, K., and Yokoyama, T. (1974).Ann. Phytopathol. SOC.Jpn. 40, 134 (abstr.) (in Japanese). Wakimoto, S., and Mukoo, H. (1963).Ann. Phytopathol. SOC.Jpn. 28, 153-158 (in Japanese with English summary). Wakimoto, S., and Uematru, T., and Mizukami, T. (1967).Ann. Phytopathol. SOC.Jpn. 33, 112 (abstr.). Watanabe, K., Tanaka, T., Fukuhara, K., Miyairi, N., Yonehara, H., and Umezawa, H. (1957). J. Antibiot., Ser. A 10, 39-45 Woodbine, M., ed. (1962).“Antibiotics in Agriculture.” Butterworth, London. Yamada, O., Kaise, Y., Futatsuya, F.,Ishida, S., Ito, K., Yamamoto, H., and Munakata, K. (1972).Agric. Biol. Chem. 36, 2013-2015. Yamada, O., Ishida, S., Futatsuya, F., Ito, K., Yamamoto, H., and Munakata, K. (1974a). Agric. Biol. Chem. 38, 1235-1240. Yamada, O.,Ishida, S., Futatsuya, F., Ito, K., Yamamoto, H., and Munakata, K. (1974b). Agric. Biol. Chem. 38, 2017-2020. Yamaguchi, H., and Tanaka, N. (1966).J. Biochem. (Tokyo) 60, 632-642. Yamaguchi, I., Taguchi, R., Huang, K. T., and Misato, T. (1969).J. Antibiot. 22, 463-466. Yamaguchi, I., Takagi, K., and Misato, T. (1972).Agric. B i d . Chem. 36, 1719-1727. Yamaguchi, I. Shibata, H., Seto, H., and Misato, T. (197.5). J. Antibiot. 28, 7-14. Yasuda, Y., Noguchi, T., Okada, K., and Aoki, K. (1969).Ann. Phytopathol. SOC. Jpn. 35, 188-193. Yonehara, H., and Gtake, N. (1966).Tetrahedron Lett. pp. 3785-3791. Yonehara, H.,Seto, H., Aizawa, S., Hidaka, T., Shimazu, A., and Otake, N . (1968). I . Antibiot. 21, 369-370. Yoshii, H. (1949).Ann. Phytopathol. SOC.Jpn. 13,37-40 (in Japanese). Yoshii, H. (195Oa). Ann. Phytopathol. SOC. Jpn. 14, 84-88 (in Japanese). Yoshii, H. (195Ob).Ann. Phytopathol. SOC.Jpn. 15, 13-14 (in Japanese). Yoshii, H. (1953).Ann. Phytopathol. SOC. Jpn. 17, 124-128 (in Japanese). Yoshii, H. (1954).Ann. Phytopathol. SOC. Jpn. 18, 17-21 (in Japanese). Yukioka, M., Hatayama, T., and Morisawa, S. (1975).Btochim. Biophys. Acta 390, 192-208. Zaumeyer, W.J. (1956).N . A . S . N . R . C . , Pub. 397, 171-196.
Enzymes Involved in P-Lactam Antibiotic Biosynthesis E. J. VANDAMME Laboratory of General and Industrial Microbiology, University of Gent, Gent, Belgium 1. Introduction ............................ 11. Structure of 8-Lactam Antibiotics. . . . . . . . . . 111. Biosynthesis Mechanisms of &Lactam Antibiotics and Their
...................... A. Precursor
89 89 92 92 93
.............
94
Cephamycin Biosynthetic Pathways . . . . . . . . . . . . . . . . . . . IV. Terminal-Sta Biosynthes .. A. Involv Biosynthesis ....................................... B. Involvement of Acylases, Esterases, and Transferases in Cephalosporin Biosynthesis . . . . . . . . . . V. Concluding Remarks References ............................................
95
C. Ring Formation
97
97 112 117 119
1. Introduction Compounds known to possess a p-lactam ring are infrequently encountered in nature, although they now appear to be more common than previously supposed. So h r , the following p-lactam ring structures have been found: the alkaloids pachystermine A and B (Kikuchi and Uyeo, 1967), the antimetabolites tabtoxin (wildfire toxin) (Stewart, 1971; Taylor et al., 1972)and (S)-alanyl-3-[cw-(S)-chloro-3-(S)-hydroxy-2-oxo-3-azetidinylmethyl](S)-alanine (Scannell et al., 1975), the antibiotics bleomycin, phleomycin (Takita et al., 1972), nocardicin A and B (Aoki et al., 1975, 1976), and what might now be called the classical P-lactam antibiotics-the penicillins, cephalosporins, and cephamycins (Abraham, 1974a,b; Gauze et al., 1972; Nagarajan et al., 1971; Stapley et al., 1972). This last group of compounds, which will be discussed here, belongs to the peptide antibiotics, the biosynthesis of which is quite different from that of protein synthesis (Abraham, 1974a; Bodanski and Perlman, 1969; Demain, 1974; Katz, 1971; Kurahashi, 1974; Maier and Groger, 1972). II. Structure of P-Lactam Antibiotics The penicillin structure may be conceived as a condensation product of L-cysteine, D-valine, and an acyl side chain. Residues of the two amino acids 89
90
E. J . VANDAMME
are present in a bicyclic dipeptide, 6-aminopenicillanic acid (6-APA), which is the nucleus of all penicillins. From the chemical point of view, this nucleus may be described as a fused lactam and thiazolidine ring system. The structure of the cephalosporins can be considered as an oxidative condensation product of acetate, L-cysteine, D-dine, and D-a-aminoadipic acid. The nucleus, composed of a /3-lactam ring fused with a dihydrothiazine ring, coupled to an acetoxygroup is named 7-aminocephalosporanic acid (7-ACA). The cephamycins are 7-methoxycephalosporin derivatives. /3-Lactam antibiotics are now known to be produced by both eukaryotic and prokaryotic microorganisms, i. e., filamentous hngi and streptomycetes. Fungi, belonging to the genera Penicillium (P. notatum, P . chrysogenum), Aspergillus (A. flavus, A . nidulans, A . ochraceus) and their sexual forms (Elander, 1975; Merrick and Caten, 1975),Trichophyton (T.mentagrophytes, T. gypseum, T . interdigitale), Microsporium, and Epidermophyton ( E . interdigitale, E . floccosum) (Cole, 1966; Elander et al., 1969; Uri et al., 1957), Mulbranchea (Aragozziniet al., 1970), Thermoascus, Gymnoascus, and Polypaecilum (Kitano et al., 1975) produce penicillins. Several hydrophobic penicillins, only differing in their side-chain structure, are produced, together with the hydrophilic isopenicillin N (Cole and Batchelor, 1963; Flynn et al., 1962). The different penicillins, normally encountered in unsupplemented fermentation broths of these fungi, are called the natural penicillins. However, by adding specific side chain precursors to the media, penicillins can be produced in a selective way: they are named the biosynthetic penicillins. In precursor-free media, accumulation of the penicillin nucleus, 6-APA, occurs (see Table I). Fungi, belonging to the genera Cephalosporium (Acremonium), Emericellopsis, Paecilomyces, Diheterospora, Scopuluriopsis, Arachnomyces, Anixiopsis, Spiroidium produce penicillin N, cephalosporin C, deacetyl-, deacetoxy-, N-acetyldeacetoxycephalosporin C, andlor related metabolites (Abrahamet al., 1974a,b; Elander et al., 1961; Fujisawaet al., 1973; Higgens et al., 1974; Kanzaki et al., 1974a; Kitano et al., 1974; Liersch et al., 1974; Newton and Abraham, 1955; Pisano and Vellozzi, 1974; Queener et al., 1974; Traxler et al., 1975). Certain Streptomyces species produce penicillin N (Miller et al., 1962), usually accompanied by a variety of 7-methoxycephalosporin-derived antibiotics (cephamycins) andlor deacetyl-3-0-carbamoylcephalosporin C (Nagarajan et al., 1971; Stapley et al., 1972; Albers-Schonberg et al., 1972), deacetoxycephalosporin C, and deacetylcephalosporin C (Higgens et al., 1974). The only penicillin type produced by these microorganisms is the hydrophilic p e n i d i n N (see Table I).
ENZYMES INVOLVED I N
P-LACTAM ANTIBIOTIC BIOSYNTHESIS
91
TABLE I NATURALAND BIOSYNTHETIC PENICILLINS H
R
Penicillins
O C H , - C O
a. Natural 6-Aminopenicillanic acid (6-APA) Benzyl (G) p-Hydroxybenzyl (X) 2-Pentenyl (F) n-Amy1 (dihydro-F) n-Heptyl (K) L-a-(bAminoadipy1) (iso-N)
HO+CH,--CO
CH3C HZC H 4 H C Hz-CO CH&HZCHzCH&Hz-CO CH3CHzCHzCHzCHzCHzCHz-CO B-HOOCCH(NHz)(CH&-CO L
D-a-(bAminoadipy1) (N)
6-HOOCCH(NHZ)(CHZ)3-C0 D
b. Biosynthetic Phenoxymethyl (V) Butylthiomethyl (BT) Allylthiomethyl (0) 3-Chloro-2-butenylthiomethyl (S)
O C- ,H C-OJ=(
CH3(CHZ),SCH,-CO CHz=CHCHzSCHz-CO CH3-C=CHCHzSCHz---CO c1
In contrast to the wide variety of side-chain structures of the natural penicillins, up to the moment, no natural cephalosporins or cephamycins are found other than those with a D-a-aminoadipyl side chain, except N-acetyldeacetoxycephalosporin C (Traxler et al., 1975). 7-ACA, the cephalosporin nucleus, has not been detected in fermentation broths of these strains. The substituting group at the C-3 position of the cephalosporim can be an acetoxy group (cephalosporin C), a -H-group (deacetoxycephalosporin C), a -OH-group (deacetylcephalosporin C) or a carbamoyl group, depending on the strain involved. The substituting group at the C-3 position of the cephamycins is variable, but seems also to be determined by the Streptomyces species involved (see Table 11).
92
E. J . VANDAMME
TABLE I1 NATURALCEPHUOSPORINS AND CEPHAMYCINS
COOH ~~
~
Cephalosporin or cephamycin'
Producing microorganisms
R3
Rz
Cephalospwium acremonium Cephalospwium, Emen'cellopsis, Paecilomyces, Scopulariopsis, Diheterospora, Spiroidium, Anoriopsis, Arachnomyces Streptomyces lipmanii, S . claouligerus NRRL 3585 Streptomyces claouligerus NRRL 3585
Cephalosporin C Deacetylcephalosporin C, Deacetoxycephalosporin C
-H -H
-0COCHI -OH
-H
-H
Deacetyl-3-0 carbamoylcephalosporin C 7-Methoxycephalosporin C
-H
-0CONHZ
-0CH3
-0COCH.q
S. lipmanii NRRL 3584
-0CH3
-OCO-C=CH
S . gdseus NRRL 3581
Cephamycin A
ACH,
Cephamycin B
-OCH,
-ocO-C=CH I OCH,
Cephamycin C
--0CHS
-0CONHZ
OH
S. griseus NRRL 3581
Streptomyces lactamdurans NRRL 3802,S. chVuZigems NRRL 3585, S. griseus NRRL 3581
"For all compounds, R, = D-~-HOOC-CH(NH~)(CH&-
Ill. Biosynthesis Mechanisms of p-Lactam Antibiotics and Their Enzymes A. PRECURSOR FORMATION
The penicillins, cephalosporins, and cephamycins are now believed to be derived fi-om heterocyclic tripeptides, which are synthesized fiom the build-
ENZYMES INVOLVED IN P-LACTAM ANTIBIOTIC BIOSYNTHESIS
93
ing blocks: L-a-aminoadipic acid, L-cysteine, and L-valine (Abraham, 1974a,b; Arnstein and Morris, 1960a,b; Trown et al., 1963; Whitney et al., 1972). Indeed, the side-chain precursor of (iso)penicillin N, cephalosporin C, and the cephamycins was found to be L-a-aminoadipic acid, and L-cysteine and L-valine are precursor molecules of the nucleus of the antibiotics. Phenylacetylvaline and phenylacetic acid were shown to behave as direct precursors of the phenylacetyl side-chain moiety of penicillin G. The 0-acetyl group of cephalosporin C comes from acetate, and the 7-methoxy group of the cephamycins is derived from methionine (Amstein and Morris, 1960a,b; Abraham, 1974a; Whitney et al., 1972). In eukaryotic /3-lactam producers, a-aminoadipic acid is an intermediate in lysine biosynthesis; in the prokaryotic producers it is derived from lysine (Kirkpatrick et al., 1973). On the basis of structural analogy and labeling experiments, a tripeptide, 6-(a-aminoadipylcysteinylvaline), which has been isolated from p-lactam producing fungi and streptomycetes, has been interpreted as an essential intermediate in the biosynthesis of penicillins, cephalosporins, and cephamycins (Arnstein and Morris, 1960a,b; Fawcett and Abraham, 1975; Loder and Abraham, 1971a,b; Whitney et al., 1972). The tripeptide was shown by Amstein and Morris (1960a,b) to be present in small amounts in the mycelium of Penicillium chrysogenum, and it has been produced by cell-free extracts of Penicillium chrysogenum from its amino acid components in the presence of an energy-generating system (Bauer, 1970). However, these workers did not establish the sequence of incorporation of the amino acids nor their optical configuration. A mixture of related peptides was obtained by Loder and Abraham (1971a,b) from the mycelium of Cephalosporium acremonium C 91. The major component of this mixture was found to be the tripeptide 6(L-cY-aminoadipyl)-L-cysteinyl-D-valine,and two minor components appeared to be tetrapeptides, both containing an additional glycine residue and one containing a residue of P-hydroxyvaline in place of valine. Recently, Fawcett and Abraham (1975) reported that similar peptides are present in the mycelium of a 7-methoxycephalosporin producing Streptomyces cluvuligerus, and Adriaens et al. (1975a,b) found the same LLDconfiguration for the P. chrysogenum tripeptide. B. TRIPEFTIDEFORMATION The enzyme mechanism by which the amino acids are combined and cyclized to form the p-lactam antibiotics is not completely understood. An enzyme, &(a-aminoadipyl)cysteinylvaline synthetase, which catalyses the
94
E. J . VANDAMME
formation of the tripeptide only from 8-(L-a-aminoadipyl)-L-cysteine and L-valine has been isolated from C. acremonium. It is mainly present in the 20,000 g particulate fraction of ultrasonic-treated and homogenized mycelium (Fawcett and Abraham, 1975). Protoplasts and their lysates have been prepared from Cephalosporium acremonium and Penicillium chrysogenum (Abraham, 1974a; Anne et al., 1974; Kohsaka and Demain, 1976; Duncan and Newton, 1970; Fawcett et al., 1973) using combined enzyme systems, such as Cytophaga enzymes or cellulase from Oxoporms plus gut juice from Helix pomutia or enzymes from Streptomyces grarninofaciens ATCC 12705 or Streptomyces venezuehe RA. Aerated protoplast suspensions of Cephalosporium produce penicillin N and cephalosporin C, and Penicillium protoplasts produce penicillin G. Lysed protoplast preparations synthesize labeled tripeptide from 14C-labeled a-aminoadipic acid, L-cysteine, and L-valine in the presence of an energygenerating system (Abraham, 1974a; Fawcett et al., 1973). Huang et al. (1975) obtained evidence for the nonparticipation of a,P-dehydrovaline intermediates in the formation of the tripeptide, although such a tripeptide derivative might be a common intermediate in the biosynthesis of penicillin and cephalosporin antibiotics (Demain, 1966; 1974).
C. RING FORMATION Addition of the labeled isomers of 8-(a-aminoadipyl)cysteinylvaline to Cephalosporium protoplast lysates indicated that only the LLD form is the precursor of penicillin N. In fact, the 50,000 g supernatant fraction of these cell-free extracts contained the responsible enzymes (Abraham, 1974a). These findings are consistent with the hypothesis that the LLD tripeptide is converted to penicillin N with optical inversion of the aminoadipic acid residue, but without the involvement of an intermediate in which the asymmetry of the D-Vdine residue is lost. It also indicates that the D-configuration of the 8-(a-aminoadipyl-)side chain of penicillin N and the cephalosporins must arise at a late stage, probably during ring formation. Abraham (1974a) also obtained further evidence that the tripeptide from Cephalosporium is indeed a precursor of penicillin N and cephalosporin C from the fact that the tripeptide began to be rapidly labeled from [14C]-valine at that moment in the fermentation cycle where rapid antibiotic production started. Using biochemical genetics as a tool toward pathway elucidation, Lemke and Nash (1972)demonstrated that C. acremonium mutants, unable to form cephalosporin C or penicillin N, fell into two classes: one type blocked in the synthesis of the tripeptide and the other blocked in the conversion of the tripeptide into antibiotic. Subsequently, they found that these two classes were complementary; i. e., heterokaryons formed from a peptide-negative
ENZYMES INVOLVED IN
p-LACTAM ANTIBIOTIC BIOSYNTHESIS
95
and a peptide-positive mutant were capable of antibiotic synthesis (Nash et al., 1974). All these data indicate that the tripeptide is indeed an intermediate in cephalosporin C and penicillin biosynthesis. Aspects of the ring-closure mechanism have also been investigated by following the incorporation of labeled cysteine and valine into antibiotics by intact mycelium (Abraham, 1974a; Aberhart and Lin, 1974; Kluender et al., 1973; Neuss et al., 1973). The 13Clabel of 2s (3S)-[4-13C]valinewas incorporated by an aerated mycelial suspension of C. acremonium exclusively into the exocyclic methylene carbon of cephalosporin C and into the a-methyl group of penicillin N (Kluender et al., 1973), and the 13C label of 2RS(3R)[4-13C] valine was found in the C-2 position of cephalosporin C and in the P-methyl group of penicillin V (Neuss et al., 1973). By the use of deuterated valines, it was established that the methyl groups remain intact during formation of the ring system. Incorporation of the carbon atoms of the valine isopropyl group into penicillin and cephalosporin C is stereospecific, and incorporation into the penicillin ring system occurs with retention of configuration at C-3.
D. DIVERGENCE OF PENICILLIN FROM THE CEPHALOSPORIN AND CEPHAMYCIN BIOSYNTHETICPATHWAYS Incorporation of chiral [4-I3C]valinein both cephalosporin C and penicillin
N supports the hypothesis, that a common dehydrovaline derivative of the tripeptide is the precursor of penicillin N and cephalosporin C and that oxidation of the methyl group (that becomes the &methyl of the penicillins) is followed by the formation of the cephalosporin C ring system. In fact, a dehydrovaline intermediate, at a pivotal position, could yield cephalosporins or could cyclize spontaneously to give penicillin N, as compounds of this type have been reported to form penicillin nonenzymically (Wolfe et al., 1969). It remains an open question whether the immediate precursor of the penicillin ring system contains a D-P-hydroxyvalineresidue, and whether the first cyclic product is a derivative of “cyclic cysteinylvaline” rather than one containing the p-lactam ring (Sjoberget al., 1965).As a result of doublelabeled [3H]-~-cysteine and [3H]-DL-valineincorporation experiments with P. chrysogenum Wis. 49-2105, Adriaens et al. (1975a,b) recently found that P-lactam antibiotic formation occurs by ring closure between carbon 3 of cysteine and the nitrogen of valine, and that the tripeptide can be transformed into isopenicillin N. According to them, an a,p-didehydrovaline intermediate formation remains possible, but seems unnecessary. As the same tripeptide acts as an essential intermediate in the biosynthesis of the structurally related penicillins and cephalosporins, and many cephalosporin-producingmicroorganisms can produce penicillin N, it is con-
96
E . J . VANDAMME
ceivable that some stage in the biosynthesis of the two ring systems might be reached by a common pathway and a necessary step then toward cephalosporin biosynthesis should be ring expansion. This idea is consistent with the fact that mutants of Cephalosporium acremonium unable to synthesize cephalosporin C, still can produce penicillin N; they are presumably deficient in the enzyme system involved in the ring expansion step (Lemke and Nash, 1972). However, Dennen et al. (1971) described an arylamidase in C. acremonium, which has specifically P-lactamase activity toward cephalosporin C, while penicillin N was not affected. This is an unlikely but possible reason for naturally occurring strains that produce only penicillin N. On the other hand, it is still possible that branching may occur before formation of the S-containing ring. However, Kohsaka and Demain (1976) demonstrated that cephalosporin production by protoplast lysates of Cephalosporium acremonium was stimulated by penicillin N. They also obtained indications that an oxygenase is involved in the conversion of penicillin to cephalosporin. These findings suggest a real intermediate role for penicillin N in cephalosporin biogenesis. Queener et al. (1974) isolated Cephalosporium acremonium mutants blocked in cephalosporin C synthesis and investigated these strains for accumulation of other p-lactam compounds. One of the blocked mutants (MH63) accumulated mainly deacetoxycephalosporin C, deacetylcephalosporin C, and penicillin N, while the parent strain (M8650-4)produced high levels of cephalosporin C, deacetylcephalosporin C, and penicillin N , but only traces of deacetoxycephalosporin C. These accumulated patterns led to the interpretation that none of the mutations in the isolates appeared to simply affect a single enzyme in the proposed pathway, involving sequentially: penicillin N, deacetoxycephalosporin C, deacetylcephalosporinC, and cephalosporin C. These pleiotropic effects might indicate strong genetic and/or biochemical interactions such as polar mutations in an operon, or defective protein subunits in a large enzyme complex, but can also be explained by a mere block in the last-step enzyme. The co-occurrence of cephamycin C and deacetylcarbamoylcephalosporin C in Streptomyces clavuligerus broths suggests that the methoxy group at C-7 is introduced at a late stage in the biogenesis of the cephamycin antibiotics (Albers-Schonberg et al., 1972). Demain (1966, 1974) proposed a biosynthesis pathway, suggesting that Amstein’s tripeptide would yield isopenicillin N, which is present in Penicillium chrysogenum broth and mycelium. Isopenicillin N would then be converted by an acyltransferase in the presence of precursors to penicillins, or to 6-APA by the action of a penicillin acylase if no precursors are available. He also considered the possibility that the two activities are functions of the same protein molecule. Cephalospwium acremonium would then possess a
ENZYMES INVOLVED IN
P-LACTAM ANTIBIOTIC BIOSYNTHESIS
97
racemase that converts the isopenicillin N to penicillin N, which might be the precursor for cephalosporin (and cephamycin) production (KohsAka and Demain, 1976). Recently Abraham and Loder (1972), Abraham (1974a), and Fawcett et al. (1975)found that both 6-APA and isopenicillin N can be converted to penicillin by Penicillium extracts. These results are consistent with, and a confirmation of, the earlier proposed suggestions of Demain (1966). The proposed pathways involved in penicillin, cephalosporin and cephamycin biosynthesis are represented in Fig. 1. At this moment, the isolation of the LLD-tripeptide molecule from Penicillium, Cephalosporium, and Streptomyces mycelia and its synthesis by their cell-free extracts, have been achieved, and its intermediate role is now well established. How it is further transformed into the corresponding p-lactam antibiotics remains to be elucidated. Enzymes potentially involved in terminal-stage reactions of p-lactam biosynthesis have been studied rather extensively during the last few years. They are discussed in the following sections.
IV. Terminal-Stage Enzyme Reactions in P-Lactam Antibiotic Biosynthesis A.
ACYLASESAND TRANSFERASES PENICILLIN BIOSYNTHESIS
INVOLVEMENT OF
IN
1 . Acylase
Fungal and microbial enzymes that hydrolyze penicillin into 6-aminopenicillanic acid (6-APA)have been described. This type of enzyme activity was originally reported by Sakaguchi and Murao (1950) in mycelial extracts of Penicillium chrysogenum. Subsequently, penicillin acylase was found to be widely distributed among microorganisms and is used on an industrial scale to catalyze removal of the side chain from biosynthetic penicillin to yield 6-APA. This product is the essential intermediate for the industrial synthesis of the semisynthetic penicillins. This enzymic coupling can be effected by the synthetic activity of penicillin acylases (Carrington, 1971; Chain, 1971; Vandamme and Voets, 1974b). The enzyme has been given different names: penicillin amidase, penicillin acylase, penicillin amidohydrolase, penicillin splitting and synthesizing enzyme, penicillin deacylase and penamidase-but it is here referred to as penicillin acylase, (EC 3.5.1.11) (Hamilton-Miller, 1966; Vandamme and Voets, 1974a,b). Three types of penicillin acylase can be recognized according to the penicillin they preferentially hydrolyze: penicillin G acylase, penicillin V
98
E. J . VANDAMME
a
9
c
co
ENZYMES INVOLVED IN
P-LACTAM ANTIBIOTIC BIOSYNTHESIS
99
acylase, and ampicillin acylase, described by Nara et al. (1972) and Okachi and Nara (1973) in Pseudomonas melanogenum and Pseudomonas ovalis. The hydrolytic activity of penicillin acylase is optimal at alkaline pH values (7.5-9.0), while synthetic activity is displayed at an acid pH optimum (5.06.0), although a few exceptions to this general rule have been reported (Holt and Stewart, 1964; Nara et al., 1971a,b; Vandamme et al., 1971a,b). The cellular location of the penicillin acylases is quite diverse, depending on the microorganism concerned. Bacillus megaterium ATCC 14945 and Streptomycetes lavendulae BRL 198 produce extracellular penicillin acylases, but in general bacterial strains produce the enzyme intracellularly. Whether the intracellular enzyme is cell-wall bound, located in the cytoplasmic membrane, or in the cytoplasm, has not yet been elucidated (Cole, 1969a,b; Kaufmann, 1964; Pruess and Johnson, 1965; Vandamme and Voets, 1974a,b,). Most of the penicillin acylases produced by fungi are intracellular (Baumannet al., 1971; Vanderhaegheet ul., 1968),although some extracellular fungal acylases have been described (Uri et al., 1963, 1964). Penicillin acylases in general have a low affinitytoward their substrates, as is indicated by their relatively high K , values (Table 111). Comparison of the substrate specificity of purified penicillin G acylases from Escherichia coli ATCC 9637 (Bondareva et al., 1969a,b; Self et al., 1969),E . coli NCIB 8743A (Vojtisek and Slezak, 1975; Cole, 1964, 1969a,b), E . coli ATCC 11105 (Kutzbach and Rauenbusch, 1974),Kluyvera citrophila KY 3641 (Shimuzi et al., 1975), Bacillus megaterium ATCC 14945 (Chiang and Bennett, 1967), and Neurosporu crassa (Rossi et al., 1973)revealed that the enzymes are relatively nonspecific, hydrolyzing aliphatic and aromatic amides and removing phenylacetyl, or other nonpolar acyl groups, not only from the penicillins, but also from the N-acyl derivatives of a variety of amino acids and of 7-ACA (Bauer et al., 1960; Cole, 1964, 1969a,b,; Huang et al., 1960, 1963; Kaufmann and Bauer, 1960, 1964; Rossi et al., 1973). On the contrary, purified penicillin V acylases from Erwiniu aroideae, Fusarium, or Penicillium all display a high specificity toward the penicillin molecule only (Baumann et al., 1971; Spencer and Maung, 1970; Thadhani et al., 1972; Vandamme and Voets, 197413, 1975; Vanderhaeghe, 1975). Baumann et al. (1971) studied the substrate specificity of the penicillin V acylase of Fusarium semitectum BC 805 and found that the intact mycelium was able to hydrolyze not only penicillins, but also phenoxyacetyl derivatives of several amino acids. However, they clearly demonstrated that two distinct enzymes were involved: a penicillin acylase, specifically acting on penicillins and an amidase, hydrolyzing N-acyl amino acid derivatives. It has been reported that several phenoxyacetylamino acids are hydrolyzed by Penicillium chrysogenum mycelium (Brunner et al., 1966a,b; Brunner and Rohr, 1965), but this enzymic-activityis also different from that responsible for the deacylation of penicillin.
TABLE 111 K, VALUES OF PURIFIEDAND CRUDEPENICILLINACYLASES
K, value Enzyme source Penicillin G acylase Kluyoera citrophila KY 3641 Bacillus megaterium ATCC 14945 (enzyme") Eschmkhia coli E . coli E . coli NCIB 8743A E . coli ATCC 9637 (immobilized enzyme) E . coli ATCC 11105 (enzyme) Penicillin V acylase Eminia aroideue (enzyme) Streptomyces lavendulae BRL 198 Fusarium semitectum F . semitectum (enzyme)
MW
(mM)
63,000
1.4
120,000 -
-
4.5 1.35-1.59 4.00 30
70,000
7.7 0.02
62,000 -
67,000
F . moniliforme AYF 255 Penicillium chrysogeum (enzyme) ~~
'Enzyme: indicates purification to homogeneity.
35 10.3 2.5-2.75 4.75 5.75 16.7
References
Shimuzi et al. (1975) Acevedo and Cooney (1973) Brandl (1965, 1972) Holt and Stewart (1964) Cole (1961a,b), Warburton et al. (1973) Bondareva et al. (1969a,b), Self et al. (1969) Kutzbach and Rauenbusch (1974) Vandamme and Voets (1974b, 1975) Batchelor et al. (1961b) Brandl (1965, 1972) Baumann et ul. (1971), WaldschmidtLeitz and Bretzel (1964) Vandamme et al. (1971a) Spencer and Maung (1970)
ENZYMES INVOLVED IN P-LACTAM ANTIBIOTIC BIOSYNTHESIS
101
The activity of penicillin acylase is extremely poor on penicilloic or penilloic acids, and substitution of the 6-APA moiety by 7-aminocephalosporanic acid (7-ACA) in most cases reduces enzyme activity. The physiological role of penicillin acylases, in the case of organisms that do not produce p-lactam antibiotics is still largely a matter of speculation. This subject has been reviewed recently by Vandamme and Voets (1974a,b). Acylases from P-lactam-producing microorganisms were first described by Rolinson et al. (1960). Cole and Rolinson (1961) demonstrated penicillin acylase activity in the mycelium of Cephalosporium sp. and Emricellopsis minima, after they found 6-APA in the fermentation broth of these molds during penicillin N production. Acylases from Penicillium chrysogenum A 9342 and Cephalsporium CMI 49137 were found to preferentially hydrolyze penicillin V (Claridge et al., 1963). Omission of side-chain precursors from fermentation media of Penicillium chrysogenum W-5120 (Erickson and Dean, 1966) and of Emericellopsis minima I M I 69015, Cephalosporium amemonium and Cephalosporium salmosynnemutum, results in the formation of 6-APA (Cole and Rolinson, 1961). Uri et al. (1963) and Cole (1966) demonstrated the presence of 6-APA in precursor-free growth media of penicillin-producing dermatophytes (Trichophyton and Epidemphyton) and also observed penicillin acylase activity. Erickson and Bennett (1965) demonstrated the presence of acylase activity in Penicillium chrysogenum W-49-408, a mutant strain unable to synthesize either penicillin or 6-APA, and in a high-producing strain P-5009. Both acylases were found to be very similar, thus indicating that penicillin acylase production is not always accompanied by penicillin formation, although all penicillin-producing fungi do display acylase activity (Cole, 1966, 1967; Kitano et al., 1975). The acylase of the nonproducing W 49-408 strain was studied in detail by Vanderhaeghe, et al. (1968). Aliphatic penicillins were the best substrates, and this acylase was not able to hydrolyze either penicillin N or isopenicillin N (Vanderhaeghe, 1975). Also, the penicillin acylase preparation, purified from Penicillium chrysogenum 51-20F3, displayed a high specificity toward the penicillin molecule (Spencer and Maung, 1970). In fact, acylase hydrolysis of penicillin N and isopenicillin N has never been observed (Vanderhaeghe, 1975).Table IV gives a survey of P-lactam antibiotic producing microorganisms and the occurrence of penicillin acylases. The substrate spectra of these acylases are represented in Table V. As only traces of 6-APA and no 7-ACA at all are found in Cephalosporium-type fermentations, the very low (if any) corresponding acylase activity might contribute to the hilure of these microorganisms to produce cephalosporins or penicillins other than those with a D-a-aminoadipic side chain. Nevertheless, Cole and Rolinson (1961) and
TABLE IV #%LACTAM ANTIBIOTIC-PRODUCING MICROORGANISMS AND THE
OCCURRENCE OF PENICILLIN ACYLASES~
~~
~
~~~
Antibiotics Microorganisms Penicillium chrysogenum Q 176, W 48701, W 39133 W 501247, W 5120 Penicillium chrysogenum sp. Penicillium chrysogenum A-9342 Trichophyton mentagrophytes Epid-phyton interdigitale Trichophyton gypseum Trichophyton interdigitale Asperigillusflavus Malbranchea pulchella Penicillium chrysogenum W-49-408 Penicillium chrysogenum P-5009 Penicillium chrysogenum SC-3576 Trichophyton mentagrophytes BRL 569, BRL 579 Epidewphytonfloccosum BRL 623, BRL 722 Aspergillus ochraceus BRL 731 Penicillium chrysogenum BRL 781, BRL 803 Penicillium sp. BRL 735, BRL 736, BRL 737 Penicillium sp. BRL 733 Penicillium BRL 807
Cephalosporins
Penicillins
6-APA
Acylase
+
+
+
iso-N
+ + + + + + + + + + + + + + +
?
+ + + + + ?
+ + ? + -
+ + +
?
+ + + + + + + + + + + + + + + + ?
References Batchelor et al. (1959, 1961a,b) Cole and Batchelor(l963), Flynnet al. (1962) Claridge et al. (1963) Uri et d.(1963, 1964)
Shimi and Imam (1966) Rode et al. (1947, Kitano et al. (1975) Erickson and Dean (1966), Erickson and Bennett (1965), Vanderhaeghe et al. (1968)
Cole (1966)
Thermoascus, Gymnoascus, Polypaecilum Penicillium chrysogenum 51-20F3, 50935, 1951, 47-638, 48-701, 49-2166 Penicillium chrysogenum D6/347/13 Penicillium chrysogenum ATCC 12690 Penicillium chrysogenum SC-6041 Cephalosporium sp. CMI 49137 Emericellopsis minima (Stolk) I M I 69015 Cephalosporium salmosynnematum MDH 3590A (Emericellopsis salmosynnemata) Emmicellopsis taricola var. glabra Paecilomyces persicinus Cephalosporium acremonium M8650-1-3, ATCC 11550 (Acremoniumchrysogenum) Streptomyces sp. Actinomyces cinereorectus
-
-
I
+ ?
+ +
? ?
? ?
f
+ + + -
+ cc
Deacetylcephalosporin C
Cephalosporium 52-54 Cephalosporium, Emericellopsis, Paecilomyces carneus, Dihetorospora, Scopulariopsb, Arachnomyces, Anixiovsis. Sviroidium ,
+ +
Desacetoxycephalosporin C
+ + + +
Kitano et al. (1975) Gatenbeck and Brunsberg (1968),Pruess and Johnson (1967), Spencer (1968) Brunner et al. (1968) Bauer (1970) Fawcett et al. (1975) Cole and Rolinson (1961)
? ?
? ? ?
Pruess and Johnson (1967) Pisano and Vellozzi (1974) Dennenet al. (1971),Lemke and Nash (1972)
N N ?
-
-
? ? ?
Miller et al. (1962) Chugasova et al. (1974) Fujisawa et al. (1973)
N
-
?
Higgens et 01. (1974), Kitano et al. (1974), Queener et al. (1974)
N N N
+ -
.
(Continued)
TABLE IV (Continued) Antibiotics Microorganisms Streptomyces claouligerus NRRL 3585
Streptomyces lactamdurans NRRL 3802, Streptomyces chouligerus NRRL 3585 Streptomyces lipmanii NRRL 3584
Cephalosporins
Penicillins
6-APA
Acylase
References
Deacetyl-3-0carbamoylcephalosporin C, deacetoxycephalosporin C Cephamycin C
N
-
?
Higgensetal. (1974),Nagarajanetal. (1971), Stapley et al. (1972)
?
?
Stapley et al. (1972)
?
Gauze et al. (1972)
7-Methoxycephalosporin C, deacetoxycephalosporin C Cephamycin A, cephamycin B
Streptomyces griseus NRRL 3851, S . chartreusis, S . cinnamonensis, S. fimbriatus, S . halstedii, S. rochei, S. oiridochromogenes Streptmnyces rubiginosoheloolus, S . laoendulae, S . aureofaciens, S . griseus
N N
?
Unidentified p-lactam antibiotics ~~
“Symbols and abbreviations: -, no synthesis,
~
~~~~~
+, synthesis, ?,
unknown, Cc, cephalosporin C, N, penicillin N, iso-N, isopenicillin N
ENZYMES INVOLVED IN
P-LACTAM ANTIBIOTIC BIOSYNTHESIS
105
Cole (1966)demonstrated that Cephalosporium-type acylases hydrolyze different biosynthetic penicillins, but not penicillin N. The synthetic tripeptide, L-a-aminoadipyl-L-cysteinyl-L-valine was also not hydrolyzed by a Cephalosporium preparation (Loder et al., 1969), although Cephalosporium enzymes were able to hydrolyze the dipeptides L- and Da-aminoadipylcysteine (Loder and Abraham, 1971a,b). It is' not known whether Penicillium acylase is able to effect this hydrolysis. In view of the recent finding that Streptomyces species are able to produce p-lactam antibiotics (see Tables I1 and IV), these particular strains deserve further attention with respect to their acylase activity. Many actinomycetes display acylase activity (Batchelor et al., 1961b; Dennen et al., 1971; Haupt and Thrum, 1967; Nara et al., 1971b), but have not been checked for p-lactam antibiotic production (see Table VI). The extracellular penicillin acylase of Streptomyces lauendulae BRL 198 hydrolyzed heptyl, 2-pentenyl, and phenoxymethylpenicillin readily at pH 9.0 (Batchelor et al., 196lb). Streptomyces erythreus and S. netropsis displayed penicillin V acylase at pH 7.5 at 28°C; these strains possessed an aspecific amide synthetase activity (Haupt and Thrum, 1967). Also Nara et al. (1971a,b) found penicillin acylase activity in Streptomyces ambofaciens SPSL-15 and in Nocardia globerula ICY 3901, a genus already described in 1960 by Huanget al. (1960) to be able to produce penicillin acylase. It is not known whether these acylases can hydrolyze penicillin N, cephalosporin, or cephamycin structures or acylate their nucleus; so far these strains have not been reported to produce p-lactam antibiotics. To what extent the penicillin acylases, synthesized by p-lactam producers, are involved in 6-APA or antibiotic biosynthesis is not exactly known. According to Erickson and Bennett (1965) and Vanderhaeghe et al. (1968), a possible origin of 6-APA in fermentation media is the deacylation of the natural aliphatic penicillins such as F, dihydro-F, and K by the action of penicillin acylases. More specifically, the detection of penicillin acylases able to synthesize penicillins &om 6-APA and an appropriate side-chain structure among p-lactam antibiotic-producing fungi has led to the assumption that these enzymes might be involved in the biosynthesis process of the antibiotics (Cole, 1966; Erickson and Dean, 1966; Spencer and Maung, 1970). Indeed, Erickson and Dean (1966) demonstrated that acylase preparations of Penicillium chrysogenum W-49408 and SC-3576 were able to synthesize at pH 6.8 and at 25°C penicillin V or G, starting from 6-APA and phenoxyacetic acid or phenylacetic acid, respectively. Cole (1966) demonstrated this reverse reaction also with a Penicillium chrysogenum BRL 807 strain. These penicillin acylases were endowed, soon after their discovery, with a potential biosynthetic role, this belief arising from the isolation of 6-APA
TABLE V PENICILLINS HYDROLYZED INTO 6-AMINOPENICILLANIC ACID (6-APA) BY ACYLASESFROM Microorganism P-Lactam antibiotic producers
i
Emericellopsis m i n i m
(Stolk) IMI 69015 Penicillium chrysogenum A-9342
ANTIBIOTIC-PRODUCING MOLDS
Penicillin
Hydrolysis"
Penicillin V Penicillin G Penicillin G Penicillin V 3-Carboxy-3-methylbutylpenicillin l-Amino-3-methylbutylpenici~h
+++
3-Carboxypropy lpenicillin Ampicillin
2-Carboxy-3-decen ylpenicillin 2-Carboxy-1-indolyleth ylpenicillin
2-Carbox yprop ylpenicillin Cephalospm'um acremonium CMI 49137 Penicillium chrysogenum P-5009
P-hCTAM
Phenethicillin Penicillin V Penicillin V Penicillin K Penicillin F Penicillin G
+ + +++ +++ +++ ++ ++ + + + +
++ +++ ++ ++ +
References Cole and Rolinson (1961) Claridge et al. (1963)
Claridge et al. (1963) Erickson and Bennett (1965)
Aspergillus flavus Dermatophytes Mutant, no antibiotic production
Penicillium chysogenum W49-408
E
-l
"+++, ++, +: extent of hydrolysis.
Penicillin G Penicillin V Penicillin G n-Undecylpenicillin n-Nonylpenicillin n-Heptylpenicillin (K) Penicillin V n-Pentylpenicillin Penicillin G n-Propylpenicillin CBH&HZOOC-(CHZ)4-CO-APA C,HSCHZOOC-(CHZ)3-CO-APA CzH5OOC-(CHz),-CO-APA L-C,H,CH,OOC-$H-(CH,),-CO-APA NHCOOCH,C,H, L-C,H~CH,OOC-$H-(CH~),-CO-APA N,
++ +++ + +++ +++ +++ +++ ++ + + + + + +
4
Shimi and Iman (1966) Cole (1966),Uriet al. (1963) Vanderhaeghe et al. (1968)
108
E. 1. VANDAMME
TABLE VI ACTINOMYCETES DISPLAYING PENICILLIN ACYLASEACTIVITY Microorganisms
References
Penicillin G acylase activity Mycobacterium phlei Nocardia F D 46973, ATCC 13655 Streptomyces ambofaciens SPSL-15
Claridge et al. (1960) Huang et al. (1960) Nara et al. (1971b)
Penicillin V acylase activity Nocmdia globerula KY 3901 Streptomyces lawendulae BRL 198 S. netropsis 2814, S. erythreus JA 4143 S . ambofaciens SPSL-15 Acthoplanes utahensis Unidentified actinomycetes
Nara et 01. (1971b) Batchelor et al. (196lb) HauptandThrum(1967) Nara et al. (1971b) Dennen et al. (1971) Nara et al. (1971b)
from fermentation broths and by its ability to couple side-chain groups to 6-APA. Although some evidence has suggested that 6-APA and, connected with it, the acylase enzyme might have a role in the biosynthetic process of penicillins, their significance in the scheme has not yet been established, especially since acylases do not hydrolyze isopenicillin N (Abraham, 1974a; Demain, 1974; W O Eand Arnstein, 1960). The possibility exists that free 6-APA is only a shunt product of the overall biosynthetic process, being formed by the hydrolytic action of acylse on some preformed natural penicillins. The role of 6-APA as an initial precursor and its subsequent acylation into penicillins is now in disagreement. However, 6-APA might be a cryptic intermediate; it can be produced as a transitory stage during hydrolysis and reacylation of isopenicillin N, as is suggested by recent experiments with P . chrysogenum extracts (Abraham, 1974a; Fawcett et al., 1975). 2. Transfwases
The transacylases or penicillin acyltransferases are enzymes (usually from penicillin-producing molds) that are capable of transferring an activated side-chain acid, or the side chain from a penicillin, to 6-APA. In this last case, the penicillin can be considered as an activated form of a side-chain molecule (Abraham, 1974a; Brunner et al., 1968; Gatenbeck and Brunsberg, 1968; Spencer and Maung, 1970). In 1967, Pruess and Johnson described a penicillin acyltransferase in extracts of Penicillium chrysogenum. This soluble enzyme catalyzed at pH 8.0 the exchange of acyl groups from penicillin V, G, K, X, and dihydro-F with
ENZYMES INVOLVED IN
P-LACTAM ANTIBIOTIC BIOSYNTHESIS
109
6-APA in the presence of sulfhydryl compounds, However, the acyl group of penicillin N was not exchanged with 6-APA. The enzyme did not appear to act as a penicillin acylase, and the course of acyltransferase production followed that of penicillin synthesis. They also confirmed the findings of Peterson and Wideburg (1960)that this strain catalyzes isotopic exchange of 35S between penicillin G and penicillin V. The penicillin N-producing Emericellopsis terricola var. glabra displayed no acyltransferase activity, but it was present in the nonpenicillin-producing Penicillium chrysogenum W-49-408 strain. The increased level of activity in high penicillin-yielding mutants suggested that the enzyme is involved in penicillin biosynthesis. Spencer (1968)prepared an extract from Penicillium chrysogenum 51-20F3 and demonstrated in a 60-fold purified preparation two activities: one exchanging the acyl group of penicillin G with 6-APA, and the other producing penicillin G starting from 6-APA and phenylacetylcoenzyme A. Brunner et al. (1968) demonstrated in Penicillium chrysogenum D6/347/ 13a side-chaincoenzyme A-(CoA)ligase,activating side-chain groups, and also a direct acylation of 6-APA with CoA derivatives of phenyl- and phenoxyacetic acids (transacylase). The first enzyme catalyzed the synthesis of phenylacetyl-CoA and phenoxyacetyl-CoA according to the reaction BCOOH
+ CoA + ATP
CoA-SCOR
+ AMP + PPi
where R is the phenylacetyl or phenoxyacetyl radical. It was found in Penicillium chrysogenum just prior to and during the stage of rapid penicillin production (Brunner et al., 1968). Phenylacetyl-CoA ligase was obtained as a crude extract from freeze-dried mycelium, after disintegration with glass beads. The resullting supernatants were treated with DEAE-cellulose, and the filtrate was fractionated with (NH4),S04. The enzyme preparation is maximally active in a pH range of 6.0 to 7.0, and it catalyzes the activation of phenylacetic, phenoxyacetic, and acetic acids with similar degrees of activity (Brunner and Rohr, 1975). The “reverse” enzyme, hydrolyzing activated side chains into an acetic acid radical and CoA, according to the reaction Phenylacetyl-CoA + H 2 0 + phenylacetic acid
+ CoA
has been recognized in extracts of a member (W-51-20F3)of the Wisconsin family of high-yielding mutants of Penicillium chrysogenum (Spencer and Maung, 1970). This phenylacetyl-CoA hydrolase was purified 130-fold and was active in the presence of EDTA and glutathione. The enzyme is 5 times as active against phenoxyacetyl-CoA as compared to phenylacetyl-Cod, and this compares to a similar ratio between the acylase activity of this preparation in hydrolyzing penicillins V and G. The purified preparation also hydrolyzes n-nitrophenyl acetate and phenoxyacetylglycine at about the same
110
E . J . VANDAMME
rate as that of phenylacetyl-CoA. The hydrolase activity shows a pH optimum of 7.6-7.8 and a K , of 3.95 mM. The molecular weight by Sephadex gel filtration is 25,000. The enzyme is sensitive to sulfhydryl inhibition and to oxidation (Spencer, 1975). These findings indicate that this ligase is involved in the formation of natural and biosynthetic penicillins. The above-mentioned findings of Brunner et al. (1968) that mycelial extracts of P . chrysogenum contain acyl-CoA:6-APA acyltransferase (transacylase) catalyzing the following reaction Acyl-CoA
+ 6-APA + penicillin + CoA,
led Brunner et al. (1968) to the conclusion that the final step in penicillin biosynthesis might involve the direct N-acylation of 6-APA by the CoAactivated side-chain precursors, formed from acetyl radicals and CoA by the phenylacety1:CoA ligase. They succeeded in this way in synthesizingpenicillins G and V, using 6-APA and the appropriate side-chain groups in the presence of ATP and CoA at an optimal pH of 7. They proposed a scheme for penicillin biosynthesis showing the acylation of 6-APA with the CoA derivative of a side-chain acid. The origin of 6-APA was not discussed, however. Gatenbeck and Brunsberg (1968) also isolated and purified 150-fold an acyl-CoA:6-APAacyltransferase from Penicillium chrysogenum ATCC 12687. Cells were ground with sand; the resulting extract was treated with ammonium sulfite, passed through a Sephadex G-25 column, eluted from a hydroxyapatite gel and a Sephadex G-200 column with phosphate buffer at pH 7.8. The purified enzyme was incubated at 30°C in the presence of 6-APA, phenylacetyl-[1-14C]-CoA,dithiothreitol and a buffer solution, pH 8.4, containing 0.2 M Tris, 50 mM phosphate, 0.2 M NaC1, 1 mM EDTA), and radioactive benzylpenicillin was produced. This enzyme preparation can utilize a number of acyl-CoA derivatives, although at different rates, e.g., phenoxyacetyl-CoA, p-methoxyphenylacetyl-CoA, octanoyl-CoA. The enzyme displayed no penicillin acylase activity; its optimum pH was approximately pH 8.5, and its activity was stimulated by the presence of thiol compounds (Gatenbeck, 1975). 3. Discussion
Whether penicillin acylase is also involved in one of the above enzymic reactions to supply 6-APA or is identical with one of the mentioned enzymic activities, is not entirely clear and deserves further investigation. In particular exchange reactions with and hydrolysis of penicillin N and isopenicillin N by different purified acylases, transferases, and acyltransferases should be studied further. Abraham and Loder (1972) and Fawcett et al. (1975) demonstrated that both isopenicillin N and 6-APA stimulate penicillin G biosynthesis, whereas penicillin N and isocephalosporin C were without effect. They found that a
ENZYMES INVOLVED I N
8-LACTAM ANTIBIOTICBIOSYNTHESIS
111
soluble protein fraction from Penicillium chrysogenum converted isopenicillin N into penicillin only in the presence of phenylacetyl-CoA. This is consistent with a real involvement of ligase and transacylase activity in penicillin biosynthesis (Fawcett et al., 1975). However, the use of a crude extract eliminated the need for phenylacetyl-CoA as a substrate for the conversion of isopenicillin N into penicillins, suggesting the action of a penicillin acyltransferase (which might be particle or membrane bound). They concluded that isopenicillin N is a substrate for an acyltransferase in Penicillium chrysogenum. Whether there is a transient formation of free 6-APA during acyltransferase action, or whether 6-APA is formed that remains coupled to an enzyme complex, is not known. In this context, the conversion of this 6-APA into penicillins by crude Penicillium extracts would be consistent with a concerted action of acylase, transacylase, and acyltransferase in penicillin biosynthesis. In this respect, the short communication by Spencer and Maung (1970) is of interest. They observed four enzymic activities in Penicillium chrysogenum 51-20F3: penicillin acyltransferase, which catalyzes exchange of side-chains from penicillins to 6-APA; 6-APA transacylase, which synthesizes penicillin from acyl-CoA and 6-APA; penicillin acylase, which hydrolyzes penicillin into 6-APA and the side-chain acid; and phenylacetyl-CoA hydrolase. Disruption of the mycelium, precipitation of the enzyme with (NH4).$04, and fractionation on Sephadex G-100 and DEAE-cellulose yield a 130-fold purification of each of the activities. The ratio of the activities was constant throughout purification and was detected in the same fraction. On polyacrylamide gel electrophoresis, all four activities were found in the same band. The influence of temperature and inhibitors on each enzymic activity was identical. Spencer and Maung (1970) claimed that the four activities are one and the same thiol-dependent enzyme. This suggests that ligase, acylase, transacylase, and acyltransferase form an enzyme complex, with multiple activities in penicillin biosynthesis. These suggestions find support in the recent experiments of Fawcett et al. (1975). Indeed, it was previously demonstrated that the synthetic capacity of penicillin acylases was enhanced by using energy-rich side-chain precursors, such as phenylacetylglycine and analogs (Bauer et al., 1960; Cole, 1964, 1969b), and for this reason the acylase could be considered to act as an acyltransferase or transacylase. It was suggested by Lemke and Brannon (1972) that the difference between penicillin acylase and acyltransferase is that the latter is an intracellular or particle bound form of the former. Up to the moment, no acyltransferase activity has been described among the Cephalosporium types; this is consistent with the fact that only a-aminoadipic acid structures have been found as side chains of their antibiotics. Isopenicillin N, but not penicillin N, is a substrate for Penicillium
112
E. J . VANDAMME
acyltransferase (Fawcett et al., 1975), although this compound does not act as substrate for penicillin acylases. However, the i c t that a crude penicillin acylase preparation from Penicillium chrysogenum, was able to produce some 6-APA when the carboxyl groups of the side chains of penicillin N and isopenicillin N were esterified, might suggest that these or related analogs of these penicillins are also substrates for acyltransferase activity (Vanderhaeghe et al., 1968). It seems that a lack of purified acyltransferases, transferases, and acylases from P-lactam producers and their poor characterizationstand in the way of a straightforward conclusion about their particular or concerted role in p-lactam biosynthesis. The biosynthetic activity of the acylases, transacylases, and acyltransferases is represented in Table VII. Quite another approach to the elucidation of the possible involvement of penicillin acylases or transferases in penicillin biosynthesis was advanced by Cooper (1972). Cooper (1972) prepared chemically a derivative of L-cysteinyl-D-dehydrovaline (thiazoline-azetidinone) from penicillin and suggested that this product is a model of a possible intermediate in the biosynthesis of penicillin and cephalosporin antibiotics. In this hypothetical pathway, the cysteine moiety would be derivatized with a-aminoadipic acid or attached to a protein surface. The proposed course of events would be amidation with L-valine, followed by p-lactam ring closure (Fig. 2). The resulting thiazoline-azetidinonemight be converted by acylase, transacylase, or acyltransferase action of Cephalosporium or Penicillium into cephalosporins and/or penicillins.
B. INVOLVEMENT OF ACYLASES,ESTERASES, AND TRANSFERASES IN CEPHALOSPORIN BIOSYNTHESIS 1 . Acylases
Microbial acylases capable of hydrolyzing cephalosporin C specifically into 7-ACA and D-a-aminoadipic acid have not been detected so far. Although cephalosporin C acylases, splitting off the a-aminoadipic acid, have been found in species of Brevibactaium, Achromobacter, and Flavobacterium, during their hydrolytic action the acetyl group of cephalosporin is also lost, so that deacetyl-7-ACA is produced rather than 7-ACA (Walton, 1964). The a-aminoadipic acid moiety of the cephalosporins can also undergo oxidative deamination by the action of pig kidney D-amino acid oxidases (Mazzeo and Romeo, 1972), but so far no microbial enzymes have been reported to carry out this reaction. Some semisynthetic cephalosporins can be split into their side-chain acid and 7-ACA by a few bacterial penicillin G acylases, but generally the rate of hydrolysis is lower than that of the corresponding penicillins. This is shown
TABLE VII PENICILLIN SYNTHESIS BY ACYLASES, TRANSACYLASES, OR ACYLTRANSFERASES FROM fl-hCTAM-PRODUCINGMICROORGANISMS
Microorganisms Penicillium chysogenum W49-408, SC-3576 Penicillium BRL 807 Penicillium chysogenum w49-408 Penicillium chrysogenum 51-20F3 Penicillium chysogenum D61347113 Penicillium chrysogenum ATCC 12687 Penicillium chysogenum
Penicillium chysogenum sc-6041
Enzyme preparation
Phenoxyacetic acid or phenylacetic acid Phenylacetic acid Intact cells Penicillin V,G,K,X, Soluble extract dihydro-F Purified enzyme Penicillin G Purified enzyme Phenylacetyl CoA Penicillin
Intact cells
Crude extract Purified enzyme Crude extract
Phcnylacetyl CoA or phenoxyacetyl CoA Phenylacetyl CoA Phenylacetic acid or phenylacetyl CoA
Crude extract
Crude extract Soluble extract
Penicillins produced
Substrates
Phenylacetyl CoA penicillin G Phenylacetyl CoA
+
Enzyme($ involved
References
+ 6-APA
Penicillin V or G
Acylase
Erickson and Dean (1966)
+ 6-APA
Penicillin G Penicillin V, G, K,X, dihydro-F Penicillin G Penicillin G Penicillins
Acylase Acyltransferase
Cole (1966) Pruess and Johnson (1967)
Acyltransferase Transacylase Acylase, transacylase acyltransferase Transacylase
Spencer (1968) Spencer (1968) Spencer and Maung (1970)
Transacylase
Gatenheck and Brunsherg (1968)
Acylase (?), transacylase (?j, acyltransferase Acylase (?), transacylase (?), acyltransferase Acylase (?), acyltransferase Transacylase, acyltransferase
Abraham (1974a,b), Loder (1972)
+ 6-APA + 6-APA + 6-APA + 6-APA + 6-APA + 6-APA
Penicillin G Penicillin V Penicillin G
+ 6-APA or
Penicillin G
isopenicillin N 6-APA or isopenicillin N
Solvent soluble penicillins
+ Isopenicillin N + Isopenicillin N
Penicillin G Solvent soluble penicillins
Brunner et al. (1968)
Abraham (1974a,h), Fawcett et al. (1975)
114
E. 1 . VANDAMME
R
B
B
j,
\
I
COOH Thiazolineazetidinone
COOH Cysteinyl-valine derivative
Cysteine derivative
R
"AXs
Cephalospovium acremaium and/or Penlcillium chrysogenum enzymes
R'CONH
1
--qk 0
o + ~ c H 2 0 c o c H 3 COOH Cephalosporins
/,
COOH R'CONH
+
0 5=CWH N
Penicillins
FIG.2. Biosynthetic pathway of penicillins and cephalosporins according to Cooper (1972). Reprinted with permission from the]ournal of the American Chemical Society 94,1018. Copyright by the American Chemical Society.
in Table VIII. Cephalosporin acylases from Bacillus megaterium and Erwinia aroideae were found to hydrolyze, respectively, the phenylacetyl and phenoxyacetyl derivatives of 7-aminodeacetoxycephalosporanic acid (7ADCA) into the side-chain and 7-ADCA (B. J. Abbott, personal communication). These two strains have previously been described for their penicillin G and penicillin V acylase activity, respectively (Vandammeand Voets, 197413). It is not known whether the penicillin acylases of P-lactam producers also display this activity. In contrast to this lack of hydrolytic cephalosporin C acylases, Japanese workers have detected bacterial enzymes able to synthesize cephalosporins, starting from 7-ACA or 7-ADCA and an appropriate side-chain ester (Takahashiet al., 1972). As side-chain structures, a-D-phenylglycine methyl ester and analogs (glycine ethyl ester, D-danine ethyl ester, D-leucine ethyl ester, and the methyl esters of D-a-cyclohexenylglycine, D-CX-P-hydroxyphenylglycine, and D-a-cyclohexylglycine) were coupled to 7-ACA or 7ADCA at pH 6 by enzymic action in microorganisms, includingXanthomonas oryzae IF03995, Acetobacter pasteurianus ATCC6033, Acetobacter turbidam ATCC9325, Gluconobacter suboxydans ATCC621, Pseudomonas naelanogenum IF012020, Mycopha dimorpha IF013212, and Protaminoaluoflauus IF013221 (Takahashi et al., 1974). This type of enzymic activity was subsequently found among a wide range of bacteria: Aeromonas, Escherichia, Staphylococcus,Arthrobacter, Proteus,
115
ENZYMES INVOLVED IN P-LACTAM ANTIBIOTIC BIOSYNTHESIS
TABLE VIII ENZYMIC PRODUCTION OF 7-ACA FROM SEMISYNTHETIC
CEPHALOSPORINS~ ~~
Penicillin acylase-producing microorganism Escherichia coli BRL 351 Nocardia FD 4697, Proteus rettgeri FD 13424 Escherichia coli NCIB 8734A, E . coli BRL 351 Kluyoera citrophila KY 3641
Substrate Benzylcephalosporin N-Phenoxyacetyl-7-ACA, N -Phenylmercapto-7-ACA Cephalothin, cephaloridine Cephalothin
References Sjoberg et al. (1967) Huang et al. (1963) Sjoberg et al. (1967); Cole (1969a) Nara et al. (1971b); Shimuzi et al. (1975)
aFrom Vandamme and Voets (1974b).
Coynebacterium, Achromobacter, Flavobacterium, Clostridium, Spirillum, and Bacillus, but has not yet been detected in cephalosporin producers. That enzymic activity was also clearly different from that of penicillin acylase, although some penicillin acylases are able to acylate 7-ACA or 7-ADCA (Marconi et al., 1975). However, the enzymic synthesis of cephalosporin C starting from 7-ACA and a-aminoadipic acid or its derivatives was not reported. As neither cephalosporin acylases nor 7-ACA have ever been found in cephalosporin-producing microorganisms, these enzymes and 7-ACA seem to have no role in the biosynthetic process of the cephalosporins. If, in the future, analogous enzymes are detected in cephalosporin or cephamycinproducing microorganisms, it is hard to believe that they could open additional perspectives toward p-lactam antibiotic biosynthesis, as it will be difficult to interpret the findings because of the still obscure role of the well-known penicillin acylases in penicillin biosynthesis. 2 . Esterases Enzymes that deacetylate cephalosporins are widespread in nature. Jeffery et al. (1961) isolated from orange peel a cephalosporin acetylesterase. This enzyme hydrolyzes cephalosporin C to deacetylcephalosporin C, other cephalosporins containing an 0-acetyl group to the corresponding deacetylcephalosporins, and 7-ACA to 7-aminodeacetylcephalosporanic acid. The enzyme is an esterase that shows highest activity with esters of acetic acid as substrates with a pH optimum between 6.0 and 6.5. A survey of microbial sources revealed that many bacteria, actinomycetes, and yeasts are capable of deacetylating cephalosporins (Demain et al., 1963; Nuesch et al., 1967). The enzyme was also found in liver and kidney tissue (O’Callaghan and Muggleton, 1963). Abbott and Fukuda (1975) reported on the purification and immobilization of a Bacillus subtilis NRRL-B-558 cephalosporin esterase. A molecular weight of about 19O,OOO, a narrow pH
116
E. J . VANDAMME
optimum at pH 7.0, and an optimum temperature between 40" and 50°C were its characteristics. In addition to cephalosporins and 7-ACA, the enzyme can hydrolyze mono- and triacetin, a-naphthyl acetate and glucose pentaacetate. The occurrence of deacetylcephalosporin C in Cephalosporium acremnium fermentations was first demonstrated by Jeffery et al. (1961). Huber and co-workers (1968) and Brannon et al. (1972) concluded that deacetylcephalosporin C found in cephalosporin C fermentations is merely a nonenzymic degradation product of cephalosporin C. However, the isolation of the carbamoyl p-lactam antibiotics from Streptomyces fermentations raised the question of the origin of the novel carbamate moiety (Nagarajanet al., 1971). Occurrence of enzymic 0-carbamoylation had already been demonstrated in Streptomyces polychromogenes (Tanaka and Sashikata, 1963). Brannon et al. (1972) found a cephalosporin C acetyl esterase in the culture broth of the carbamoyl-cephalosporin producing Streptomyces clavuligerus NRRL 3583, able to deacylate cephalosporin. The enzyme is inhibited by diisopropyl fluorophosphate, known to be an effective inhibitor of acetyl esterases (Jansen and Balls, 1952). The enzyme was only detected extracellularly. No evidence was obtained for a possible biosynthetic pathway in Streptomyces clavuligerms for cephalosporin C through deacetylcephalosporinC to the carbamoylcephalosporin. Also, it is not known which enzymes are involved in the terminal stages of cephamycin biosynthesis. Fujisawa et al. (1973) isolated mutants of Cephalosporium sp. M8650 and 52-54 strains, some of which produced only deacetylcephalosporin C (mutants 20, 29, 36, 40), while another mutant (81) initially produced cephalosporin C, which was subsequently converted into deacetylcephalosporin C. They found that strain 81, but not the other mutants nor the wild type, produced a cephalosporin C esterase, with optimum pH at 8.0, and concluded that, in the mutants 20, 29, 36, and 40, deacetylcephalosporin C is produced de novo and in strain 81 by enzymic decomposition of cephalosporin C. If so, cephalosporin C should be synthesized by enzymic acetylation of deacetylcephalosporin C. 3. Transferases Indeed, by incubating cell-free extracts from the wild type or mutant 81 in the presence of acetyl-CoA, deacetylcephalosporin C, and Mg2+ at pH 7.0, cephalosporin C was produced (Fujisawa et al., 1973, 1975). The responsible enzyme was named acetyl-CoA:deacetylcephalosporinC acetyltransferase. This transferase activity was not present in cell-free extracts of strains 20,29, 36, and 40 or in the cephalosporin C esterase fraction from strain 81. Accordingly, deacetylcephalosporin C accumulation in those mutants was due to the lack of acetyltransferase activity. Kanzaki et al. (1974b)and Fujisawa and Kanzaki (197513) concluded that the terminal biosynthetic step proceeds
ENZYMES INVOLVED IN P-LACTAM ANTIBIOTIC BIOSYNTHESIS
117
through a step catalyzed by the acetyltransferase, that deacetylcephalosporin C is an intermediate in cephalosporin C biosynthesis, and that racemization of the L-a-aminoadipyl moiety takes place before deacetylcephalosporin synthesis. These researchers also discovered some novel Cephalosporium metabolites with a potential role as intermediates in cephalosporin C biosynthesis (Fujisawa and Kanzaki, 1975a; Kanzaki et al., 1974a). Cephalosporin Cnegative mutants, obtained from Cephalosporium acremonium ATCC 14553 by N'-methyl-N '-nitro-N-nitrosoguanidine treatment, were shown to accumulate deacetylcephalosporin C accompanied by a cephalosporoate. This latter compound accumulated only in culture broths of mutants defective in acetyltransferase, and it is probably a degradation product of deacetylcephalosporin C. They proposed a biosynthetic scheme for cephalosporin C as follows: Tripeptide + deacetoxycephalosporin C
C + cephalosporin C
4 deacetylcephalosporin
Queener and Capone (1974) and Liersch et al. (1974) came to the same conclusion and reported on an enzyme catalyzing the hydroxylation of deacetoxycephalosporin C to deacetylcephalosporin C. Hence, Cephalosporium or Streptomyces strains, blocked in their hydroxylating (and acetylating) enzymes, produce deacetoxycephalosporins. Deacetoxycephalosporin C may be used in the industrial preparation of new cephalosporin antibiotics. Chemical deacylation removes the aminoadipyl side chain to yield 7-aminodeacetoxycephalosporanicacid (7-ADCA). This compound can be reacylated chemically or enzymically with cephalosporin acylases to produce new antibiotics (Takahashi et al., 1972). In strains lacking acetyltransferase activity, deacetylcephalosporin C can be considered as an end product of the p-lactam antibiotic biosynthetic pathways. However, deacetylcephalosporin C found together with cephalosporin C in many fermentations is most likely a degradation product of preformed cephalosporin C. Although, the acyl-CoA acetyltransferase has a definite role as the terminal-stage enzyme in cephalosporin C biosynthesis, whether a similar enzymic activity is involved in cephamycin biosynthesis is still an open question. V. Concluding Remarks Experiments with broken-cell systems, especially with protoplasts and their lysates (Abraham, 1974a; Kohsaka and Demain, 1976), have been encouraging with respect to the elucidation of p-lactam antibiotic biosynthesis. Such systems eliminate permeability barriers, but still give rise, as do all experiments with cell extracts, to modified enzyme activities caused by loss of membrane supports or conformational changes. The availability of cell lysates derived from high-producing strains of Penicillium, Cephalosporium,
118
E. J . VANDAMME
and Streptomyces used in the fermentation industries would certainly help throw more intense light on this complex problem. However, the question is still there whether the biosynthesis of p-lactam antibiotics can be achieved by soluble cytoplasmic enzymes or whether it requires, at least in some steps, the integrity of membrane- or particle-bound enzymes or enzyme complexes. On the other hand, biosynthetic mechanisms can be studied in intact cells using the techniques of biochemical genetics (Nash et al., 1974). Specific mutations that influence the availability of the building blocks influence p-lactam biosynthesis and can resolve the relationships between primary metabolism and antibiotic synthesis. Nonantibiotic-producing mutants of Penicillium, Cephalosporium, and Streptomyces mutants are also gaining importance as potential tools for the elucidation of intermediates and enzymes involved in p-lactam antibiotic synthesis. It should be noted that Penicillium chrysogenum and Cephalosporium acremonium species, from which all modern industrial strains are derived, contain viral particles that could influence the complex biosynthetic processes in the cell (Banks et al., 1969; Day and Ellis, 1971). However, there seems to be no relationship between antibiotic biosynthesis and the virus titer of the strain (Lemke and Nash, 1974). Viruses for the p-lactamproducing streptomycetes have not yet been reported. There are also indications that plasmid genes are involved in the production of certain antibiotics by streptomycetes (Akagawa et al., 1975; Kirby et al., 1975). However, this phenomenon has not yet been studied in P-lactam-producing streptomycetes. Hyphal differentation of Cephalosporium into arthrospores coincides with active antibiotic formation, indicating an interrelation between p-lactam antibiotic synthesis and stages of cell differentation (Nash and Huber, 1971; Queener and Ellis, 1975). Gordee and Day (1972) found that addition of exogenous penicillin V, G, or 6-APA during penicillin fermentation inhibited further accumulation of the antibiotic, suggesting that penicillin is a negative regulator of its own biosynthesis. All the above potential implications stress the overall complexity of p-lactam antibiotic biogenesis. Nevertheless, in recent years much progress has been made toward a fundamental understanding of these biosynthetic processes (Abraham, 1974a; Demain, 1974; Fawcett et al., 1975). ACKNOWLEDGMENT This review was born during a postdoctoral stay at the Sir William Dunn School of Pathology, University of Oxford, England. The author wishes to thank Professor E. P. Abraham, University of Oxford, and Professor A. L. Dernain, Massachusetts Institute of Technology, Cambridge, Massachusetts, for their helpful discussions, criticism, and stimulating advice during the preparation of the manuscript. The author is indebted to Professor J. P. Voets, University of Gent, for encouragement and a leave of absence.
ENZYMES INVOLVED IN P-LACTAM ANTIBIOTIC BIOSYNTHESIS
119
REFERENCES Abbott, B. J., and Fukuda, D. S. (1975).Appl. Microbiol. 30, 413. Aberhart, D. J., and Lin, L. J. (1974).I . Chem. Soc., Perkin Trans. 1 p. 2320 Abraham, E. P. (1974a). “Biosynthesis and Enzymic Hydrolysis of Penicillins and Cephalosporins.” Univ. of Tokyo Press, Tokyo. Abraham, E. P. (197413). Deu. Znd. Microbiol. 15, 3. Abraham, E. P., and Loder, P. B. (1972).Proc. Znt. Ferment. Symp., 4th, 1972 Abstracts, p. 82. Acevedo, F., and Cooney, C. L. (1973). Biotechnol. Bioeng. 15, 493. Adriaens, P., Meesschaert, B., Wuyts, W., Vanderhaeghe, H., and Eyssen, H. (1975a). Antimicrob. Agents Chemother. 8, 638. Adriaens, P., Vanderhaeghe, H., Meesschaert, B., and Eyssen, H. (1975b). Antimierob. Agents 6.Chemother. 8, 15. Akagawa, H., Okanishi, M., and Umezawa, H. (1975). J. Gen. Microbiol. 90, 336. Albers-Schonberg, G., Arison, B. H., and Smith, J. L. (1972). Tetrahedron Lett. p. 2911. A n d , J., Eyssen, H., and Desomer, P. (1974). Arch. Mikrobiol. 98, 159. Aoki, H., Kohsaka, M., Hosoda, J., Komori, T., and Imanaka, H. (1975). Fijteenth Proc. lntersci. Conf. Antimicrob. Agents Chemother., 1975 Abstracts , p. 97. Aoki, H., Sakai, H., Kohsaka, M., Konomi, T., Hosoda, J., Kubochi, Y., Iguchi, E., and Imanaka, H. (1976).J. Antibiot. 29, 492. Aragozzini, F., Toppino, P., and Rindone, B. (1970). Ann. Microbiol. Enzimol. 20, 43. Amstein, H. R. V., and Morris, D. (196Oa). Biochem. J. 76, 323. Amstein, H. R. V., and Morns, D. (1960b). Biochem. J . 76, 357. Banks, G. T., Buck, H. W., Chain, E. B., Darbyshire, J. E . , and Himmelweit, F. (1969). Nature (London) 222, 89. Batchelor, F. R., Doyle, F. P., Nayler, J. H. C., and Rolinson, G. N. (1959).Nature (London) 183, 257. Batchelor, F. R., Chain, E. B., and Rolinson, G. N. (1961a).Proc. R . SOC. London, Ser. B 154, 487. Batchelor, F. R., Chain, E. B., Richards, M . , and Rolinson, G. N. (196lb). Proc. R. SOC. London, Ser. B 154, 522. Bauer, K. (1970). Z. Naturforsch., Teil B 25, 1125. Bauer, K., Kaufmann, W., and Offe, H. A. (1960). Naturwissenschaften 47, 469. Baumann, F., Brunner, R., and Rohr, M. (1971). Hoppe Seyler’s Z. Physiol. Chem. 352, 853. Bodansky, M., and Perlman, D. (1969). Science 163, 352. Bondareva, N. S., Levitov, M. M., and Goryachenkova, E. V. (1969a). Biokhimiya 34, 96. Bondareva, N. S., Levitov, M. M., and Rabinovich, M. S. (1969b). Biokhimiya 34, 478. Brandl, E. (1965). Hoppe Seyler’s Z. Physiol. Chem. 342, 86. Brandl, E. (1972). Sci. Pharm. 40, 1. Brannon, D. R., Fukuda, D. S., Mabe, J. A , , Huber, F. M., and Whitney, J. G. (1972). Antimicrob. Agents 6.Chemother. 1, 237. Brunner, R., and Rohr, M. (1965). Abstr., Fed. Eur. Biochem. SOC. Meet., 2nd, 1965 A. 99, p. 68. Brunner, R., and Rohr, M. (1975).In “Methods in Enzymology” (J. H. Hash, ed.), Vol. 43, p. 476. Academic Press, New York. Brunner, R., Rohr, M., and Baumann, F. (1966a). Allg. Prakt. Chem. 17, 66. Brunner, R., Rohr, M., and Zinner, M. (196613). Monatsh. Chem. 97, 952. Brunner, R., Rohr, M., and Zinner, M. (1968). Hoppe Seyler’s Z. Physiol. Chem. 349, 95. Carrington, T. R. (1971). Proc. R. SOC. London, S e r . B 179, 321. Chain, E. (1971). Proc. R. SOC. London, Ser. B 179, 293.
120
E. J . VANDAMME
Chiang, D., and Bennett, R. E. (1967).J. Bacteriol. 93, 302. Chugasova, V. A , , Terekhova, L. P., and Fedorova, G. B. (1974). Antibiotiki (Moscow) 19,195. Claridge, C. A,, Gourevitch, A,, and Lein, J. (1960). Nature (London) 187, 337. Claridge, C. A,, Luttinger, J. R., and Lein, J. (1963). Proc. SOC. E r p . B i d . Med. 113, 1008. Cole, M. (1964). Nature (London) 203, 519. Cole, M. (1966). Appl. Microbiol. 14, 98. Cole, M. (1967). Process Biochem. 2, 35. Cole, M. (1969a).Biochem. J. 115, 733. Cole, M. (1969b). Biochem. J. 115, 747. Cole, M., and Batchelor, F. R. (1963).Nature (London) 198, 383. Cole, M., and Rolinson, G. N. (1961). Proc. R. SOC. London, S e r . B 154, 490. Cooper, R. D. G. (1972).J. Am. Chem. SOC. 94, 1018. Day, L. E., and Ellis, L. F. (1971). Appl. Microbiol. 22, 919. Demain, A. L. (1966). In “BiosynthesisofAntibiotics” (J. F. Snell, ed.), Vol. 1, p. 20. Academic Press, New York. Demain, A. L. (1974). Uoydia 37, 147. Demain, A. L., Walton, R. B., Newkirk, J. F., and Miller, I. M. (1963).Nature (London) 199, 909. Dennen, D. W., Allen, C. C., and Carver, D. D. (1971). Appl. Microbiol. 21, 907. Duncan, M., and Newton, G. G. F. (1970).Acta Fac. Med. Unio. Bmn. 37, 129. Elander, R. E. (1975). Deo. Ind. Microbiol. 16, 356. Elander, R. P., Stauffer, J. F., and Backus, M. P. (1961).Antirnicrob. Agents Annu. p. 91. Ehnder, R. P., Gordee, R. S., Wilgus, R. M., and Gale, R. M. (1969).J. Antibiot. 22, 176. Erickson, R. C., and Bennett, R. E. (1965). Appl. Microbiol. 13, 738. Erickson, R. C., and Dean, L. D. (1966).Appl. Microbiol. 14, 1047. Fawcett, P. A., and Abraham, E. P. (1975)Zn“Methods ofEnzymology” (J. H. Hash, ed.), Vol. 43, p. 471. Academic Press, New York. Fawcett, P. A., Loder, P. B., Duncan, M. J., Beesley, T. J., and Abraham, E. P. (1973).J. Gen. Microbiol. 79, 293. Fawcett, P. A., Usher, J. J., and Abraham, E. P. (1975). Biochem. J . 151, 729. Flynn, E. H., McCormick, M. H., Stamper, M. C., De Valeria, H., and Godzeski, C. W. (1962).J. Am. Chem. SOC. 84, 4594. Fujisawa, Y., and Kanzaki, T. (1975a).J. Antibiot. 28, 372. Fujisawa, Y., and Kanzaki, T. (197513). Agric. B i d . Chem. 39, 2043. Fujisawa, Y.,Shirafuji, H., Kida, M., Nara, K., Yoneda, M., and Kanzaki, T. (1973). Nature (London),New Biol. 246, 154. Fujisawa, Y., Kitano, K., and Kanzaki, T. (1975). Agric. Biol. Chem. 39, 2049. Gatenbeck, S. (1975). I n “Methods in Enzymology” (J. H. Hash, ed.), Vol. 43, p. 474. Academic Press, New York. Gatenbeck, S., and Brunsberg, U. (1968). Acta Chem. Scand. 22, 1059. Gauze, G. F., Chugasova, V. A,, Laiko, A. V., and Terekhova, L. P. (1972). Antibiotiki (Moscow) 17, 963. Gordee, E. Z., and Day, L. E. (1972). Antirnicrob. Agents k. Chemother. 1, 315. Hamilton-Miller, J. M. T. (1966). Bacteriol. Reo. 30, 761. Haupt, I., and Thrum, H. (1967). 2. A&. Mikrobiol. 7, 343. Higgens, C. E., Hamill, R. L., Sands, T. H., Hoehn, M. M., Davis, N. E., Nagarajan, R., and Boeck, L. D. (1974).J . Antibiot. 27, 298. Holt, R. J., and Stewart, G. T. (1964). Nature (London) 201, 824. Huang, F. C., Chan, J. A,, Sih, C. J., Fawcett, P., and Abraham, E. P. (1975). J. Am. Chem. SOC. 97, 3858. Huang, H. T., English, A. R., Seto, T. A., Shull, G. M., and Sobin, B. A. ( l W ) . J . Am. Chem. SOC. 82, 3790.
ENZYMES INVOLVED IN
P-LACTAM ANTIBIOTIC BIOSYNTHESIS
121
Huang, H. T., Seto, T. A., and Shull, G. M. (1963).Appl. Microbiol. 11, 1. Huber, F. M., Baltz, K. M., and Caltrider, P. G. (1968).Appl. Mierobiol. 16, 1011. Jansen, E. F., and Balls, A. K. (1952).J . Biol. Chem. 194, 721. Jeffery, J.D’A., Abraham, E. P., and Newton, 6 . 6 . F. (1961). Biochem. J. 81, 591. Kanzaki, T., Fukita, T., Shirafuji, H., Fujisawa, Y., and Kitano, K. (1974a).J. Antibiot. 27,361. Kanzaki, T., Shirafuji, H., Fujisawa, Y., Fukita, T., Nara, K., Kitano, K., and Kida, M. (1974b). Proc. Znt. Symp. Genet. Znd. Microwg., 2nd, 1974 Abstracts, p. 32. Katz, E. (1971). Pure Appl. Chem. 28, 551. Kaufmann, W. (1964). Biochem. Biophys. Res. Commun. 14, 458. Kaufmann, W., and Bauer, K. (1960). Naturwissenschaften 47, 474. Kaufmann, W., and Bauer, K. (1964). Nature (London) 203, 520. Kikuchi, T., and Uyeo, S. (1967). Chem. Pharm. Bull. 15, 549. Kirby, R., Wright, L. F., and Hopwood, D. A. (1975). Nature (London) 254, 265. Kirkpatrick, J. R., Doolin, L. E., and Godfrey, 0. W. (1973).Antimicrob. Agents 67 Chemother. 4, 542. Kitano, K., Kintaka, K., Suzuki, S., Katamoto, K., Nara, K., and Nakao, Y. (1974).J . Ferment. Technol. 52, 785. Kitano, K., Kintaka, K., Katamoto, K., Nara, K., and Nakao, Y. (1975). Hakko Kogaku Zasshi 53, 339. Kluender, H., Bradley, C. H., Sih, C. J., Fawcett, P., and Abraham, E. P. (1973). J. Am. Chem. SOC. 95, 6149. Kohsaka, M., and Demain, A. L. (1976). Biochem. Biophys. Res. Commun. 70, 465. Kurahashi, K. (1974). Annu. Rev. Biochem. 43, 445. Kutzbach, C., and Rauenbusch, E. (1974). Hoppe Seyler’s Z. Physiol. Chem. 355, 45. Lemke, P. A,, and Brannon, D. R. (1972). In “Cephalosporins and Penicillins: Their Chemistry and Biology” (E. H. Flynn, ed.), p. 370. Academic Press, New York. Lemke, P. A,, and Nash, C. H. (1972). Can. J . Mierobiol. 18, 255. Lemke, P. A,, and Nash, C. H. (1974). Bacteriol. Rev. 38, 29. Liersch, M., Nuesch, J., andTreichler, H. J. (1974). Proc. Symp. Genet. Ind. Microorg., 2nd, 1974 Abstracts, p. 48. Loder, P. B. (1972). Postepy Hig. Med. Dosw. 26, 493. Loder, P. B., and Abraham, E. P. (1971a). Biochem. J. 123, 471. Loder, P. B., and Abraham, E. P. (1971b). Biochem. J. 123, 477. Loder, P. B., Abraham, E. P., and Newton, G. G. F. (1969). Biochem. J. 112, 389. Maier, W., and Groger, D. (1972). Pharmuzie 27, 491. Marconi, W., Bartoli, F., Cecere, F., Galli, G., and Morisi, F. (1975). Agric. Biol. Chem. 39, 277. Mazzeo, P., and Romeo, A. (1972).J . Chem. Soc., Perkin Trans. 1 20, 2532. Merrick, M. J., and Caten, C. E. ( 1975). J . Appl. Bacterial. 38, 121. Miller, I. M., Stapley, E. O., and Chaiet, L. (1962). Bacteriol. Proc. p. 32. Nagarajan, R., Boeck, L. D., Gorman, M., Hamill, R. L., Higgens, C. E., Hoehn, M. M., Stark, W. M., and Whitney, J. G. (1971).J. Am. Chem. SOC. 93, 2308. Nara, T., Okachi, R., and Misawa, H. (1971a).J. Antibiot. 24, 321. Nara, T., Misawa, M., Okachi, R., and Yamamoto, M. (1971h). Agric. B i d . Chem. 35, 1676. Nara, T., Okachi, R., and Kato, F. (1972). Proc. Znt. Fennent. Symp., 4th, 1972 Abstracts, p. 207. Nash, C. H., and Huber, F. M. (1971). Appl. Mierobiol. 22, 6. Nash, C. H., Delahiguera, N., Neuss, R., and Lemke, P. A. (1974). Deu. Znd. Microbiol. 15, 114.
Neuss, N., Nash, C. H., Baldwin, J. E., Lemke, P. A,, and Grutzner, J. B. (1973). J. Am. Chem. SOC. 95, 3797. Newton, G. G. F., and Abraham, E. P. (1955). Nature (London) 175, 548.
122
E . I. VANDAMME
Nuesch, J., Gruner, J., Knusel, F., and Treichler, H. J. (1967). Pathol. Microbiol. 30, 880. O’Callaghan, C. H., and Muggleton, P. W. (1963). Biochem. J. 89, 304. Okachi, R., and Nara, T. (1973).Agric. Biol. Chem. 37, 2797. Peterson, W. H., and Wideburg, N. E. (1960).Proc. Int. Congr. Biochem., 4th, 1958 Vol. 15, p. 136. Pisano, M. A,, and Vellozzi, E. M. (1974). Antimicrob. Agents h? Chemother. 6, 447. Pruess, D. L., and Johnson, M. J. (1965).J. Bacteriol. 90, 380. Pruess, D. L., and Johnson, M. J. (1967).J. Bacteriol. 94, 1502. Queener, S. W., and Capone, J. J. (1974). Proc. Znt. Symp. Genet. 2nd. Microorg., 2nd, 1974 Abstracts, p. 33. Queener, S. W., and Ellis, L. F. (1975). 75th ASM Annu. Meet. Abstracts, p. 195. Queener, S. W., Capone, J. J., Radue, A. B., and Nagarajan, R. (1974).Antimicrob. Agents h? Chemother. 6 , 334. Rode, L. G., Foster, V. W., and Schuhardt, V. T. (1947).J. Bacteriol. 53, 565. Rolinson, G. N., Batchelor, F. R. Butterworth, D., Cameron-Wood, J., Cole, M., Eustace, G. C., Hart, V., Richards, M., and Chain, E. B. (1960). Nature (London) 187, 236. Rossi, D., Romeo, A., Lucente, G., and Tinti, 0. (1973). Farmuco, Ed. Sci. 28, 262. Sakaguchi, K., and Murao, S. (1950).]. Agric. Chem. SOC. Jpn. 23, 411. Scannell, J. P., Pruess, D. L., Blount, J. F., Ax, A. H., Kellett, M., Weiss, F., Demny, T. C., Williams, T. H., and Stempel, A. (1975).J. Antibiot. 28, 1. Self, D. A., Kay, G., Lilly, M. D., and Dunnill, P. (1969). Biotechnol. Bioeng. 11, 337. Shimi, I. R., and Imam, G. M. (1966). Biochem. J. 101, 831. Shimuzi, M., Okachi, R., Kimura, K., and Nara, T. (1975). Agric. Biol. Chem. 39, 1655. Sjoberg, B., Thelin, H., Nathorst-Westfelt, L., Vantamelen, E. E., and Wagner, E. R. (1965). Tetrahedron Lett. 4, 281. Sjoberg, B., Nathorst-Westfelt, L., and Ortengren, B. (1967).Acta Chem. Scand. 21, 547. Spencer, B. (1968). Biochem. Biophys. Res. Commun. 31, 170. Spencer, B. (1975).In “Methods in Enzymology” 0. H. Hash, ed.), Vol. 43, p. 482. Academic Press, New York. Spencer, B., and Maung, G. (1970). Biochem. J . 118, Proc. 29. Stapley, E. O., Jackson, M., Hernandez, S., Zimmerman, S. B., Currie, S. A., Mochales, S., Mata, J. M., Woodruff, H. B., and Hendlin, D. (1972).Antimimob. Agents hr Chemother. 2,122. Stewatt, W. W. (1971). Nature (London) 229, 174. Takahashi, T., Yamazaki, Y., Kato, K., and Isono, M. (1972).J . Am. Chem. SOC. 94, 4035. Takahashi, T., Yamazaki, Y., and Kato, K. (1974). Biochem. J. 137, 497. Takita, T., Muraoka, Y., Yoshioka, T., Fujii, A,, Maeda, K., and Umezawa, H. (1972). J. Antibiot. 25, 755. Tanaka, N., and Sashikata, K. (1963).J. Gen. Appl. Microbiol. 9, 409. Taylor, P. A., Schnoes, H. K., and Durbin, R. D. (1972). Biochim. Biophys. Acta 286, 107. Thadhani, S. B., Borkar, P. S., and Ramachandran, S. (1972). Biochem. J. 128, Proc. 49. Traxler, P., Treichler, H. J., and Nuesch, J. (1975).J. Antibiot. 28, 605. T r o w , P. W., Smith, B., and Abraham, E. P. (1963). Biochem. J. 86, 284. Uri, J., Valu, G., and Bekesi, I. (1963). Nature (London) 200, 896. Uri, J., Valu, G., and Bekesi, I. (1964).Natufiuissenschaften 51, 298. Uri, J . , Szathmary, S., and Herpay, Z. (1957). Nature (London) 179, 1029. Vandamme, E. J . , and Voets, J. P. (1974a). Meded. Fak. Landbouwwet., Rijksunio. Gent 39, 1463. Vandamme, E. J., and Voets, J. P. (197413).Adu. Appl. Microbiol. 17, 311. Vandamme, E. J., and Voets, J. P. (1975). Erperientia 31, 140.
ENZYMES INVOLVED I N
P-LACTAM ANTIBIOTIC BIOSYNTHESIS
123
Vandamme, E. J., Voets, J. P., and Beyaert, 6 . (1971a).Meded. Fak. Landbouwwet. Rijksuniu. Gent 36, 577. Vandamme, E. J . , Voets, J. P., and Dhaese, A. (1971b). Ann. Znst. Pasteur, Paris 121, 435. Vanderhaeghe, H. (1975). In “Methods in Enzymology” (J. H. Hash, ed.), Vol. 43, p. 721. Academic Press, New York. Vanderhaeghe, H., Claesen, M., Vlietinck, A., and Parmentier, 6 .(1968).Appl. Microbiol. 16, 1557. Vojtisek, V., and Slezak, J. (1975). Folia Microbiol. (Prague) 20, 224. Waldschmidt-Leitz, E., and Bretzel, G. (1964). Hoppe SeyZer’s 2. Physiol. Chem. 337, 222. Walton, R. B. (1964). Deo. Znd. Microbiol. 5, 349. Warburton, D., Dunnill, P., and Lilly, M. D. (1973). Biotechnol. Bioeng. 15, 13. Whitney, J. G., Brannon, D. R., Mabe, J. A , , and Wicker, K. J. (1972). Antimicrob. Agents G Chemother. 1, 247. Wolfe, S., Bassett, R. N., Caldwell, S. M., and Wasson, F. (1969).]. Am. Chem. Soc. 91,7205. WoH, E. C., and Arnstein, H. R. V. (1960). Biochem. J. 76, 375.
This Page Intentionally Left Blank
Information Control in Fermentation Development D. J. D. HOCKENHULL Glaro Laboratories Ltd., Ulverston, Cumbria, England I. Introduction . . . . . , . . ....................... A. Information for Process Documentation . . . . . . . . . . . . . . . . B. Information for Technical Management . . . . . . . . . . . . . . . . 11. Research and Develop 111. Project Initiation Reques Program) . . . . . . . . . . . . . ...................... IV. Formal Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Periodical Reports.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Weekly Report.. . .............. B. Monthly Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , C. Quarterly and Half-Yearly Reports . . . . . D. Half-Yearly Project Re ........................ E. Annual Report . . ....................... VI. Laboratory and Plant Protocols . . . . A. General Management Material B. Equipment Operating Procedur ............... VII. The Standard Operating Procedure . . . . . . . . . . . . , . . . . . . . . . . VIII. Direct Experimental Records . . . . . . . . . . . . . A. Experimental Instructions . . . B. Laboratory Notebooks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Program Job Packs.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , D. Pilot Plant Records ....................... E. Analytical Records . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Computer Storage . ....... G. Plant Graphs.. , . . . .............. IX. Miscellaneous Informatio .................
.
XII. Making the Best Use of Data . . . ............ References . . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
125 129 130 133 133 135 138 138 138 140 141 142 142 142 142 143 146 147 147 148 149 151 151 152 153 153 154 156 159
1. Introduction New products, and increasingly efficient means of producing them, are what industry asks of research and development (R&D). The know-how involved has to be communicated to the manufacturing end of the business; indeed, the main output from R & D is technical information. The form and content of this should be satisfactory to, and usable by, whichever sector of the Company needs it (and is perhaps paying for its time). The first stage in the process of informing is the generation of data. These can be defined, for the purpose of this review, as being raw experimental results, such as instrumental readings, analytical figures, and other firsthand observations. The second stage in the process is the converting of these into 125
126
D. J. D. HOCKENHULL
patterns that have useful meaning. The data are systematized, compared, collated, and otherwise worked upon to gain maximum interest summarized in the smallest compass. Thus is achieved the clearest possible view of those experimental relationships with which the informant should be most concerned. Following from this emerges the third stage-producing instructions for carrying out the most profitable methods that have been developed. In this study I shall discuss the various ways of handling information. I shall consider the various vehicles at our disposal for storing and publishing information. I shall look critically at these in the light of the particular jobs they are supposed to do. I shall also give some indication of how such information vehicles fit in with the major needs of industry. Are they as useful as they might be in supporting the internal organizational needs of the laboratory and pilot plant? And do they contribute to rapid economic exploitation of new discoveries on a manufacturing scale? Many people are involved in R & D activities. Investigations consume many man-hours and generate astronomical amounts of data. There is too much to deal with sensibly without reducing it all to a pattern simple enough for one brain to think about. In Ashby’s terminology (1961), there is too much variety. Edwards and Lees (1973)put it thus: “Unduly high informational load is an external agent of stress.” Miller (1960),as quoted by them, has listed the mechanisms that are used by man to reduce such stress: 1. Omission-temporary nonprocessing of material 2. Error-processing incorrect information, which may enable the system to return to normal processing afterwards 3. Queuing-delaying the response during a period of high overlap of input information in the expectation that it may be possible to catch up in a lull 4. Filtering-neglecting to process certain categories of information while processing others 5. Cutting categories of discrimination-responding in a general way to the input but with less precision than would be done at lower rates 6. Escaping from the task-making no decision, guessing, or tossing a coin Inevitably, most of these result in performance deterioration. The reduction of data to manageable proportions is carried out by summarizing, selection, and categorization. We exclude only what is unnecessary to our current purpose in order to build the data into a new informational structure. If we do this effectively, the value of the reduced d a t a - o r information, as we may now call it-should be much greater. We must be careful, however, not to throw out potentially useful facts. The specific aims of our current experimentation may well be superseded as a result of other ways of looking at the data. Some time in the future we may
INFORMATION CONTROL IN FERMENTATION DEVELOPMENT
127
want to look at aspects we had not hitherto considered important. So we need to store the data in a retrievable form. This may be done either as primary unprocessed results or after systematic data reduction. Deciding how much of each kind we should store depends on the cost of the original data, the cost of storage space, and the cost of reduction. These are the main criteria that should decide our day-to-day policy. Another factor is the fluidity of the field-where development is rapid, information may become obsolete in five years or even in one year; e.g., when surface culture of mold fungi was superseded by deep culture, only the most general of conclusions were relevant to the new order. However, my main preoccupation here will be to list and describe the collection and reporting of results. I shall describe the various vehicles for doing this and discuss their several advantagesfor the different tasks involved in the preparation of information for the direction of technical development. Before continuing with the study, let us look at an example. Figure 1 describes a typical experimental procedure taken from the field of systems engineering (MacFarlane, 1964). The example given is a very simple one. It entails subjecting a real combination of things-physical system-to a series of arbitrary known changes, observing how the instrumental readings vary in response (measuring system); setting out some sort of descriptive hypothesis (model system); and further regularizing this by describing the behavior of the system in mathematical terms (mathematical system). The description is tested against further experimental variations of the physical system and, as a result, the model and mathematical systems are further modified to give a truer approximation to reality. Ideally, the measuring system should mirror the behavior of the physical system exactly. In real life, however, especially in biological work, it does so only imperfectly; either our methods are clumsy or we cannot make measurements without interfering with the experimental conditions by doing so. The model system is basically a description of what is happening in abstract terms; i.e., it is a collection of abstract objects derived from the consideration of the relationships “between measurements performed on the physical system in terms of state, work, power energy, signal and information.” Finally, the mathematical system is a set of abstract mathematical objects together with defined sets of relationships between them. It is used together with the model system to predict the behavior of the physical system. The example just described may concern very simple investigations as well as more complex ones. Typically, the task could be (a) to find the relationship of load and extension in a stretched spring; (b) to plot the pH characteristics of the titration of acetic acid with caustic soda; or (c) to find the relationship between the growth rate and temperature of a bacterium. The most basic type of experiment is subject to drastic reduction of data and
128
D. J. D. HOCKENHULL
physical system
physical system
and predicted system behavior
t Adjustment of measuring, model, and mathematical systems to give an accurate comparison between observed and predicted system behavior
FIG. 1. Experimentation charted as a series of system interrelationships.The arrows direct the sequence in which the various systems are developed and modified. From MacFarlane (1964). Reprinted with permission from “Engineering Systems Analysis,” p. 1. G. Harrap, London.
summarization. In biological work, this is more diEcult. The complexity of the experiments is high, and the number of covariants very great; the number of different physical systems we can choose from any set of experiments is high also. Many experiments may be required to establish a single set of relationships. Or, taking different experimental series together might reveal other relationships and answer other questions. Or, perhaps late in an investigation we may realize that certain relationships could be significant. This boils down to the need, on the one hand, to have procedures that reduce the data we have to manageable proportions and, on the other, to store a great deal of the original material to keep our options open and, in case it comes in useful, to back up further systematization. For instance, we may have to use the results for comparing the costs of different processes, perhaps years after the original work was done. We may need the results as older data for comparison with new data, or for testing out experimental models that did not exist when the original results were acquired. These possibilities all emphasize the need to store data adequately and to have simple means for their retrieval. At the same time, data reduction must be effective enough for us to manage the ongoing activities without being snowed under with detail-for example, to answer questions and to communicate necessary innovations to the production area. Different kinds of research and development units require different kinds of informational structures. The information generated may be specific to the
INFORMATION CONTROL IN FERMENTATION DEVELOPMENT
129
activities and investigations. Equally, different information will be needed for their control. Briefly, the data must be treated in a manner appropriate to the way in which they will be used and to whom they may be useful. This is not to be thought of as a permanent structuring, even in one area of activity. As a field develops, new needs grow because technologies advance and establishments grow in size and diversity. I shall, however, draw from my experience in the pharmaceutical industry. I shall describe various informational and communicational vehicles that have been used over a period. I shall point out their purposes and their effectiveness in serving these ends. Similar problems have been discussed elsewhere, especially in the chemical industry. My study, however, will deal with the special problems of the biological industries. It may also throw light from a different direction on common problems. My hope is that this study will provide the basis for a flexible approach to information handling, so that the efficiency of a process can be altered and improved in response to altering needs. The conclusions developed should be relevant whatever the style of management or whatever the nature of the scientific and technical activities considered. Technical information is used in two principal ways. First, for the definition of improved methods of production and, second, for the better management of R & D. We may define the objectives more specifically by listing a number of functions subsumed under these two headings. A. INFORMATIONFOR PROCESSDOCUMENTATION
1. If processes are not adequately described, they will not be repeatable or translatable to another scale (particularly, the production scale), nor will they provide a basis for future work. 2. The Company’s interests have to be protected against its competitors. Reliably documented information has to be furnished for obtaining patent protection. Evidence of prior use has to be established against the corresponding patent application of business rivals. 3. Technical information has to be communicated to other working groups. The program of work may have relevance to what other individuals are doing. The methods used may be useful to others. Findings on one organism may illuminate the behavior of another. Such information can minimize duplication of effort. It may explain phenomena encountered in other areas. It may put into appropriate words some thoughts that until then were vague or ambiguous. Such information may often be qualitative or descriptive as well as mathematical and concrete. It may suggest new approaches in theory or technology. Finally, such information will reveal the existence of knowledgeable individuals with whom common problems may
130
D. J. D. HOCKENHULL
be discussed. In return, other groups may help with the solution of the problems brought to their attention. 4. One must provide a memory store for results and for the reasoning and phenomena leading up to them. It is especially important to identify good ideas, in spite of their having come to nothing in the past. The current technology may have been too weak to support them. After the lapse of a few years, new techniques and the ability to look at the problem from a different angle have often been proved to have revived such ideas and brought them to successful fruition.
B.
INFORMATION FOR
TECHNICAL MANAGEMENT
1. No department can run at maximum efficiency if the decisions as to long-term and short-term aims are based on unsound information. The amount of effort-in men, equipment, and cost-must be adjusted to give the greatest return in actual or potential process development and in the creation of new entrepreneurial opportunities. The accurate assessment of progress in each area is then essential to check the results against the targets previously set. As a result of such comparisons, new targets may be set, new projects started, unpromising lines curtailed, and resources redeployed. 2. The right kind of informational system is necessary for adequate regulation of responsibility. Regular information in an impersonal form from his submanagers tells a boss what is going on at regular intervals and warns him when his visits should be “social” or when he should intervene in the work. The discipline of producing regular written information improves the under-managers’ powers of self-criticism. The objective viewpoint thus taken strengthens greatly their ability to do their jobs. Written reports make it easy to ask for help or guidance in future schemes. They are also aidesmemoire to help the boss work out which major problems, technical or managerial, he should discuss and with whom he should discuss them. Gellerman (1973) sums this up as follows: “Nothing, literally nothing, is more valuable than reliable information. To know what is really happening, what is really possible and what other people believe about both is fir more important than having money, factories or armies of workers. To know what is happening enables a manager to put even limited assets to decisive use: not to know may cripple even the mightiest Company.” Thus there are many reasons for creating an informational system in R & D. Its completeness and efficacy will depend on the needs of the situation and on the motivation of the human elements composing it. By and large, both the strength and the weakness of an efficient information system is that it lays the protagonists open to criticism. This human problem can best be
INFORMATION CONTROL IN FERMENTATION DEVELOPMENT
13 1
dealt with by fair and enlightened management. Technical successes also make life easier by engendering trust. It is not a good sign when written reports are neglected or when their place is taken by verbal ones. This is especially true of the more bequent ones, such as monthly or fortnightly section reports. The absence of downward communication can have a similarly bad effect on morale. Gellerman (1973) also says, “Higher levels keep information from the lower, partly to limit their exposure to criticism and partly on the basis of a wholly inappropriate military model of communication (where, for the sake of secrecy, information is given only to those “with a need to know”-which is typically interpreted as meaning hardly anyone). But lower levels also keep information from the higher, partly in the adolescent belief that what they do not know will not hurt them and partly to protect a sort of territorial right to information that gives them prestige and power (or the illusion of both).” In short, the value of information must be recognized at the top, and the promulgation of adequate systems must be passed on down. There must be a means €or those at the top to gain access to every part of the organization should necessity dictate, but it should not be so difficult that it interferes with their main preoccupations-which are strategic. A manager should not have to waste his subordinates’ time to find out what they are doing-that information should come to him at regular intervals. He should be lefl free to discuss new possibilities, their impact on present conditions, possible expansion of resources, intensification of activity, and so on. 3. A third point is that writing is a good discipline. Describing what one has done and fitting it into one’s frame of reference is useful. Good also is writing it up to fit into contexts in which different use is made of the data. There is good also in examining the pros and cons of the various ways of looking at the data. Writing, like hanging, is a wonderful clearer of the mind. Provided that the writer is free to indulge in a reasonable amount of speculation, the act of committing his observations to paper can often display novelty where it exists. Thus the projection of future work can be made much more certain. The discipline of regularly writing-up work can make the task of data reduction much easier. Use breeds facility, and continuous application spreads the labor thin. The ongoing fitting of every experiment into the historical scene as one goes along helps to keep the detail down to manageable levels. In this way, the problems are kept free from clutter so that the major issues can be decided first and the less important details made to follow from the master plan. However, we must be careful not to be dominated by that to which we have become accustomed. We must not be dis-
132
D. J. D. HOCKENHULL
couraged from enterprising and original experiments because they are not in the traditional canon or because our plans are made with a too rigid and logical basis. Let us not forget, however, that most of the results are pragmatic. We often know that the phenomenon follows from the conditions imposed on it, but we cannot give a rational explanation. Often, we can only describe the conditions in qualitative terms. This does not matter so long as we have enough information to repeat the experiment as often as we please. Our aim is to fit the results of our work into the technology, not necessarily into the basic science-to help control the universe, not explain it. Accordingly, the underlying theory is not very important to us post &to. In the longer term, however, we do not neglect the basics. Those experimental results we have must be interpreted in the light of theory to give understandable patterns and to systematize our findings. With the help of a good fundamental knowledge of the sciences we use, we can look forward to the discoveries of tomorrow. Furthermore, unless experimentation is based on both rational and creative speculation, an investigation drops to the level of “bung another newt in the cauldron, dearie.” However, we should not forget that the end of experimentation is to be able to carry out newer and better processes that will be judged in financial terms. A danger in any R & D organization-consequent to some extent upon the basic university training of its members-is to be concerned with proving a particular point regardless. That is, trying to show oneself, as an expert, to be backing the right theory so hard that it blinds one to obvious opportunities, such as introducing arbitrary changes. Such blindness leads to doing experiments in the head rather than on the plant. And, finally, it leaves no room for serendipity. So, having expanded upon the kinds of use we may make of processed information, let us proceed to a study of the various ways of storing and promulgating information. The examples will be drawn as usual from the field of research and development in the pharmaceutical fermentation industry. The types of work involved are experimental process development, strain improvement (applied genetics), analytical methodology, and backup work of an explorative nature (biochemistry, microbiology, enzymology, molecular biology, etc.). As indicated above, I shall describe the various forms of storing and processing information. These descriptions will give a concrete basis for discussion of the jobs they are intended to do and their effectiveness in doing them. I shall not be able to dot every i and cross each t, because each R & D organization is different from every other. Differences of topic, managerial style, the areas of search, the state of particular projects and their previous
INFORMATION CONTROL IN FERMENTATION DEVELOPMENT
133
histories, the kind of staff and their collective expertise, the Company mores, all introduce their quota of variety into the decision-makingbetween alternative informational forms. I do, however, hope to give a picture of what is available. Especially I want to bring out the necessary differencm in form and content of each device and its appropriateness in satisfying particular needs.
II. Research and Development Budget This document may be produced by the appropriate Manager of Hesearch or of Development or both. It is a statement of what products are in need of development, how much improvement can reasonably be expected, and how much return on expenditure this is likely to yield. The computations are based on statements from the Production Management and the likely outcome of work in progress. The principal factor is, however, the existing commitments of the plant. The more cash flow there is from a product, the more development may have to be done on it. This viewpoint is modified with new and experimental products or when marketing information clearly indicates that a lowering of price can affect the market situation to an exceptional degree. The R & D plans for the year are finally decided upon by the Development and the Production Directors together. By and large, the budget concerns itself only with the broadest elements of control. The ways in which the money available to each product is spent are generally left to the discretion of the Development Manager, who is, in the short term, limited by his resources and staf€. The budget is completed by a construction and maintenance statementthis, according to custom, in my Company is a part of the factory annual budget. The statement explains, however, what money is available for new equipment and how this will be spent. Ill. Project Initiation Request (Research or Development Program)
This brings us down to practical work-to the particular deployment of effort as opposed to the general long-term strategy of the R & D Budget. The request document is produced before work may begin in a particular area. It sets out the aims of the investigation in a concrete way. These aims should not be diffuse but, rather, have a well defined and limited prior objective. The objective should be reflected in the title, which must not be too catholic. The document then states what is to be done, what knowledge and theory exist currently, the benefits likely to accrue from the work, criteria of pro-
134
D. J. D. HOCKENHULL
gress, the expected duration of the investigation, and the cost in terms of time, manpower, and equipment. It sets dates for review and for interim reports of the project. As an example, we may take such a title as “Investigation of the possibility of applying continuous carbohydrate feeding to the production of penicillin.. . .” The benefits likely to accrue follow fiom the possibility of using cheaper carbohydrates, like sucrose and glucose, instead of the expensive lactose, which was in use at the time that project was initiated. Further benefits which might also accrue include the possibility of carrying on extended fermentations (hitherto limited by the top level of lactose that could be included before inoculation) and by the use of less pure, cheaper sugar sources, such as crude starch hydrolyzate. Special equipment might be needed for sterile additions of nutrient, and the designing of this might have to be included in the project. Some idea might be obtained as to the financial return on some of the process changes possible, and that, in turn, would affect the size of the project. On this particular project a good deal of background knowledge would, in fact, already exist. Hypotheses would have been made and discussed in the literature as to how lactose was assimilated and used. There would aIso be some knowledge of continuous fermentation techniques. Theoretical concepts of the relationship between growth and product formation between primary and secondary metabolism would also be useful if they existed at the time. (Of course, the example is “made up.” The history of this project is that it actually started in a University laboratory in Wisconsin, and its development took place piecemeal through the industry over a number of years. But the example should nevertheless have utility.) Such a document, if well drafted, is of great value. It is particularly so to its originator. It keeps him to the point. He does not dissipate his energies by too frequent a change of line. It gives him a yardstick by which to measure his progress, and it gives him objectives to meet. It is also useful to the R & D manager (and, to a great extent, to the director above him). It enables them to manage the work. In particular, the manager has a useful means of assessing what is to be expected from his team and whether he has available the right kind of skills and equipment. Frequent informal review is ensured and attention is drawn to current difficulties. Thus the manager is put in a better position to allocate his resources to the various projects he has running. Such formal programming is useful in relating each branch of activity to the general departmental budget. It is also useful in establishing a common understanding with the production units so that they are aware of what kind of developments to expect in the future and are advised of how “their” money is being spent.
INFORMATION CONTROL IN FERMENTATION DEVELOPMENT
135
All formalizing procedures have dangers. Experimental plans may be followed too inflexibly. This can lead to overperseverance with unsuccessful techniques. It may cause the suppression of a promising “lead on grounds of irrelevance (although it could equally result in setting up that “lead with a project of its own). On the other hand, a definite plan of campaign enables one to stand off and look at it from time to time with a cold, critical eye. The circulation of such a document is important. On the one hand, it should be distributed widely enough to bring in the maximum of technical support. On the other hand, the list should be selective enough to omit carping and negative busybodies. Programs designed to help with particular plant problems, as, for example, the feasibility of using a cheaper grade of ingredient, the development of more uniformly behaving inocula, the testing of improved strains of microorganisms, or the development of prototype equipment, all gain by discussion with the plant managers. Such talks will be more valuable at the drafting stage and, even more so, later when financial and technical help has to be asked for. On the other hand, the selfsame individuals might be obstructive to a project if they thought that it was too theoretical and “way out. ” The project initiation request might then be the wrong way to sell them on the line of work chosen. In sum, the initiation procedure is useful in setting aims and methods. It must be used with a light hand, or it will restrict the emergence of novelty. It ensures the regular review of subprojects. It should abort frustrations and unprofitable areas of endeavor. It enables work to be coordinated inside the R & D Department and in contiguous areas such as the Company’s “Research Institute” or the production units. Finally, the Project Initiation, or whatever it is decided to call it, needs to be a formal document with a standard format. In fact, some companies using this technique provide specially printed manuscript paper to help maintain uniformity. The most important point is that the case shall be well presented. The